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Abstract 
In this project, a wide range of cyclic imines and cyclopropenones were synthesised to form 
highly fuctionalised heterocyclic products via a formal [3+2]-cycloaddition reaction. The 
synthesis of pyridines (II) will be described in this thesis and was achieved by heating 
azabicyclo[3.2.0]hept-2-en-4-ones (I) that were obtained from the reaction of 4-membered 
ring cyclic imines with cyclopropenones via a formal [3+2]-cycloaddition reaction. Some of 
the 1-azetines (R = naphth) underwent an unexpected ring expansion to give the 
alkylsulfanylbenzo[f] isoquinolines (III). 1,2,4-Oxadiazoles (VI)  have been synthesised from 
a 4-aryl-3,3-difluoro-1-azetine via the formation of the nitrile oxide cycloadduct (V). The 
reactivity of 4-aryl-3,3-difluoro-1-azetine towards cyclopropenones to try to form (VII) will 
also be discussed. Homotropane related heterocycle (IV) was obtained when a 4-vinyl-1-
azetine was treated with diphenylcyclopropenone. 
 
The use of 5- and 6-membered cyclic imines for the synthesis of pyrrolo-fused heterocycles 
(VIII) i.e. pyrrolizidines, indolizidines, pyrrolo-isoquinolines and pyrrolo-β-carbolines which 
 5 
 
are widespread in natural products and medicinal chemistry is also discussed. The reactivity 
of cyclopropenones with azides is also discussed, via conversion into iminophosphoranes 
followed by aza-Wittig reaction to give products (IX) and (X). 
 
Finally, a methodology has been developed for the catalytic coupling reactions of amidoxime 
and alcohol substrates using cyclopropenones. A series of alkyl bromides (XI) and novel 
1,2,4-oxadiazoles (XII) has been synthesised with the involvement of 
diphenylcyclopropenone as a catalyst. These 1,2,4-oxadiazoles are important due to their roles 
in drug discovery and as ligands in supramolecular chemistry. 
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1.1. Chemistry and biological roles of cyclopropenones 
The first synthesis of a cyclopropenone was reported by Breslow et al.
1 
and then Volpin and 
his co-workers,
2
 both in 1959. After that, cyclopropenones attracted significant attention 
among organic chemists due to their exceptional electronic and structural properties.
3
 The 
aromatic behaviour of cyclopropenone according to Hückel’s rule,4 means that the derivatives 
of cyclopropenone have derived a special attention in the world of organic synthesis. The 
delocalisation of π-electrons on the oxygen atom of carbonyl functional group makes the 
oxygen atom more electronegative than ordinary carbonyl compounds (Figure 1.1).
5
  
 
Figure 1.1: Stability of cyclopropenone. 
Cyclopropenones are amphiphilic molecules so that electrophilic reagents attack the electron-
rich O-atom of the C=O group, and nucleophilic reagents react readily with carbonium ion of 
the three-membered carbocycle to give a wide range of organic reactions.
3-5
 Also, 
cyclopropenones have a large ring strain,
6
 which allows cycloaddition reactions and 
transformations such as ring opening
7
 and ring enlargement.
8
 Cyclopropenones can also be 
used as building blocks for the construction of biologically active compounds,
9
 and as 
catalysts.
10 
The cyclopropenone ring has been found in naturally occuring compounds such as 
antibiotic penitricin 3 which was isolated from the culture filtrate of penicillium aculeatum 
and it was found to show anti-Gram-negative activity,
11
 and its derivatives 4 & 5.
12
  
 
Figure 1.2: Naturally occurring derivatives of cyclopropenone. 
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Later on, penitricin 3 and its derivatives 6, 7 were synthesised and showed significant 
antibacterial activity
13
 whereas derivative 8 showed inhibitory activity against XIIIa factor.
14 
 
Figure 1.3: Synthesised derivatives of cyclopropenone. 
Cohen et
 
al.
 
have described that the synthetic peptidyl cyclopropenone 9
15
 behaves as an 
irreversible covalent inhibitor of a cysteine protease, alkylating the catalytic cysteine of 
papain. They also reported that it could be used as an alternative substrate for the enzyme. 
 
Figure 1.4: Structure of peptidyl cyclopropenone.
 
1.2. Cyclopropenones as catalysts 
Nucleophilic substitution reactions of alcohols and their derivatives are important 
transformations in organic chemistry.
16
 The Mitsunobu reaction
17
 has become a key method 
for the nucleophilic substitution reactions of alcohols that convert an alcohol into a variety of 
functional groups with inversion of stereochemistry, using triphenylphosphine and an 
azodicarboxylate such as diethyl azodicarboxylate or diisopropyl azodicarboxylate. There are 
some drawbacks in Mitsunobu reaction, including the toxic and explosive nature of 
diazocarboxylate and separation of desired product from triphenylphosphine oxide and 
dicarboxyhydrazine byproducts.
18
 Alternative methods are needed despite the efforts that 
there have been with recent advances in Mitsunobu reaction.
10
 In this regard, Lambert and co-
workers established a strategy for the promotion of dehydration reactions including 
 12 
 
alcohols,
19
 carboxylic acid chlorodehydration,
20 
and the Beckmann rearrangement
21
 based on 
cyclopropenium ions (Figure 1.5).
22
 
 
Figure 1.5: Reactivity of cyclopropenone as a catalyst. 
The treatment of alcohols, carboxylic acids or oximes with cyclopropenone that reacted 
rapidly with an activating reagent to produce cyclopropenium salt as described in Figure 1.5. 
Then, cyclopropenium ion was treated with alcohols, carboxylic acids or oximes to generate a 
cyclopropenium activated intermediate that could undergo the final nucleophilic substitution 
and produce the cyclopropenone as the byproduct,
21
 regenerating the catalyst. The mechanism 
proposed by Lambert and his co-workers for alcohol dehydration is shown in Figure 1.6.
21
 
The cyclopropenone was reacted with oxalyl chloride to produce the 1,1-
dichlorocyclopropene 19 that converted into cyclopropenium chloride salt 20 by ionization. 
After that, this salt was reacted with alcohol substrate 21 to generate protonated 
cyclopropenyl ether 22. The neutral cyclopropene re-ionized to provide the alkoxy 
cyclopropenium salt after deprotonation of cyclopropenyl ether 23. Finally, the nucleophilic 
attack of chloride ion on cyclopropenium salt 24 produced the desired aryl chloride 25 and 
regenerated the catalyst diphenylcyclopropenone 18.
22
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Figure 1.6: Mechanism for the formation of alkyl halide using DPCP as catalyst. 
In 2013, Lambert et al. also developed a strategy for the nucleophilic substitution of alcohols 
using methanesulfonate ion with inversion of configuration in the presence of 
diphenylcyclopropenone as catalyst (Scheme 1.1).
23
  
 
Scheme 1.1: Catalytic reaction of DPCP. 
1.3. Synthesis of cyclopropenones 
There are four main routes for the synthesis cyclopropenones as follows: 
3a
 
(a) Cyclopropene Ketal Route 
 14 
 
(b) Carbene-Insertion Route 
(c) Trichlorocyclopropenylium Ion Route 
(d) Tetrachlorocyclopropene Route 
All four methods involve the hydrolysis of 3,3-disubstituted cyclopropene derivatives to give 
the cyclopropenones.
3a
 The first method (cyclopropene ketal route) to the synthesis of 
diphenylcyclopropenone, reported the reaction of benzyl dichloride 30 with (2,2-
dimethoxyvinyl)benzene 29 in the presence of potassium t-butoxide.
1
 The proposed 
mechanism involved the addition of benzyl dichloride 30 to the double bond of ketene acetal 
29 to give the cyclopropene ketal intermediate 1-chloro-2,3-diphenyl-2,3-diphenyl-3,3-
dimethoxycyclolopropane 31 which converted to intermediate 32 by the β-elimination of HCl 
followed by hydrolysis to give the required diphenylcyclopropenone (DPCP) (Scheme 1.2). 
 
 
Scheme 1.2: Synthesis of DPCP.
 
Similarly, Vol’pin et al.2 synthesised diphenylcyclopropenone by the treatment of 
diphenylacetylene 33 with dibromocarbene which was produced in the reaction mixture by 
the reaction of bromoform 34 with potassium t-butoxide to obtain 3,3-dibromo-1,2-
 15 
 
diphenylcyclopropene 35 as an intermediate which was hydrolysed to give the 
diphenylcyclopropenone (Scheme 1.3). 
 
Scheme 1.3: Preparation of DPCP.
 
West et al.
24 
synthesised a series of symmetrical and unsymmetrical disubstituted 
diarylcyclopropenones 40 and 44 using a trichlorocyclopropenium ion 37 which was 
generated by the reaction of tetrachlorocyclopropene 36 with aluminium chloride (Scheme 
1.4). 
 
Scheme 1.4: Synthesis of symmetrical and unsymmetrical disubstituted 
diarylcyclopropenones.  
Recently, Lambert et al.
21
 prepared the dithioanisylcyclopropenone 46 by the reaction of 
tetrachlorocyclopropene with thioanisole 45 in the presence of aluminium chloride (Scheme 
1.5). 
 16 
 
 
Scheme 1.5: Synthesis of dithioanisylcyclopropenone. 
The mechanism involved in the synthesis of cyclopropenone from tetrachlorocyclopropene by 
the reaction of benzene derivatives with trichlorocyclopropenium occurs via a Friedel-Crafts 
route
25
 and followed by hydrolysis,
26 
as seen in (Figure 1.7). 
 
Figure 1.7: Mechanism for the synthesis of dithioanisylcyclopropenone. 
A modified Favorskii reaction was introduced by Breslow et al.
27 
which involved the ring 
closure of 1,3-dibromo-1,3-diphenypropan-2-one 52,
 
followed by elimination of HBr from 
intermediate 53 caused by reaction with an triethyl amine (Scheme 1.6). 
 17 
 
 
Scheme 1.6: Synthesis of DPCP via Favorskii reaction. 
1.4. Reactivity of diphenylcyclopropenone  
Diphenylcyclopropenone has been shown to react with a wide range of compounds containing 
the C=N moiety, usually to form highly functionalised heterocyclic compounds via a formal 
[3+2] cycloaddition reaction.
28 
This type of reaction is used frequently in this thesis and so is 
briefly reviewed here. 
While investigating the utility of diphenylcyclopropenone for the synthesis of heterocycles, 
Aly and his co-workers have reported the synthesis of pyrrolo[2,1-b]1,3,4-oxadiazoles (58a-e, 
Scheme 1.7).
28c
 They proposed in their mechanism that the diphenylcyclopropenone attaches 
across the C=N double bond of compound 54 via formal [3+2] cycloaddition reaction  to give 
the intermediate 56 which is then followed by aromatisation via cyclisation to form 
intermediate 57 with the loss of hydrogen sulfide giving the oxadiazoles (58a-e).  
Scheme 1.7: Synthesis of pyrrolo[2,1-b]1,3,4-oxadiazoles using DPCP. 
 18 
 
1974, Eicher
5c
 studied the rectivity of diphenylcyclopropenone with acyclic imines to give the 
pyrrolidinone products 63 via a formal [3+2] cycloaddition reaction. The mechanism for this 
reaction as shown below in Scheme 1.8.  
 
Scheme 1.8: Reactivity of DPCP with acyclic imine. 
After this Eicher,
5d
 Heimgartner,
5g
 Yoshida
5f
 and smalley and Hemming
5k
 have further 
explored the reactivity of diphenylcyclopropenone with cyclic imines such as 64, 66 and 68 to 
give the pyrrolidinone ring containing products 65, 67 and 69 via a formal [3+2] 
cycloaddition reaction as shown in Scheme 1.9. 
 
Scheme 1.9. A formal [3+2]-cycloaddition reaction of DPCP with cyclic imines. 
 19 
 
The Hemming group continued earlier work in the field and has investigated the reactions of 
diphenylcyclopropenone with 4-, 5-, and 6-, membered ring cyclic imines 71 to give the 
pyrrolizidines, indolizidines and pyrroloazepines 72 (Scheme 1.10).
29 
One of the aims of this 
thesis was to extend this work to get some pyrrolizidines, indolizidine, pyrroloazepine and 
other heterocyclic pyrrolo natural product core structures.  
 
Scheme 1.10: Synthesis of heterocyclic pyrrolo natural compounds. 
1.5. Importance of pyrrolizidine, indolizidine and pyrroloazepine alkaloids  
Polyhydroxylated pyrrolizidines, such as hyacinthacine A1/A2
30-31
 (73a-b) and hyacinthacines 
B1/B2
32
 (74a-b) (Figure 1.8)
28b
 are important in biological studies where they have gained 
attention as glycosidase inhibitors. Glycosidases play vital roles in different kinds of diseases, 
for example, in various cancers, diabetes and viral infections such as AIDS.
33 
Also, there are 
non-polyhydroxylated pyrrolizidines, such as jenamidines 75, which inhibit leukaemia cell 
lines at clinically useful levels.
34
 
Naturally occurring indolizidine alkaloids, such as indolizidine 223AB
 
76, are secreted by the 
skin of the frog species dendrobatidae.
35
 These kinds of compounds have gained attention as 
inhibitors of nicotinic receptor-channels and as potential leads in the search for treatments for 
Alzheimer’s disease and other neurological disorders.36 Polyhydroxylated indolizidine 
heterocycles,
 
for example swainsonine 77, are interesting as glycosidase inhibitors, 
antitumour,
 
 antiviral, immunoregulatory, and antidiabetic agents.
37 
The pyrroloazepine 
nucleus is present in the stemona alkaloids, for example, stenoamide 78, which have been 
used as treatments for a range of respiratory diseases.
28b 
 20 
 
 
Figure 1.8: Heterocyclic pyrrolo natural compounds.
 
1.6. Pyrrolo-isoquinoline alkaloids 
Due to the presence of isoquinoline and tetrahydroisoquinoline heterocycles as a basic unit in 
a wide range of naturally occurring alkaloids, these compounds have got considerable 
attention in the field of biological science.
38
 For example, nuevamine
39 
79, is a naturally 
occurring alkaloid which was isolated from Berberis darwinii Hook. 
 
In 1968, Kapadia et al.
40
 were the first that isolated pyrroloisoquinoline alkaloids such as 
peyoglutam 80 and mescalotam 81 from the peyote cactus. 
 21 
 
 
Wang and co-workers isolated the tricyclic lactam trolline alkaloid 82 from Trollius 
chinensis.
41
 
 
Trolline alkaloids showed antibacterial activity against respiratory bacteria such as Klebsiella 
pneumoniae, Staphylococcus aureus, Staphylococcus pneumonia and also found reasonable 
antiviral activity against influenza viruses A and B.
41b 
Zhang and co-workers in 2002, isolated two isoquinoline alkaloids crispine A 83 and crispine 
B 84 during photochemical studies of the plant carduus crispus
42 
and these compounds have 
showed antitumor properties.
43
 
 
In 2011, M. Miyazaki et al.
44
 synthesised enantiopure Crispine A using 6,7-dimethoxy-3,4-
dihydroisoquinoline 85 as a starting material (Scheme 1.11).
 
 22 
 
 
Scheme 1.11: Synthesis of isoquinoline alkaloids.
 
In 2012, L.Moreno et al. synthesised the pyrrolo[2,1-a]isoquinolin-3-one alkaloid 92 which 
has potential as an antimicrobial agent (Scheme 1.12).
45 
 23 
 
 
Scheme 1.12: Synthesis of pyrrolo-isoquinoline derivatives. 
1.7. Pyridines 
As well as pyrrolo-based natural products, this thesis will also describe and build upon a new 
pyridine synthesis that was developed in the group. Pyridines are basic heterocyclic 
compounds which are structurally similar to benzene ring containing compounds, where one 
CH group of the benzene ring is replaced with a nitrogen atom (see, for example, compounds 
100, 101 and 102).
46 
 
 24 
 
 
Figure 1.9: Pyridine and its derivatives.
 
1.7.1. Biological roles of pyridines 
The derivatives of pyridine play a vital role in biological chemistry
47 
due to their applications 
in the pharmaceutical industry, agrochemical industry, natural product chemistry, and as well 
in materials science.
48
 Many enzymes use the pyridine nucleotide (NADP) 105 in living 
organisms where it has significant importance in oxidation-reduction processes.
49
 Naturally 
occurring pyridine alkaloids include epibatidine 103 which was isolated from the skin of the 
Ecuadorian frog Epibatidores tricolor and is a potent analgesic,
50
 and nicotine 104 which is 
well known as  the major active component of tobacco (Figure 1.10).
46,50-51
 Pyridoxine 
(vitamin B6) 102 plays a key role in the production of red blood cells. 
 25 
 
 
Figure 1.10: Pyridine natural products.
 
The synthetic derivatives of pyridine are playing vital roles as therapeutic agents. For 
example, pyridoxime 106 as an antidote for poisoning by organophosphates, sulphapyridine 
107 is an antibacterial agent, A3 adenosine receptor antagonist 108 is an antiinflammatory and 
antiasthmatic agent, 5- HT1A receptor agonist 109 is an antidepressant agent, and the 
endothelin pyridine derivative 110 designed for the treatment of pain, inflammation, asthma, 
hypotension, heart failure and hypertension (Figure 1.11).
46, 52-55
 
 26 
 
 
Figure 1.11: Pyridine drugs in the pharmaceutical industry.
46, 52-55 
The derivatives of pyridine are also utilized as herbicides, fungicides and bactericides that 
have significant importance in the field of agriculture (Figure 1.12).
46, 55-57
 
 
Figure 1.12: Pyridine derivatives in the field of agrochemicals.
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1.7.2. Synthesis of pyridines 
Anderson was isolated the pyridine base from bone oil but the correct structure of pyridine 
was not proposed until 1869.
58-59
 Condensation methods have become the most common way 
to synthesise many pyridines by the reaction of amines with carbonyl compounds. Other 
methods for the preparation of the pyridine core are defined by the number of atoms in each 
fragment contributing to the pyridine ring,
 
as shown in (Figure 1.13).
46
 
 
Figure 1.13: Approaches for preparations of pyridine cores. 
Ammonia (NH3) is the most used nitrogen source for the synthesis of many pyridines,
60 
including [5+1] condensation with 1,5-dicarbonyl compounds, as shown in (Scheme 1.13).
61
 
 
Scheme 1.13: Synthesis of pyridine via [5+1] condensation. 
In 1882, Hantzsch introduced a [2+2+1+1] condensation method for the synthesis of the 
pyridine core,
 
where ammonia is also used as a source of nitrogen. Symmetrical pyridines 
were synthesised by this methodology in which ammonia reacted with formaldehyde 126 and 
 28 
 
two equivalents of ethyl 3-oxobutanoate 125 to give the target pyridine 129 after 
aromatisation of the isolable intermediate dihydropyridine 128 (Scheme 1.14).
62
 
 
Scheme 1.14: Synthesis of pyridine via Hantzsch method.
 
The [3+3] condensation process has become useful to synthesise unsymmetrical pyridines 
from starting materials that are easily available (Scheme 1.15).
63
 
 
Scheme 1.15: Synthesis of pyridine via [3+3] condensation process. 
Amongst all the preparative approaches for pyridine cores, the [3+2+1] approach is the most 
frequently used. In 1999, Katritzky et al.
 
prepared tri-substituted pyridines in good yields 
using [3+2+1] approach by the reaction of α-benzotriazolyl ketone 134 with α,β-unsaturated 
compound 133 to construct a 1,5-dicarbonyl intermediate 136 which finally gave the target 
pyridine 138 via aromatization of intermediate amide 137 via lost of benzotriazole (BtH) 
(Scheme 1.16).
64
 
 29 
 
 
Scheme 1.16: Synthesis of triphenylpyridine via [3+2+1] approach. 
Methods that do not rely on a cycloaddition process for the preparation of pyridines are of 
particular interest in the thesis. Such a reaction was developed by Kondrat’eva and Huan in 
1965 which involved the addition of a dienophile to an oxazole 139 where the subsequent 
extrusion of H2O gives the substituted pyridine (Scheme 1.17).
65
 
 
Scheme 1.17: Synthesis of pyridine via oxazole. 
In 2010, D. Coffinier et al.
66
 has studied a new cycloaddition approach using azoenamines 
with acetylenedicarboxylates. The synthesis of the pyridine started by the reaction of the keto 
hydrazone 143 with pyrrolidine 144 as starting materials in toluene to form azoenamine 145 
in quantitative yields. Addition of DIPEA and then treatment of compound 145 with diethyl 
acetylenedicarboxylate 146 gave dihydropyridine 149 which then formed the desired pyridine 
compound 150 via loss of aniline (Scheme 1.18). 
 30 
 
 
Scheme 1.18: Synthesis of subsituted pyridine from azoenamine. 
In 2008, Barluenga et at.
67
 described the first example of a catalysed intermolecular hetero-
dehydro-Diels-Alder reaction that occurs between dienyne 151 and nitrile 152 in the presence 
of a gold catalyst. The mechanism of this reaction involved intermediate 153 through 
coordination between gold and the triple bond of the 1,3-diene-5-yne which converted into 
154 due to resonance. Complex 154 was reacted with benzonitrile giving the species 155 due 
to regioselective nucleophile attack of the nitrile. The intermediate 155 resonates to 156 and 
 31 
 
then into 157 followed by rearrangement that led to the formation of dihydropyridine 158 
which then decomplexes to give the target pyridine 159 (Scheme 1.19).
67
 
 
Scheme 1.19: Synthesis of tetra-substituted pyridine. 
In 2011, Hemming et al. developed a strategy for the synthesis of pyridines 162 (Scheme 
1.29)
8
 via a [2+2]-cycloreversion of the adduct 161 obtained from the reaction between 4-
aryl-1-azetine 160 and readily available diphenylcyclopropenone 18. This process will be 
discussed in more detail later as it forms part of the discussion of this thesis. 
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Scheme 1.20: Synthesis of pyridines from cycloadducts. 
1.8. The Staudinger-aza-Wittig reaction 
The aza-Wittig reaction has become a useful tool for the synthesis of heterocyclic compounds 
containing C=N double bonds.
68
 The aza-Wittig reaction is used for the synthesis of cyclic 
imines by the reaction of iminophosphoranes 163 with carbonyl compounds to construct C=N 
double bond under mild reaction conditions (Scheme 1.21).
69 
Later in this thesis the 
construction of C=N via this route is used to produce cyclic imines for cyclopropenone 
additions and is also explored with cyclopropenone as the ketones 164.
 
 
Scheme 1.21: The aza-Wittig reaction. 
The first synthesis of an iminophosphorane 163 was reported by Staudinger in 1919 by the 
reaction of triphenylphosphine with an alkyl azide.
70 
These iminophosphoranes
71
 are used as 
reagents and intermediates in organic synthesis,
68
 as precursors for the aza-Wittig reaction and 
for the construction of heterocyclic natural products.
72 
For example, Majumdar et al.
73
 have 
developed a strategy to synthesis piperazine-2,5-dione derivatives via intramolecular aza-
Wittig reaction (Scheme 1.22). The synthesis of piperazine-2,5-dione was carried out by the 
reaction of amino ester 167 with chloroacetyl chloride to give compound 169 which 
converted into 170 with the treatment of sodium azide. The azide group containing compound 
170 was reacted with PPh3 to obtain iminophosphorane 171 which finally cyclised to give the 
1-benzylpiperazine-2,5-dione 172 via intramolecular aza-Wittig reaction (Scheme 1.21).
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Scheme 1.22: Synthesis of piperazine-2,5-dione derivatives via intramolecular aza-Wittig 
reaction.
 
The piperazine-2,5-diones are important due to the presence of this ring in natural products
74 
with biological activities
75
 such as antiviral,
76
 antifungal,
77
 antitumour,
78
 antithrombic
79 
and 
antibacterial.
80 
In 2015, Zhong et al.
81
 developed a methodology to synthesis 2-acylquinazolines and 3H-1,4-
benzodiazepine-3-ones via Ugi 4C/Staudinger/aza-Wittig reaction (Scheme 1.23).
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Scheme 1.23: Synthesis of 2-acylquinazolines and 3H-1,4-benzodiazepine-3-ones via Ugi 
4C/Staudinger/aza-Wittig reaction.
 
In this synthesis, the reaction of 4-chloroaniline or tert-butylamine 176 with 
azidobenzaldehyde 177 gives an intermediate that was converted to Ugi 4C product 178 or 
179 respectively with the treatment of n-butyl isocyanide 174 and benzoylformic acid 175. 
The azide-containing compound 178 or 179  was reacted with PPh3 in toluene and heated for 
2 h to give the intermediate iminophosphorane 180 or 181 which was further heated and 
transformed into the corresponding dihydro-quinazoline 182 and 3H-1, 4-benzodiazepine-3-
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ones 183 (Scheme 1.23), that are interesting in medical science due to their biological 
activities.
81-82  
1.9. 1,2,4-Oxadiazoles 
Another heterocycle of interest in this thesis (see discussion) is the 1,2,4-oxadiazole. 
Oxadiazoles represent an important class of five-membered heterocycles, and exist in three 
different regioisomeric forms as 1,2,4-oxadiazole 184, 1,2,5-oxadiazole 185 and 1,3,4-
oxadiazole 186 which contain two nitrogen atoms, two carbon atoms and one oxygen atom.
83
 
 
1.9.1. Medicinal roles for 1,2,4-oxadoazoles 
1,2,4-Oxadiazoles are often used as an amide or ester bioisostere, and they are well known in 
medicinal chemistry.
84-96 
These oxadiazoles have different biological activities such as 
anticancer,
85
 anti-inflammatory,
86
 immunosuppressive,
87 
antidiabetic,
88 
antimicrobial and 
antioxidant,
89
 antihyperglycemic,
90
 antitrypanosomal
91
, anti-HIV agents
92 and Alzheimer’s 
disease,
93
 some examples of which are shown in (Figure 1.14). 
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Figure 1.14: Importance of 1,2,4-oxadiazoles. 
Derivatives of 1,2,4-oxadiazoles are also useful for DNA interaction
97
 and inhibiting bacterial 
infections.
98
 They also play an important role in materials chemistry, such as polymers,
99
 
liquid crystals,
100
 luminescent materials
101
 and corrosion inhibitors.
102
 1,2,4-Oxadiazole ring 
containing compounds also show interesting fungicidal and larvicidal properties.
103 
There are 
also several drug molecules (Figure 1.15),
 
where the 1,2,4-oxadiazole is the main component, 
for example, antitussive drugs such as perebron 191 and Libexin 192, the serotonin agonist 
193 which is used for treatment of migraine, and L-690548, 194, for Alzheimer’s disease.104 
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Figure 1.15: Drugs of 1,2,4-oxadiazoles. 
Recently, Carbone and his colleagues
105
 have isolated two indole alkaloids, Phidianidines A 
195a and B 195b from the marine opithobranch mollusc phidiana militaris that contain the 
1,2,4-oxadiazole as the basic core unit, the first natural products with a 1,2,4-oxadiazole ring. 
 
They also described that phidianidines 195a & 195b showed high cytotoxicity against both 
high proliferating tumour cells and embryonic cells such as fibroblasts and myoblasts in in 
vitro assays. 
1.9.2. Synthetic methods for 1,2,4-oxadiazoles  
There are two common routes amongst the known methodologies for the synthesis of 1,2,4-
oxadiazoles. 
i) 1,3-dipolar cycloaddition methodology 
ii) Amidoxime methodology 
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In the first methodology, the nitrile 196 undergoes a 1,3-dipolar cycloaddition with the 
nitrile oxide 197 to obtain the required 1,2,4-oxadiazoles 198 depending upon the 
substitution groups of nitrile and nitrile oxide. In the second route, the 1,2,4-oxadiazoles 
201 are obtained by reactions of different carboxylic acid derivatives with amidoximes 
199 which are easily synthesised from nitriles 196 by the reaction of these with 
hydroxylamine hydrochloride (Scheme 1.24).
99
 
 
Scheme 1.24: Synthesis of 1,2,4-oxadiazoles. 
In 2013,
 
the Hemming group synthesised a series of 1,2,4-oxadiazoles using 1,3-dipolar 
cycloadditions between 1-azetines and nitrile oxides.
 
They used different substituted 4-
membered ring cyclic imines 202 with nitrile oxides to give the corresponding cycloaddition 
products which were heated in toluene to obtain the 1,2,4-oxadiazoles 205 using [2+2]-
cycloreversion of intermediate 204 in good yields (Scheme 1.25).
106
 
 
Scheme 1.25: Synthesis of 1,2,4-oxadiazoles. 
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In 2014, Y. Wang et al.
107
 synthesised 1,2,4-oxadiazole (212, Scheme 1.26) as a novel gpr119 
agonist that is a class of human G protein-coupled receptor. The compound 212 was made by 
treatment of tetrahydroquinoline-7-ol 208 with 2,6-dichloropyridin-4-yl)-1,2,4-oxadiazole 
211. The oxadiazole 211 was obtained from isonicotinoyl chloride 209 and amidoxime 210 
(Scheme 1.26). 
 
Scheme 1.26: Synthesis of 1,2,4-oxadiazole ring containing heterocyclic compound. 
In 2015, C. S. Jiang et al.
108
 synthesised a series of indole-based 1,2,4-oxadiazole derivatives 
and assayed them for neuroprotective effects against Aβ25-35, hydrogen peroxide and oxygen-
glucose deprivation-induced neurotoxicity in SH-SY5Y cells, Scheme 1.27 shows the 
synthesis. 
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Scheme 1.27: Synthesis of indole-base-1,2,4-oxadiazoles. 
The work started with the preparation of 1,2,4-oxadiazoles 220 and 222 by the reaction of 
commercially available 5-bromo-2-furaldehyde 213 with hydroxylamine hydrochloride in 
ethanol to give aldoxime 214 in good yield (90 %) which was then converted into the required 
nitrile compound 215 using dichloro(p-cymene)ruthenium(II) dimer. The synthesis was 
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continued by addition of hydroxylamine hydrochloride to nitrile 215 to obtain the amidoxime 
intermediate 216 and after that the compound 216 was treated with indole-3-acetic acid 217 to 
give the key intermediate 1,2,4-oxadiazole 218. Finally, oxadiazole intermediate 218 was 
reacted with different boronic acid pinacol esters 219 and 221 to give the targeted novel 
indole-based 1,2,4-oxadiazoles 220 and 222 derivatives as neuroprotective agents (Scheme 
1.25), based upon the marine-derived natural products 195a and 195b (please see above on p. 
37). 
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Chapter 2 
 
Results and discussion 
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2.1. Aims of the discussion 
The first aim of this research was to use cyclopropenones in organic synthesis as shown 
below (Figure 2.1). The synthesis of cyclopropenones and cyclic imines will also be 
discussed, along with a discussion of how these species react together. 
 
 
Figure 2.1: Roles of cyclopropenone in organic synthesis. 
The imines used include rings that give access to pyrrrolo-β-carbolines and pyrrolo-
isoquinolines. The imines used also include 1-azetines and it will be shown that these 
reactions gave rise to a range of products including pyridines, benzoisoquinolines, 7-
azabicyclo[4.2.1]nonanes and 1,2,4 oxadiazoles. Figure 2.2 summarises the general process 
to be explored. 
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Figure 2.2: Reactivity of cyclic imine with cyclopropenone. 
The next aim of this research (Figure 2.3) was to use cyclopropenones such as 
diphenylcyclopropenone as a catalyst for the bromination of alcohols to give bromides 227 
and for the coupling of amidoximes 228 with carboxylic acids 229 for the synthesis of a series 
of 1,2,4-oxadiazoles 230. 
 
Figure 2.3: DPCP as catalyst. 
The reaction of cyclopropenones was also explored with azides via conversion of the azides 
into iminophosphoranes 231 followed by aza-Wittig reaction with the cyclopropenone.  
 
Scheme 2.4: Aza-Wittig reaction of cyclopropenones. 
Finally, the synthesis of the natural product 3-O-[(E)-(2-oxo-4-(p-tolyl)but-3-en-1-yl] 
kaempferol 236 will be discussed. 
 45 
 
 
Figure 2.5: Synthesis and purification of natural product. 
2.2. Synthesis of cyclopropenones 
The initial reactions undertaken here involved the synthesis of dianisylcyclopropenone 
(DACP) 237 and ditolylcyclopropenone (DTCP) 241 following the published literature.
23, 109
 
The dianisylcyclopropenone 237 (Scheme 2.1) was synthesised by treating 
tetrachlorocyclopropene with anisole in the presence of aluminium chloride in 
dichloromethane. The required compound 237 was obtained in 51 % yield.   
 
Scheme 2.1: Synthesis of dianisylcyclopropenone. 
The structure of required cyclopropenone 237 was assigned by 
1
H, 
13
C, DEPT-135, COSY 
and IR spectroscopy. The spectral data collected for compound 237 matched those reported in 
the literature.
23
 The 
1
H NMR spectrum recorded for cyclopropenone 237 showed four 
aromatic protons at 7.94 ppm as a doublet with coupling constant (J = 8.6 Hz) and the other 
four aromatic protons at 7.08 ppm with coupling constant (J = 8.6 Hz) whilst the singlet peak 
at 3.93 ppm represented the methoxy groups and confirmed the formation of 
dianisylcyclopropenone 237. IR spectroscopy also showed an absorbance peak at 1842 cm
-1
 
for C=O group which furthur helped to assign the structure of cyclopropenone. 
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The synthesis of ditolylcyclopropenone 241 started from p-tolylacetic acid as a starting 
material. Following a procedure by Lambert et al,
109
 p-tolylacetic acid was reacted with N,N′-
dicyclohexylcarbodiimide in the presence of 4-(dimethylamino)pyridine to give the required 
diaryl ketone 239 in 32 % yield. The compound 239 was treated with bromine solution in 
acetic acid to give the 1,3-dibromo-1,3-di-p-tolylpropan-2-one 240. After that, the 
dibromoketone 240 was treated with triethylamine to obtain the desired cyclopropenone  
(241, Scheme 2.2). 
 
Scheme 2.2: Synthesis of ditolylcyclopropenone. 
The proton and carbon spectra obtained for compounds 239 and 240 matched those already 
reported in the literature.
110
 The 
1
H NMR spectrum obtained for 241 showed four aromatic 
protons at 7.89 ppm as a doublet with (J = 8.1 Hz) and the other four aromatic protons at 7.40 
ppm with coupling constant (J = 8.1 Hz) whilst the singlet signal at 2.49 ppm represented the 
methyl groups. The IR spectrum for compound 241 showed an absorbance peak at 1831 cm
-1
 
for C=O group which confirmed the synthesis of ditolylcyclopropenone.  
2.3. Diphenylcyclopropenone (DPCP) as catalyst  
Lambert and co-workers have reported the catalytic synthesis of alkyl chlorides from alcohols 
using cyclopropenones as catalysts in the presence of activating reagent oxalyl chloride.
109 
Denton et al.
10
 also developed a method for the chlorination and bromination of alcohols 
under catalytic Appel conditions but there was a limitation caused by triphenylphosphine 
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oxide due to the problematic purification of desired product from it. To overcome this 
drawback, we aimed to combine these two processes in order to design a strategy for the 
catalytic bromination of alcohols using DPCP as catalyst in the presence of an activating 
reagent such as oxalyl chloride and a bromide source. Our findings are summarised in 
Scheme 2.3. 
 
Scheme 2.3: Catalytic bromonation of alcohols using DPCP as catalyst. 
Initially, benzyl alcohol was chosen and a catalytic amount 15 mol % of DPCP and then NaBr 
were added to the reaction mixture before the addition of oxalyl chloride solution in DCM 
over 5 h. The reaction was monitored by TLC but unfortunately it did not give the desired 
results. The reaction was repeated but this time LiBr was used and the reaction was followed 
by TLC. 
1
H NMR analysis of the reaction mixture indicated a mixture of benzyl chloride and 
benzyl bromide. The proportion of benzyl bromide was improved by increasing the amount of 
LiBr but unfortunately the problem of a mixture was still seen. Benzyl bromide and benzyl 
chloride could not be separated due to very similar polarities on the TLC plate and so NMR 
(Figure 2.6 & Figure 2.7) was used for analysis. Finally, the desired product benzyl bromide 
was obtained in pure form by increasing the addition time of the oxalyl chloride in 
dichloromethane over 15 h as shown in Figure 2.6 and Figure 2.7. 
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Figure 2.6: 
1
H spectra for BnCl & BnBr. 
 
Figure 2.7: 
13
C spectra for BnCl & BnBr. 
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This set of conditions was applied to 5 other benzyl alcohols to give the corresponding 
bromide products (227b-f) in good yields as described in Scheme 2.3. It should be noted that 
when the reaction was attempted in the absence of DPCP, no reaction was observed. 15 mol 
% of DPCP was found to be optimal.  
The catalytic processes were also attempted in the presence of LiF instead of LiBr and with 
iodide sources but were unsucessful. Similar work in the Hemming group is underway to get 
the fluoro and iodo products but no further work was done for this thesis. 
2.4. Synthesis of 1,2,4-oxadiazoles 
Due to the importance of 1,2,4-oxadiazoles in the pharmaceutical industries as described in 
the introduction, our laboratory has had a long interest in the synthesis of 1,2,4-oxadiazoles. 
The synthesis of 1,2,4-oxadiazoles from amidoximes 228 and carboxylic acids 229 requires 
activation of the carboxylic acid. We wanted to know if we could use the known DPCP 
catalysed activation of carboxylic acids 229 to allow coupling to amidoximes 228 in order to 
make N-acyl amidoximes 242 and hence 1,2,4-oxadiazoles 230 as shown in Scheme 2.4 
below. In this project we focused on making 1,2,4-oxadiazoles with pyridyl substituent as 
these were proving to be interesting ligands in a collaborative project with a supramolecular 
research group.  
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Scheme 2.4: Synthesis of 1,2,4-oxadiazoles. 
The reaction was started by the treatment of diphenylcyclopropenone (DPCP) with oxalyl 
chloride and then adding a mixture of acid 229 and triethylamine to the reaction mixture
 
and 
then adding amidoxime  228 to the mixture to produce N-acyl amidoximes 242 which were 
furthur heated to reflux overnight in toluene to obtain the desired 1,2,4-oxadiazoles 230a-k in 
good yields.
 
This is shown later in Figure 2.10. Compounds 230a-k were fully characterised 
by NMR and MS. For example, the 
1
H NMR analysis of 1,2,4-oxadiazole 230b (see Figure 
2.8) showed the disappearance of the amide and hydroxyl groups peaks in the recorded 
1
H 
NMR spectrum of N-acyl amidoxime 242b which indicated the formation of the carbon-
oxygen bond of the 1,2,4-oxadiazole by the removal of H2O. The carbon spectrum for target 
compound 1,2,4-oxadiazole showed the CH2 signal at 3.82 ppm and methyl group at 2.35 
ppm. The spectrum also showed 5-quatenary peaks at 179.0, 168.2, 146.3, 137.3 and 130.2 
ppm, respectively and six aromatic CH proton peaks between 150.3 - 123.1 ppm which 
helped to assign the structure of 1,2,4-oxadiazole 230b. 
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Figure 2.8: 
1
H and 
13
C spectra of 1,2,4-oxadiazole. 
The IR spectrum also showed the disappearance of absorbance peaks for hydroxyl group at 
3469 cm
-1
, for amide bond (NH) at 3301 cm
-1
 and for the carbonyl group at 1740 cm
-1
, 
respectively. Finally, MS confirmed the synthesis of 1,2,4-oxadiazole 230b. Similarly, other 
1,2,4-oxadiazoles were characterised as described for the synthesis of 1,2,4-oxadiazole 230b. 
Figure 2.9 shows how the N-acylamidoximes are formed from the carboxylic acid and 
(COCl)2 with DPCP as catalyst. It is found that amidoximes could be coupled to carboxylic 
acids at room temperature by using 1.1 equivalents of (COCl)2 in the presence of 1.0 
equivalent of DPCP. In this process the DPCP reacts with (COCl)2 to form a 1,1-
dichlorocyclopropene and then a cyclopropenium ion with enhanced nucleophilicity. Figure 
2.10 shows an alternative mechanism involving ketene 247. 
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Figure 2.9: Suggested mechanism (A) for the synthesis of N-acyl amidoximes. 
Figure 2.10: Suggested mechanism (B) for the synthesis of N-acyl amidoximes. 
The suggested mechanism
111 
for the synthesis of the 1,2,4-oxadiazole involves the 
dehydration and cyclisation to obtain the desired 1,2,4-oxadiazole
 
as shown in Figure 2.11. 
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Figure 2.11: Suggested mechanism for synthesis of 1,2,4-oxadiazole. 
The synthesis of 1,2,4-oxadiazoles using benzoic acid and its derivatives was attempted but 
unfortunately the desired results were not obtained. This reaction was noted to fail at the first 
step i.e. the amide bond formation between the amidoxime and carboxylic acid. This is 
interesting because it might suggest that the coupling method proceeds via the ketene type 
intermediate (see Figure 2.10) and this is being explored elsewhere in the Hemming group. 
Again, when the acylation of the amidoxime was attempted with no DPCP present, no 
reaction was observed. 
 
 2.5. Synthesis of 1-azetines 
The next part of this work was to look at the reactions of cyclopropenones with imines 
commencing with 1-azetines. The first step towards the synthesis of 1-azetines involved the 
synthesis of 4-aryl-azetidinones. According to a published procedure 
8 
commercially available 
styrene, 2-vinylnaphthalene, 1-vinylnaphthalene and 4-vinylbiphenyl were reacted with 
chlorosulfonyl isocyanate 253 producing the corresponding chlorosulfonyl β-lactams 254 
using a [2+2] cycloaddition approach. After this, the chlorosulfonyl group was removed using 
sodium carbonate and sodium sulfite to give the corresponding 4-aryl-1-azetidine-2-ones 
255a-d. The second step towards synthesis of 1-azetines involved the preparation of 
thiolactams by the reaction of Lawesson’s reagent (LR) with the corresponding lactam in 
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THF. These reaction mixtures were heated at reflux for 2 h to get the required thiolactams 
(256a-d, Scheme 2.5). 
 
Scheme 2.5: Synthesis of 4-aryl-1-azetidines. 
The proposed mechanism
68, 70 
involved in the thionation process is shown below. The ylidic 
intermediate obtained due to the breakage of the sulfur-phosphorus bond during the reflux 
process is the reactive species, and behaves as a sulfur nucleophile towards the lactam 
carbonyl (Figure 2.12). 
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Figure 2.12: Mechanism inovoled for the synthesis of thiolactam. 
The final step in the synthesis of 1-azetines involved the alkylation of thiolactams with 
Meerwein’s reagents (trimethyl or triethyloxonium tetrafluoroborate) in dichloromethane. 
These reaction mixtures were stirred for 1 h at room temperature and then at reflux for 1 h. 
These reaction mixtures were worked up using 50 % aqueous potassium carbonate to give the 
desired 1-azetines 257a-d. 
The proposed mechanism for the synthesis of the 1-azetines involves an attack from the 
thiolactam sulfur to triethyl oxonium tetrafluoroborate due to the presence of electron-pair on 
the nitrogen atom. The carbonate work-up deprotonates the iminium intermediate.
112
 
 
Figure 2.13: Mechanism involved for synthesis of cyclic imines. 
 
All compounds gave consistent spectroscopic data. For example, the 
1
H NMR spectrum 
obtained for phenylazetidinone 255a showed a broad singlet signal for the amide proton at 
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6.15 ppm, a doublet of doublets (J = 5.3 Hz and 2.3 Hz) at 4.75 ppm for the CH proton of the 
1-azetidinone ring and a multiplet of peaks for the phenyl protons between 7.42 - 7.30 ppm. 
The proton peaks for the methylene group of the 1-azetidinone ring appeared as a doublet of 
doublets of doublets (J = 14.9, 5.3 and 2.3 Hz) at 3.47 ppm and a doublet of doublets (J = 
14.9 and 2.3 Hz) at 2.92 ppm. The 
13
C NMR spectrum contained for  phenylazetidinone 255a 
showed a carbon peak for the C=O group at 168.0 ppm, four carbon signals for the phenyl 
ring at 140.2, 128.9, 128.3 and 125.7 ppm, a carbon peak for CH at 50.4 ppm and the carbon 
signal for CH2 at 48.1 ppm, respectively. The 
1
H NMR spectra obtained for 4-aryl-1-azetidin-
2-thiones 256a-d showed a broad singlet signal for the amide proton around 8.19 – 8.52 ppm, 
a doublet of doublets for the CH proton of 1-azetine ring and multiplet peaks for the aromatic 
protons. The signals for the methylene group of the 1-azetine ring showed as a doublet of 
doublets of doublets and a doublet of doublets. The 
13
C NMR spectra recorded for  these 
azetidinthiones 256a-d showed a characteristic signal for the quatenary carbon (S=C) at 204.5 
ppm, signals as expected for the aromatic rings, a carbon peak for CH between 56.5 – 59.1 
ppm and methylene signal between 51.2 – 56.5 ppm. The 1H NMR spectra of 1-azetines 
257a-d showed the disappearance of the amide NH bond and the emergence of proton signals 
for the methyl and ethyl groups in the recorded spectra of 1-azetines 257a-d, which confirmed 
the preparation of these 4-membered cyclic imines. Similarly, In the 
13
C spectra recorded for 
1-azetines 256a-d, the disappearance of the distinctive signal of the quatenary carbon (C=S) 
and the emergence of carbon signals for the carbon atoms of C=N and ethyl or methyl groups 
were diagnostic. 
Interestingly, when 4-ethyllthio-2-(2ʹ-naphthyl)-1-azetine 257c was synthesised from the 
corresponding thiolactam 4-(2ʹ-naphthyl)-1-azetidine-2-thione 256b and left overnight rather 
than used immediately, the 1-azetine was not the isolated product, but underwent 
rearrangement to give the benzoisoquinoline 268a, as shown in Scheme 2.6.  Further 
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investigation of this reaction was carried out and benzoisoquinoline could be isolated in good 
yields (73 %) after storage of the sample of crude. 1-azetine 257c in CDCl3 for one week. It is 
possible that 1-azetine 257c was converted into the benzoquinoline via the vinylic imine 265 
as an intermediate (see Scheme 2.6) using a [2+2] ring opening then 6π-electrocyclisation and 
aromatization by loss of hydrogen.
113
 The structure of benzoisoquinoline 268a was supported 
by NMR spectroscopy and MS spectrometry. 
 
Scheme 2.6: Proposed mechanism for benzoisoquinolines. 
The 1-azetines 257d and 257e behaved in the same manner and gave the benzoisoquinolines 
(268b & 268c-see experimental).  
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The phenyl and biphenyl 1-azetines 257a, 257b and 257f did not form the analogous 
isoquinolines and were noted to be pure when formed from the corresponding thiolactams. 
2.6. Synthesis of cycloadducts with 1-azetines  
The synthesis of cycloadducts 269 proceeded by the reaction of cyclopropenones 1 with 
different 1-azetines 257 in acetonitrile as shown in Scheme 2.7. These reaction mixtures were 
stirred at room temperature for 24 h and gave the desired compounds 269a-f as shown in 
Table 2.1. 
 
Scheme 2.7: Synthesis of cycloadducts. 
Table 2.1: Formation of cycloaddition products 
Entry Product R R
1
/R
2
 X yield (%) 
1 269a Phenyl 4-MeC6H4 Me 65 
2 269b Phenyl 4-MeC6H4 Et 67 
3 269c Phenyl 4-OMeC6H4 Me 42 
4 269d Phenyl 4-OMeC6H4 Et 39 
5 269e Naphthyl 4-MeC6H4 Et 42 
6 269f Naphthyl 4-MeOC6H4 Et 33 
 
The proposed mechanism
28b
 involves the electron donating thioalkyl group stimulating the 
nucleophilic attack from the azetine nitrogen to cyclopropenone 1 to give the intermediate 
270 (Figure 2.14) which then undergoes an intramolecular attack on the electrophilic carbon 
to form the cycloaddition
 
compounds. 
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Figure 2.14: Mechanism for a formal [3+2] cycloaddition reaction. 
The title compounds 269a-f were characterized by NMR and IR analysis and mass 
spectrometry. The 
1
H NMR spectrum obtained for cycloadduct 269a showed a mixture of 
diastereomers. The methyl groups of 269a were observed at 2.31, 2.22, 2.17, 2.11, 2.02 and 
1.97 ppm, respectively which confirmed the mixture of diastereomers. The proton peak for 
the CH of the 4-membered ring of one diastereomer appeared as a multiplet peak between 
5.46 – 5.44 ppm, whilst the proton peak for the CH of the other diastereomer was observed as 
a doublet of doublets at 4.15 ppm. The four methylene proton signals of both diastereomers 
appeared as doublet of doublets at 3.06 ppm, a multiplet peak between 2.93 - 2.83 ppm and a 
doublet of doublets at 2.38 ppm, respectively. The aromatic proton peaks of both 
diastereomers appeared between 7.53 - 6.66 ppm. The 
13
C NMR spectrum recorded for 269a 
showed two carbon signals for the C=O groups at 202.7 and 202.5 ppm for the two 
diastereomers, respectively. The 
13
C spectrum also showed two carbon peaks for the 4-
membered ring CH at 66.4 and 65.9 ppm whereas the carbon peaks for the confirmed CH2 
appeared at 34.5 and 31.2 ppm. The structure of compound 269a was also confirmed with 
mass spectrometry MS (ESI)
+ 
412.2 and consistent HRMS. The IR spectrum recorded for 
269a showed an absorbance peak at 1675 cm
-1
 for C=O group. 
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2.7. Synthesis of pyridines from cycloadducts 
The chemistry of the cycloaddition products 269a-d was explored by heating them at reflux in 
toluene. Pyridines 273a-d were formed in reasonable yields (see Table 2.2) after complete 
consumption of starting materials by indication of TLC (Scheme 2.8). 
 
Scheme 2.8: Synthesis of pyridines. 
The proposed mechanism
8
 involved the formation of a styrene 252a and 
azacyclopentadienone 271 by [2+2] cycloreversion in the first step and then a regioselective 
[4+2] hetero Diels-Alder cycloaddition. The intermediate 272 gave the pyridines 273a-d by 
chelotropic extrusion of carbon monoxide and aromatization via loss of hydrogen.
 
In previous 
work, the aromatic R
1
 & R
2
 groups were limited to phenyl, so this work has extended the 
scope of the reaction, by showing that other diaryl cyclopropenones can react. 
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Table 2.2: Formation of pyridines 
Entry Product R
1
/R
2
 X yield (%) 
1 273a 4-MeC6H4 Me 58 
2 273b 4-MeC6H4 Et 61 
3 273c 4-MeOC6H4 Me 67 
4 273d 4-MeOC6H4 Et 55 
 
The 
1
H NMR spectrum for pyridine 273a showed the disappearance of the carbonyl signals at 
202.7 and 202.5 pm which had been present in the spectrum recorded for cycloadduct 273a 
and the emergence of a pyridine proton as a singlet at 7.09 ppm. In addition, the spectrum 
showed the proton signals of three methyl groups at 2.57, 2.21 and 1.15 ppm, respectively. 
Eight protons of the two substituted aryl groups and five protons of the phenyl group 
appeared between 7.20 – 6.65 ppm and helped confirm the synthesis of the pyridine. The 13C 
spectrum for compound 273a showed the carbon peaks of the three methyl groups at 21.2, 
21.1 and 13.3 ppm, respectively. All aromatic CH and quaternary carbons were also present. 
The structure of compound 273a was confirmed through MS (ESI)
+
 : m/z [M+1] 382.2 and 
consistent HRMS. Similarly, the structural data of the other pyridines 273b-d was consistent 
with the proposed structures. 
2.8. Synthesis of 7-azabicyclo[4.2.1]nonane from a 4-vinyl-1-azetine 
The preparation of a 4-methyl-4-vinyl-1-azetidin-2-one 275 (Scheme 2.9) was the initial step 
for the synthesis of 1-azetine 277. According to a published procedure,
82
 commercially 
available isoprene was reacted with chlorosulfonyl isocyanate producing the chlorosulfonyl β-
lactam 274 via a [2+2] cycloaddition. After this, the chlorosulfonyl group was removed using 
sodium carbonate and sodium sulfite to give the target 4-methyl-4-vinyl-1-azetidin-2-one 275 
which was converted to the thiolactam 276 in the presence of Lawesson’s reagent (LR). The 
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next step involved the alkylation of the thiolactam with trimethyl oxonium tetrafluoroborate 
to give 2-methylthio-4-methyl-4-vinyl-1-azetine 277 which was used for the next step 
(cyclopropenone reaction) without purification. As per previous work in the group with ethyl 
analogue, it is found that this gave cycloadduct 278 which rearranged to  7-
azabicyclo[4.2.1]nonane 279, as a  result  of  an  aza-Cope  [3,3]-sigmatropic  rearrangement. 
The reaction confirmed previous work in the group,
28a
 provided another example and gave 
some material whose chemistry could be explored, unfortunately compound 279 was formed 
to be unreactive (i.e. stable to heat & not convertable to 280 by Wittig reaction).  
  
Scheme 2.9: Synthesis and suggested mechanism for the synthesis of 279. 
The 
1
H NMR spectrum obtained for compound 279 showed signals for the four protons of the 
two methylene groups at 3.04, 2.90, 2.71 and 2.56 ppm and one signal at 5.32 ppm for CH of 
the alkene. The 
1
H NMR spectrum also showed two peaks for the methyl groups at 2.03 and 
1.65 ppm, respectively. The aromatic protons were observed between 7.57 - 7.06 ppm. The 
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number of carbons found in the 
13
C NMR spectrum for compound 279 also matched with the 
structure.
 
2.9. Synthesis of F-containing cycloadducts and 1,2,4-oxadiazoles from a fluorinated 1-
azetine 
In order to see if fluorinated adducts of 1-azetines could behave in the same way as 1-azetines 
257a-f, a fluorinated 1-azetine was made. We hoped this would help us to further understand 
the pyridine mechanism suggested in Scheme 2.8 above. Following a procedure adopted by 
Marcotte et al,
114
 imine 281 was treated with ethyl bromodifluoroacetate 282 in the presence 
of freshly prepared zinc dust
115 
to obtain the azetidinone 283. Deprotection of the p-
methoxybenzyl group of compound 283 with ceric ammonium nitrate (CAN) proceeded 
smoothly to give the required β-lactam 284. After that, 3,3-difluoro-4-phenyl-1-azetidin-2-one 
284 was reacted with Lawesson’s reagent (LR) to produce the β-thiolactam 285 which was 
treated with triethyl oxonium tetrafluoroborate in dichloromethane to obtain 1-azetine 286. 
The 4-ethylthio-3,3-difluoro-2-phenyl-1-azetine 286 was reacted with p-methoxyphenyl 
hydroximoyl chloride 288 to afford the 5-ethylthio-6,6-difluoro-2-(p-methoxyphenyl)-7-
phenyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-ene 289 in 78 % yield. After that, the cycloadduct 
was heated in toluene to obtain the 1,2,4-oxadiazole 290.  Attempts were also made for the 
synthesis of cycloadduct 287 by the reaction of 4-ethylthio-3,3-difluoro-2-phenyl-1-azetine 
286 with DPCP in acetonitrile at room temperature. This reaction was monitored by TLC and 
after 30 h there was shown a very slight indication of a new spot, yellowish in colour. Even 
after 90 hours, TLC revealed the dense spots of starting materials side by side with the faint 
new spot. Heating to reflux did not improve the reaction. No product could be isolated and the 
identity of the faint new spot could not be established.  
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Scheme 2.10: Synthesis of cycloadduct and 1,2,4-oxadiazole. 
The NMR data of 1,2,4-oxadiazole 290 was matched with that  previously reported in the 
literature,
106
 whereby our group had made the same compound from the corresponding non-
fluorinated analogue. 
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2.10. Synthesis of cycloadducts from the reaction of 5 & 6-membered cyclic imines with 
diphenylcyclopropenone 
The aim of this section of the work is to synthesise a range of cyclic imines in order to obtain 
the cycloadducts via a formal [3+2] cycloaddition route after treatment with cyclopropenones 
(DPCP, DTCP and DACP). 5-(methylthio)-3,4-dihydro-2H-pyrrole 291 and methylthio 
tetrahydropyridine 293 are five- and six-membered ring cyclic imines which were synthesised 
from their corresponding thiolactams following the published procedure in the literature.
28b, 
113
  
 
Scheme 2.11: A formal [3+2] cycloaddition reaction of DPCP. 
The cyclic imines 291 & 293 were reacted with DPCP to obtain the pyrrolo-ring cycloadducts 
292 and 294 and the data was matched with that previously reported by our group.
28b,113
 
Unfortunately cyclic imines 291 and 293 did not react with ditolylcyclopropenone or 
dianisylcyclopropenone and the starting materials were observed at the end of reactions. 
A new cyclic imine, 3-ethylthio-2-azabicyclo[2.2.1]hept-2,5-diene 297, was also synthesised 
from the commercially  available lactam, 2-azabicyclo[2.2.2]hept-5-en-2-one 295, which was 
converted to thiolactam 296 in the presence of Lawesson’s reagent. The thiolactam was 
treated with triethyloxonoium tetrafluoroborate to give the azacycloheptadiene 297. This 
cyclic imine was treated with cyclopropenones (DPCP, DTCP and DACP) in order to attempt 
to form the cycloadducts via a formal [3+2] cycloaddition reaction but unfortunately it gave 
only results with DPCP. The other cyclopropenones (DTCP and DACP) again showed no 
reaction and starting materials were recovered. However, the reactivity of the cycloadduct 298 
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was explored by heating it in toluene. TLC showed no indication of reaction and only starting 
material 298 was observed by NMR analysis. It was hoped that compound 298 might undergo 
a retro [4+2] cycloaddition to generate the azacyclopentadienone seen above (Scheme 2.8), 
but no evidence for this was seen. 
 
Scheme 2.12: Formal [3+2] cycloaddition reaction of azabicycloheptadiene. 
The 
1
H NMR spectrum obtained for azacycloheptadiene cycloadduct 298 showed the methyl 
group as a triplet at 1.34 ppm whilst the peak for methylene group attached to the methyl 
group appeared as a multiplet between 2.76 - 2.61 ppm. The CH directly attached to the 
nitrogen atom and the CH attached to the C-S appeared as multiplets between 4.01 - 3.94 and 
3.41 - 3.39 ppm, while the two protons of the CH2 group appeared as two sets of multiplets 
between 1.93 - 1.81 and 1.71 - 1.65ppm, respectively. The proton peaks of the alkene 
appeared as two sets of doublets of doublets at 6.69 and 6.50 ppm having coupling constants 
(J = 5.3 and 2.9 Hz). The spectrum also showed the signals of the two phenyl groups between 
7.43 - 7.05 ppm. The 
13
C NMR spectrum obtained for  compound 298 showed the carbon 
signal for the C=O group at 201.0, two carbon peaks for CH2 at 44.1 and 22.9 pm and the 
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carbon peak for CH3 at 14.1 ppm. The assigned structure of the new compound 298 was also 
supported with the help of MS. 
2.11. Reactivity of cyclic imines containing two heteroatoms in the ring with 
cyclopropenone 
The synthesis of cyclic imines was obtained that contained another heteroatom. The cyclic 
imines 302 and 303 were synthesised from the commercially available lactam via convertion 
to the thiolactam 301. These pyrazines were unreactive towards diphenylcyclopropenone, 
dianisylcyclopropenone or ditolylcyclopropenone under many different reaction conditions. 
 
Scheme 2.13: Synthesis of cyclic imines.  
Also prepared as part of this investigation were the pyrazinones 311 and 312 as shown in 
Scheme 2.14. Looking at Scheme 2.14, the preparation of N-chloroacetyl-N-benzylglycine 
ethyl ester 305 was achieved by the reaction of chloroacetyl chloride with N-benzylglycine 
ethyl ester in the presence of tetrabutyl ammonium hydrogen sulfate and after that it was 
converted to N-azidoacetyl-N-benzylglycine ethyl ester 306.
73
 Azide 306 was reacted with 
triphenyl phosphine in wet THF to give the iminophosphorane as an intermediate which 
cyclised to give 1-benzylpiperazin-2,5-dione 308. After that, the 1-benzylpiperazine 308 was 
thionated in the presence of Lawesson’s reagent to obtain the thiolactam product 309. The 
product 1-benzylpiperazin-2,5-dithione 310 was also obtained as a side product during 
formation of compound 309. 1-Benzylpiperazin-2,5-dione 308 and 1-benzyl-5-
thioxopiperazine-2-one 309 were converted to cyclic imines 311 & 312 after treatment with 
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triethyloxonium tetrafluoroborate. These pyrazinone cyclic imines were found to be 
unreactive towards DPCP, DTCP and DACP and only starting materials were recovered.  
 
Scheme 2.14: Synthesis of cyclic imines and attempted synthesis for cycloadducts. 
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The benzoxathiazine 315 was synthesised and explored its reactivity. The synthesis of 
benzoxathiazine-2,2-dioxide 315 has been reported by Y. Liu et al
116a 
by the reaction of 
salicylaldehyde 313 with freshly prepared sulfamoyl chloride 314 in DMA as shown in 
Scheme 2.15. The reaction was repeated and then attempted to react compound 315 with 
cyclopropenones. No successful reactions were observed. Guo et al.
116b
 reacted compound 
315 with isocyanoacetate to form the imidazoline 316. The reaction of isocyanoacetate with 
1-azetines 256b was attempted under Guo’s conditions but again observed no successful 
reactions, and were unable to form bicyclic 318.  
 
Scheme 2.15: Synthesis of benzoxathiazine and its attempted reactions. 
 
2.12. Synthesis of pyrrolo-isoquinoline alkaloids from the reactions of cyclopropenones 
with 3,4-dihydroisoquinolione cyclic imines 
Next we decided to look at some benzo-fused cyclic imines. As shown in Scheme 2.16, the 
first step was the reaction of 1,2,3,4-tetrahydroisoquinoline 319 with N-bromosuccinimide 
followed by treatment with 30 % sodium to obtain the target 3,4-dihydroisoquinoline 321 
after loss of HBr.
117
 After this, diphenylcyclopropenone was reacted with 3,4-
dihydroisiquinoline 321. The reaction mixture was monitored by TLC and even after 10 
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minutes, the starting cyclic imine and cyclopronenone had disappeared and a new spot 
emerged on the TLC plate. After this, the solvent was removed under reduced pressure but 
unfortunately no product could be identified.  The same reaction was repeated but this time 
the reaction was performed in deuterated chloroform and followed by 
1
H NMR analysis. 
The expected product 322 could not be seen but it was clear that a very similar product had 
formed. After 3 h in Deuterated chloroform, this new product could be isolated and was 
identified as the hydroxy compound 323 formed in 50 % yield. DACP behaved the same and 
reacted with imine 321 to give compound 325 in 53 % yield. 
 
Scheme 2.16: Synthesis of pyrrolo-isoquinoline derivatives. 
The 
1
H NMR spectrum for compound 323 showed all 14 aromatic protons between 8.07 - 
6.91 ppm. The proton signals of the methylene next to nitrogen showed as two sets of 
doublets of doublets at 3.82 and 3.78 ppm with the other methylene group showing one 
proton at 3.54 ppm and the other as a multiplet between 2.63 - 2.47 ppm overlapping with the 
OH. The 
13
C NMR spectrum recorded for compound 323 showed a signal for the C=O group 
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at 198.1 ppm, two carbon signals for CH2 at 40.7 and 29.3 ppm, respectively. The carbon 
spectrum also revealed ten carbon peaks for CH and eight for quatenary carbon including the 
alcohol at 85.7ppm which helped to determine the structure of 323. The structure of 
compound 323 was also established through MS(ESI)
+
: m/z [M + H] 354.1 and consistent 
HRMS which confirmed the additional oxygen atom. The IR spectrum further helped to 
assign the structure with the OH at 3256 cm
-1
. The data of compound 325 was characterised 
in a similar way and all data was consistent with the structure of compound 325, including the 
diagnostic OH. 
In order to get some further examples of this process, the 6,7-dimethoxy-3,4-
dihydroisoquinoline 85 was synthesised according to the published procedure
44
 as shown in 
Scheme 2.17. The reaction behaviour of this cyclic imine 85 was determined to be similar to 
3,4-dihydroisoqinoline with both diphenylcyclopropenone and 2,3-bis(4-
methoxyphenyl)cycloprop-2-en-1-one (Scheme 2.17). It was again noted that the products 
had an OH at the bridgehead rather than the expected H and (Figure 2.15) proposes a 
mechanism.
5, 29
 The mechanism proposes that the hydroxy pyrrole 336 readily picks up O2 to 
form hydroperoxide 337
29
 which can then cleave to give the observed product 329. 
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Scheme 2.17: Synthesis of pyrrolo-isoquinoline. 
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Figure 2.15: Proposed mechanism for formation of the pyrrolo isoquinolines with OH group. 
 
7-Nitro-3,4-dihydroisoquinoline 338 was synthesised using KNO3 with 3,4-hydroisoquinoline 
338.
117 
However, when diphenylcyclopropenone, dianisylcyclopropenone or 
ditolylcyclopropenone were mixed with cyclic imine 7-nitro-3,4-dihydroisoquinoline 338, no 
reaction was observed. It may be the case that the electron rich 85 promotes reaction but the 
electron poor 338 stops it. 
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Scheme 2.18: Synthesis of isoquinoline imine and its attempted cycloaddition reactions.
 
2.13. Synthesis of pyrrolo-indoles from the reactions of cyclopropenones with 3,4-β-
carboline cyclic imines 
β- and γ-carboline alkaloids are interesting targets due to their biological roles and potential in 
medicinal chemistry.
118,119
 With this in mind, we were interested in the synthesis of these 
indole scaffolds. Pictet Spengler condensation is a common route for the synthesis of indole 
and isoquinoline alkaloids,
120
 and so we used a route based on this
 
for the attempted synthesis 
of cyclic imine 342. However, the formation of 9H-pyrido[3,4-b]indole 343 was observed 
instead of the desired cyclic imine 342. Compound 343 is known in the literature
121
 and is not 
useful for our cycloaddition studies because aromatic C=N systems do not react. 
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Scheme 2.19: Attemted synthesis for 4,9-dihydro-3H-pyrido[3,4-b]indole cyclic imine. 
In order to make an imine that would be suitable for a formal [3+2] cycloaddition reaction, we 
used tryptamine 341 and converted it into the amide 345 by reaction with glutaric anhydride 
346. Bischler-Napieralski ring closure
122 
then gave the known imine 346. Compound 346 was 
then treated with the cyclopropenones DACP, DPCP and DTCP, respectively. DPCP and 
DACP showed successful reactions and gave the cycloadducts 347 and 348 which were 
isolated in 74 % and 80 % yield, respectively. DTCP did not react. Imine 346 was chosen 
because it was available from trypamine 341 as shown in Scheme 3.20 and because it has a 
substituent that would block the brigehead OH formation seen in Schemes 2.15 and 2.16, 
above. 
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Scheme 2.20: Synthesis of pyrrolo-indole alkaloids. 
The mechanism involved for the synthesis of cyclic imine 346 is as shown in Figure 2.16
122
 
and the proposed mechanism for the formation of cycloaddition product 347 has already been 
discussed above (p73).   
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Figure 2.16: Mechanism for the synthesis of cyclic imine 346. 
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The data for amide 345 and cyclic imine 346 are matched with that previously reported in the 
literature.
122 
The structure of compound 347 was confirmed by analytical techniques. The 
1
H 
NMR spectrum of 347 showed the presence of the indole (NH) at 8.97 ppm and the other 
aromatic protons between 7.55 - 7.05 ppm. The 
1
H spectrum for compound 347 also revealed 
the methylene (CH2) signals and methoxy peak towards the upfield region of the spectrum. 
The 
13
C NMR spectrum for this product also showed the methylene peaks at 41.6, 36.7, 33.7, 
22.3 and 19.1 ppm and the methoxy group at 69.9 ppm. A total of 11 quaternary carbons 
including the two carbonyls and the bridgehead sp
3
 carbon were seen along with the expected 
number of aromatic CH signals. The IR spectrum also showed the absorbance peaks for the 
amine and carbonyl groups which are consistent with the structure of compound 347. The 
structure of 347 was also consistent with data obtained from high resolution mass 
spectrometry.  
The tryptamine 336 was also reacted with succinic anhydride 349 in the presence of thionyl 
chloride to produce the amide ester 359 which was converted into imine 360 and reacted with 
DPCP to give the cycloadduct 361. The structure of the compound 361 was confirmed by 
analytical techniques. 
 
Scheme 2.21: Synthesis of pyrrolo-indole derivative. 
 79 
 
The 
1
H NMR spectrum for compound 361 showed a signal for the indole NH proton at 9.27 
ppm and signals between 7.56 – 7.11 ppm for the fourteen aromatic protons. The peaks 
corresponding to eight methylene protons were found between 4.09 – 2.44 ppm and a singlet 
peak depicted the OCH3 protons at 3.76 ppm in the proton spectrum of 361 (Figure 2.17).  
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Figure 2.17: 
1
H spectrum of 361. 
 
 
Figure 2.18: 
13
C spectrum of 361. 
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The 
13
C NMR spectrum recorded for this compound (Figure 2.18) showed a signal at 52.0 
ppm for the methyl peak of OCH3, while the signals corresponding to the two carbonyl groups 
(C=O) were found at 197.8 ppm and 173.4 ppm, respectively. The carbon spectrum also 
revealed the four methylene carbon peaks at 41.8, 28.9 and 22.3 ppm, respectively. The 
13
C 
spectrum recorded for this compound also showed the quaternary and aromatics peaks which 
are consistent with the structure of compound 361. The structure of compound 361 was also 
confirmed by MS (ESI)
+
: m/z [M+H] 463.2 and consistent HRMS. The IR spectrum recorded 
for compound 361 showed an absorbance peak at 3269 cm
−1 
for the N-H bond. The IR 
spectrum also showed an absorbance at 1744 cm
−1 
and at 1639 cm
−1 
for the ester and ketone 
carbonyl groups, respectively. 
2.14. Reactivity of azide-terminal containing compounds with cyclopropenones 
The aim of this part of the work was to combine our interest in cyclopropenones and imine 
formation by reacting cyclopropenones with iminophosphoranes using the aza-Wittig 
reaction. For this purpose, azide compounds were synthesised in order to give the required 
iminophosphorane intermediates after treatment with triphenylphosphine. For the azide 
synthesis, the initial step was the reaction of N-ethylaniline with chloroacetyl chloride in the 
presence of tetrabutylammonium hydrogen sulfate to give the 2-chloro-N-ethyl-N-
phenylacetamide 362 which was converted to 2-azido-N-ethyl-N-phenylacetamide 363 after 
treatment with sodium azide (Scheme 2.22). The iminophosphorane
73 
intermediate was 
obtained after reaction of azido compound 363 with PPh3 which was converted into the 
product 364 in the presence of diphenylcyclopropenone, which is a tautomer of the expected 
product 365. When the iminophosphorane intermediate was treated with 
dianisylcyclopropenone, a different reaction was seen and the product was tentatively 
assigned the structure 366, as discussed below.  
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Scheme 2.22: Reactivity of cyclopropenones with azide-terminal substrate. 
The 
1
H NMR signals for the CH2 and CH3 for the compound 364 were observed at 3.59 and 
1.17 ppm, respectively. One proton peak for CH of 364 appeared as a singlet at 6.74 ppm, 
whilst the other sixteen CH protons were observed between 7.56 - 6.95 ppm. The 
13
C NMR 
spectrum recorded for this compound showed a carbon signal for the C=O group at 155.4 
ppm. The 
13
C spectrum also showed a carbon peak for the CH2 at 46.0 ppm whereas the 
carbon peak for CH3 appeared at 12.9 ppm. Only one CH2 was present-fully consistent with 
compound 364. There were also observed eleven carbon peaks for CH and five quaternary 
carbons in addition to the C=O. The structure of compound 364 was also confirmed by mass 
spectrometry MS (ESI)
+
: m/z [M+H] 367.2 and consistent HRMS. Finally, an IR spectrum 
recorded for 364 showed an absorbance peak at 1686 cm
-1
 for C=O group. The structural part 
of compound 366 which is shown in a circle (Scheme 2.22) was similar to compound 364 but 
DEPT135 analysis revealed an additional CH2 group. One carbonyl, two OCH3 and one CH3 
signals were present in the 
13
C NMR spectrum of compound 366. This spectrum also showed 
eight CH and seven quaternary carbon peaks plus the C=O group at 167.7 ppm. The assigned 
structure of compound 366 was also consistent with results obtained by mass spectrometry 
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confirming the extra oxygen atom and IR analysis, which showed the NH at 3369 cm
-1
. The 
suggested mechanism for the formation of compound 366 will be discussed later in this thesis. 
The formation of compound 366 and especially of the proposed structure 366 was unsual and 
so more examples were sought. So, as shown in Scheme 2.23, the 1-(2-
chloroacetyl)pyrrolidin-2-one 367 was synthesised from 2-pyrrolidinone as starting 
material.
123
 Following a procedure by Takeuchi et al,
124 
1-(2-chloroacetyl)pyrrolidin-2-one 
367 was reacted with sodium azide in dry dimethylformamide to give the required azide 368. 
After this, azide 368 was treated with triphenylphosphine in THF and then after 45 minutes, 
the intermediate iminophosphorane was reacted with diphenylcyclopropenone to give the 
predicted compound 369. When the intermediate iminophosphorane was mixed with DACP, 
the reaction was complex and we could not identify any product (eg 370) from the reaction 
mixture. 
 
Scheme 2.23: Reactivity of cyclopropenones with 1-(2-azidoacetyl)pyrrolidin-2-one. 
Next, 2-chloro-1-(1-piperidyl)ethanone 371 was synthesised according to a published 
procedure,
73
 then reacted with sodium azide to obtain the required compound 372 as shown in 
Scheme 2.24. After this, 2-azido-1-(1-piperidyl)ethanone 372 was reacted with 
triphenylphosphine and the iminophosphorane intermediate was reacted with 
diphenylcyclopropenone or dianisylcyclopropenone, respectively, to get the compounds 373 
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and 374. In this process, both DPCP and DACP behaved exactly as per Scheme 2.24, giving 
the products 373 and 374. 
 
Scheme 2.24: Reactivity of cyclopropenones with 2-azido-1-(1-piperidyl)ethanone. 
The data for compound 373 was straightforward. For compound 374, the 
1
H NMR showed the 
NH at 6.04ppm. The 
13
C NMR showed the CH2 that is next to the NH as well as the the 
correct number of CH and Cq signals. The data was consistent and so the tentative structure 
374 is assigned. To get furthur examples and to help verify this unexpected reaction, (E)-4-(p-
tolyl)but-3-en-2-one 376 was synthesised by the reaction of p-tolualdehyde 375 with acetone 
in a Claisen-Schmidt reaction.
125 
Following a procedure by Babu et al,
126
 α,β-unsaturated 
ketone 376 was reacted with pyrrolidone hydrotribromide in dry THF to give the (E)-1-
bromo-4-(p-tolyl)but-3-en-2-one 235 as shown in Scheme 2.25. Compound 235 was reacted 
with sodium azide to obtain the required azido-compound 377 which was treated with 
triphenylphosphine in THF to obtain the iminophosphorane intertemediate. After 45 minutes, 
a solution of diphenylcyclopropenone in acetonitrile was added to the iminophosphorane. 
This time, a product consistent with hydroxylamine 378 was obtained unlike when 
diphenylcyclopropenone was reacted in Scheme 2.22 - 2.24, above. With DACP, this 
iminophosphorane intermediate gave no reaction. The lack of consistent results at this stage 
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and the lack of remaining time meant that this interesting set of reactions was not explored 
further. 
 
Scheme 2.25: The reactivity of (E)-1-azido-4-(p-tolyl)but-3-en-2-one with cyclopropenones  
and the synthesis of a natural product. 
The 
1
H NMR spectrum recorded for compound 378 showed a singlet peak for the CH of the 
3-membered carbocycle at 7.80 ppm and triplet for the amine (NH) with coupling constant 4.5 
Hz at 6.4 Hz. The signals for the CH=CH appeared as a doublet with coupling constant J = 
16.1 Hz at 7.56 ppm and a doublet with coupling constant J = 16.1 Hz at 6.61 ppm, 
respectively. The proton spectrum also showed a methylene signal as doublet (J = 4.5 Hz) at 
4.41 ppm. The methyl group appeared at 2.31 ppm and the aromatic protons showed between 
7.56 - 6.94 ppm. The 
13
C NMR spectrum recorded for this compound showed a peak for the 
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methyl carbon at 21.6 ppm and a signal at 198.5 ppm for the C=O group. There were also 
observed six carbon peaks for the quaternary carbons excluding the C=O and eleven CH 
signals in the 
13
C NMR spectrum, consistent with the structure assigned. The structure of 
compound 378 was also assigned by MS and consistent HRMS which confirmed the 
additional oxygen. IR spectroscopy further helped to assign the structure of compound. The 
formation of the compounds with structures 366, 370, 374 & 378 can be explained (Figure 
2.19) by the following suggested mechanism in which H2O must add to the initial product at 
some point. We are still seeking X-ray confirmation of the structure of the N-O species 366, 
370, 374 & 378. It is possible that in compounds 366, 370, 374, the OMe as the aryl group 
stabilises intermediate 379 whereas in compound 378, the intermediate is stabilised by the 
adjacent enone. 
 
Figure 2.19: Mechanism for N-O formation. 
3-O-[(E)-(2-Oxo-4-(p-tolyl)but-3-en-1-yl] kaempferol 236 was synthesised by  the reaction of 
bromo-containing compound 235 with kaempferol. The spectral data for compound 235 
matched those described in the literature
127
 but the yield of the reaction has been improved 
from 19 % to 34 % and the unreacted kaempferol was recovered as starting material by flash 
chromatography. This compound 3-O-[(E)-(2-oxo-4-(p-tolyl)but-3-en-1-yl]kaempferol was 
required for a biological screening programme carried out at the University and forms part of 
a proposed new project area, which could not be explored in this project due to time 
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limitations: it was carried out in this thesis because we had ready access to the coupling 
partner 235. 
The final reaction explored was to check the behaviour of cyclopropenone with benzyne. 
There are number of methods reported in the literature to generate benzyne under harsh 
conditions.
128
 But after generation of benzyne in 1983 by Kobayshi by the reaction of 
trimethylsilylphenyl triflates with fluoride source in acetonitrile under mild conditions.
129,130
 
The unstable benzyne was generated in situ (see Scheme 2.26) by the the reaction of 
trimethylsilylphenyl triflate 381 with cesium fluoride in acetonitrile at room temperature and 
tried to trap it by reaction with DACP to give the intially hoped cyclopentadienone 383. In the 
event product 384 was isolated, a reaction that was reported in a full study in the literature
5j
 at 
the time when we were starting our investigation. 
 
Scheme 2.26: Cycloaddition reaction of benzyne with DACP. 
The 
1
H and 
13
C NMR data of compound 384 matched that reported in the litrature,
5j
 and the 
fact that others had now explored this key reaction led us to stop this aspect of our work. 
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2.15. Conclusion: 
In the first part of this thesis, highly fuctionalised cycloadducts were obtained after treatment 
of cyclic imines with cyclopropenones via a formal [3+2]-cycloaddition reaction as a key step 
allowing the synthesis of pyridines, pyrrolo-isoquinolines and pyrrolo-β-carbolines. Some of 
the 6-membered ring imines explored were piprazine based i.e. had an extra heteroatom in the 
ring and were found to be unreactive. The naphthyl-substituted 4-membered cyclic imines 
underwent a ring expansion to give the benzoisoquinolines but 4-phenyl and 4-biphenyl-1-
azetines were found not to undergo the same ring expansion. The pyrrolo-isoquinolines that 
were formed (from a dihydroisoquinoline) were noted to have an extra hydroxy on the 
bridgehead carbon. 
When a 4-vinyl-1-azetine was treated with diphenylcyclopropenone the cycloaddition product 
rearranged to a 7-azabicyclo[4.2.1]nonane, as a  result  of  an  aza-Cope [3,3]-sigmatropic  
rearrangement, an observation that confirmed previous studies in the group with an analogous 
system. A fluorinated 1-azetine was also synthesised in order to compare reactivity to the 
non-fluorinated systems. Previous work was reported for the synthesis of a series of 1,2,4-
oxadiazoles using 1,3-dipolar cycloadditions between non-fluorinated 1-azetines and nitrile 
oxides. When 2-ethylthio-3,3-difluoro-4-phenyl-1-azetine was reacted with p-methoxyphenyl 
hydroxymoyl chloride, it was found to give the F-containing cycloadduct product which could 
be heated in toluene to obtain the 5-ethylthio-3-(p-methoxyphenyl)-1,2,4-oxadiazole. This 
fluorinated 1-azetine was found not to react with cyclopropenones.  
A novel methodology had been developed previously in the Hemming group for the synthesis 
of pyridines by the reaction of 4-aryl-1-azetines with diphenylcyclopropenone. This work in 
this thesis has extented the scope of the reaction to include other diarylcyclopropenones.  
A range of azides were also synthesised, converted to iminophosphoranes as intermediates 
which were reacted with diphenylcyclopropenone and dianisylcyclopropenone and formed a 
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series of proposed cyclopropene products, some with an unexpected, tentative, N-O linked 
side-chain. 
A catalytic methodology has been developed for the synthesis of primary alkyl bromide 
compounds from the corresponding alcohol substrates in the presence of 
diphenylcyclopropenone. A series of 1,2,4-oxadiazoles have been synthesised from 
amidoximes as starting materials which were formed with the involvement of cyclopropenone 
as a catalyst to couple carboxylic acids to oximes in the presence of oxalyl chloride.  
2.16. Future work: 
The figure below shows the diverse range of cyclopropenones that are available. The number 
of potential cyclic imines is also huge and so much time could be spent exploring these 
reactions, as summarised in Figure 2.20. 
 
Figure 2.20: Graphical presentation for the roles of cyclopropenones. 
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Finally, it might be of interest to explore how compounds such as the indolizinoindole 347 
can be used, as outlined below:  
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CHAPTER 3 
 
 
Experimental 
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3.1. General Experimental 
All reactions were carried out in dry glassware under an atmosphere of dry nitrogen unless 
mentioned otherwise. 
Infrared spectra were measured by Nicolet 380 FT-IR instrument as a thin film for oils and 
neat for solids and absorption peaks (max) are quoted in wave numbers (cm-1). 
Deuterated chloroform (CDCl3) was used as solvent unless otherwise stated to record the 
nuclear magnetic resonance (NMR) spectra. 
1
H NMR spectra were recorded on Bruker DPX-
400 (400 MHz), Bruker DPX-500 (500 MHz). Signal splitting patterns are described as 
singlet (s), doublet (d), doublet of doublets (dd), doublet of triptets (dt), triplet (t), multiplet 
(m), quartet (q). 
Low resolution mass spectra were measured on a Bruker Daltonics micrOTOF mass 
spectrometer operating at a positive ion mode under an electrospray ionisation method. High 
resolution mass spectra were measured on Kratos Concept IS spectrometer. 
Reagents and solvents used during experimentation were purchased from Sigma Aldrich and 
Acros organics. 
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3.2. 2,3-Bis(p-methoxyphenyl)cycloprop-2-en-1-one
 
 
To a stirred slurry of AlCl3 (2.30 g, 17.10 mmol) in dry dichloromethane (25 mL), was added 
tetrachlorocyclopropene (2.00 mL, 16.31 mmol) at - 78 °C under an inert N2 atmosphere. The 
reaction mixture was left for 10 min with stirring at the same temperature. After this time, 
anisole (3.51 mL, 32.61 mmol) was added as a solution in DCM (8 mL) slowly over 15 min 
via syringe, and then the reaction mixture was kept overnight at rt with stirring. The reaction 
mixture was poured into water (15 mL). After this, the aqueous phase was washed with 
dichloromethane (10 mL x 2), and then the combined organic extracts were washed with brine 
(15 mL x 2). The organic layer was dried (MgSO4) and the solvents were removed in vacuo. 
The crude product was purified by flash chromatography affording the title compound. 
Rf 0.42 (ethyl acetate/petroleum ether = 1:2); white solid 2.20 g, 51 % yield; mp 122 - 123; 
lit.,
131
 mp 120 - 121 ºC. 
 
1
H NMR (400 MHz, CDCl3) δ ppm 7.94 (4H, d, J = 8.6 Hz, Ar), 7.08 (4H, d, J = 8.6 Hz, 
Ar), 3.93 (6H, s, OCH3).  
13
C NMR (100 MHz, CDCl3) δ ppm 157.9 (C), 155.4 (C=O), 147.4 (C), 133.5 (CH), 117.1 
(C), 114.7 (CH), 56.6 (OCH3).  
IR max (cm
-1
) 3029, 2929, 1842, 1607, 1597, 1424, 1301, 1254, 1032, 830, 710.  
As reported previously.
23 
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3.3. 2,3-Bis(p-tolyl)cycloprop-2-en-1-one 
 
A solution of  Nʹ,N′-dicyclohexylcarbodiimide (2.71 g; 13.07 mmol) and 4-
(dimethylamino)pyridine (0.40 g; 3.27 mmol) in dry tetrahydrofuran (30 mL) was stirred at rt 
under an inert N2 atmosphere and treated dropwise with  a solution of 4-tolylacetic acid (1.95 
g; 13.01 mmol) in dry tetrahydrofuran (10 mL). The resulting mixture was stirred at rt for 16 
h. After this time, the reaction mixture was filtered through Celite
® 
The crude product was 
purified by flash chromatography (ethyl acetate/ petroleum ether; 1:4), affording the diaryl 
ketone as a yellow oil (1.08 g, 32 %, Rf = 0.35). The ketone (0.62 g; 2.60 mmol) was then 
dissolved in acetic acid (5 mL), and a solution of bromine (0.27 mL, 5.20 mmol) in acetic 
acid (2.5 mL) was added dropwise. After 0.5 h, the reaction was poured into water (20 mL) 
and the product was collected by filtration. The crude product (dibromoketone) was air dried 
for several hours, then dissolved in dry dichloromethane (5 mL). After that, triethylamine 
(0.55 mL, 3.91 mmol) in dry dichloromethane (5 mL) was added dropwise and then the 
reaction mixture was left for 1 h at room temperature with stirring. The reaction mixture was 
quenched with 1 M HCl (5 mL), followed by brine (10 mL). The organic layers were dried 
(MgSO4), and then solvents removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound 
Rf 0.49 (ethyl acetate/ petroleum ether; 2:1); orange solid 0.087 g, 13 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.89 (4H, d, J = 8.1 Hz, Ar), 7.40 (4H, d, J = 8.1 Hz, Ar), 
2.49 (6H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 154.9 (C=O), 147.1 (C), 143.5 (C), 131.6 (CH), 130.1 
(CH), 121.9 (C), 21.3 (CH3). 
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IR max (cm
-1
) 3021, 2913, 1831, 1600, 1342, 811, 1039, 489.  
As reported previously.
109 
3.4. 2-(Nʹ,Nʹ-diisopropylamino)-3-phenylcycloprop-2-en-1-one 
 
To a stirred slurry of AlCl3 (0.79 g; 6.75 mmol) in dry dichloromethane (12.5 mL), was added 
tetrachlorocyclopropene (0.75 mL; 6.95 mmol) at 0 °C under an inert N2 atmosphere. The 
reaction mixture was left for 10 min with stirring at the same temperature. Benzene (0.48 mL, 
6.20 mmol) in dichloromethane (15 mL) was added, and then the reaction mixture was kept at 
rt overnight. The reaction mixture was poured into water (8 mL). After that, the aqueous 
phase was washed with dichloromethane (15 mL x 2), and the combined organic extracts were 
washed with brine (8 mL x 2). The organic layer was dried (MgSO4) and the solvents were 
removed in vacuo. This crude oil was dissolved in acetone (3 mL) and crushed ice (8 g) was 
added. After this, the mixture was stirred at rt for 3 h and then acetone was removed by 
evaporation under reduced pressure. The remaining solution was filtered and filtrate solid was 
further washed with cold diethyl ether to give the crude white solid (1-hydroxy-2-
phenylcyclopropenone). The crude product (0.089 g; 0.61 mmol) was cooled to 0 °C under an 
inert argon atmosphere and 1 drop of DMF was added followed by 0.5 mL of thionyl chloride 
were added. The reaction mixture was stirred at 0 °C for 10 min, allowed to warm to rt and 
then stirred for 10 min more at the same temperature. The reaction mixture was concentrated 
under reduced pressure and further put under high vacuum for 1 h to remove any excess 
thionyl chloride. The crude product was dissolved in DCM (3 mL) was cooled to 0 °C and 
diisopropylamine (0.25 mL, 1.75 mmol) was added and the reaction mixture was left to warm 
to rt for 3 h with stirring. The reaction mixture was quenched with saturated aqueous 
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ammonium chloride (5 mL) and the aqueous phase was washed with dichloromethane (10 mL 
x 2), and then the combined organic extracts were washed brine (5 mL x 2). The organic layer 
was dried (MgSO4) and the solvents were removed in vacuo. The crude product was purified 
by flash chromatography affording the title compound. 
Rf 0.42 (ethyl acetate/petroleum ether = 1:2); yellow solid 0.042 g, 30 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.60 (2H, d, J = 7.4 Hz, Ph), 7.45 - 7.34 (3H, m, Ph), 
4.25 - 4.17 (IH, m, CH), 3.69 - 3.61 (1H, m, CH), 1.39 (12H, dd, J = 6.5 and 6.5 Hz). 
IR max (cm
-1
) 3031, 2976, 1855, 1603, 1579, 1440, 1143, 786. 
MS (ESI)
+
 : m/z [M + H] 230.1. 
HRMS: [M] for C15H19NO calculated 229.1466, found 229.1467. 
1
H & IR data consistent with the previous reported data.
109
 Together with an unidentified 
product which appeared (IR; C=O at 1860 cm
-1
) to be a cyclopropenone but lacked 14 mass 
units (- CH2 by HRMS). 
3.5. Benzyl bromide 
 
To a stirred solution of diphenylcyclopropenone (0.06 g; 0.30 mmol), lithium bromide (0.521 
g; 6.0 mmol) and benzyl alcohol (0.22 g; 0.21 mL, 206 µL, 2.0 mmol) in dichloromethane (10 
mL), was added oxalyl chloride (0.33 g; 0.22 mL, 220 µL, 2.60 mmol) dropwise through an 
addition funnel over 15 h under an inert atmosphere at rt. After this time, the reaction solution 
was filtered and then solvents removed in vacuo. The crude product was purified by flash 
chromatography (only hexane), affording the title compound. 
Rf 0.31 (100 % hexane); colourless oil 0.24g, 70 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.28 - 7.25 (2H, m, Ph), 7.23 - 7.14 (3H, m, Ph), 4.36 
(2H, s, CH2). 
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13
C NMR (100 MHz, CDCl3) δ ppm 137.8 (C), 129.1 (CH), 128.8 (CH), 128.4 (CH), 33.7 
(CH2). 
Previously reported.
132 
3.6. 2-Methoxybenzyl bromide 
 
To a stirred solution of diphenylcyclopropenone (0.06 g; 0.30 mmol), lithium bromide (0.521 
g; 6.0 mmol) and 4-methoxybenzyl alcohol (0.28 g; 0.27 mL, 266 µL, 2.0 mmol) in 
dichloromethane (10 mL), was added oxalyl chloride (0.33 g; 0.22 mL; 220 µL; 2.60 mmol) 
dropwise through an addition funnel over 15 h under an inert atmosphere at rt. After this time, 
the reaction solution was filtered and then solvents removed in vacuo. The crude product was 
purified by flash chromatography (ethyl acetate/ hexane; 50:3), affording the title compound. 
Rf 0.67 (ethyl acetate/hexane = 50:3); white solid 0.230 g, 57 % yield; mp 52-53 ºC; lit.,
133
 
mp 47-50 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.38 - 7.31 (2H, m, Ar), 6.98 - 6.91 (2H, m, Ar), 4.62 
(2H, s, CH2), 3.93 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 157.4 (C), 130.9 (CH), 130.2 (CH), 126.0 (C), 120.7 
(CH), 110.9 (CH), 55.6 (CH3), 29.1 (CH2). 
Previously reported.
133 
3.7. 3-Methoxybenzyl bromide 
 
To a stirred solution of diphenylcyclopropenone (0.06 g; 0.30 mmol), lithium bromide (0.521 
g; 6.0 mmol) and 4-methoxylbenzyl alcohol (0.28 g; 0.27 mL, 266 µL, 2.0 mmol) in 
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dichloromethane (10 mL), was added oxalyl chloride (0.33 g; 0.22 mL; 220 µL; 2.60 mmol) 
dropwise through an addition funnel over 15 h under an inert atmosphere at rt. After this time, 
the reaction solution was filtered and then solvents removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
Rf 0.67 (ethyl acetate/hexane = 50:3); colorless liquid 0.26 g, 65 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.16 – 7.14 (1H, t, J = 7.9 Hz, Ar), 6.86 (1H, d, J = 7.7 
Hz, Ar), 6.82 (1H, s, Ar), 6.72 (1H, dd, J = 8.2 and 2.1 Hz, Ar), 4.34 (2H, s, CH2), 3.68 (3H, 
s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 159.8 (C), 139.2 (C), 129.8 (CH), 121.3 (CH), 114.2 
(CH), 114.2 (CH), 55.3 (CH3), 33.6 (CH2). 
IR max (cm
-1
) 3001, 2939, 1599, 1585, 1487, 1453, 1263, 1154, 1038, 778, 730. 
Previously reported.
134
 
3.8. 4-Methoxybenzyl bromide 
 
To a stirred solution of diphenylcyclopropenone (0.06 g; 0.30 mmol), lithium bromide (0.521 
g; 6.0 mmol) and 4-methoxybenzyl alcohol (0.28 g; 0.27 mL, 266 µL, 2.0 mmol) in 
dichloromethane (10 mL), was added oxalyl chloride (0.33 g; 0.22 mL; 220 µL; 2.60 mmol) 
dropwise through an addition funnel over 15 h under an inert atmosphere at rt. After this time, 
the reaction solution was filtered and then solvents removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
Rf 0.67 (ethyl acetate/hexane = 50:3); colorless liquid 0.28 g, 70 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.38 – 7.36 (2H, m, Ar), 6.93 - 6.91 (2H, m, Ar), 4.55 
(CH2), 3.83 (CH3). 
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13
C NMR (100 MHz, CDCl3) δ ppm 159.7 (C), 130.5 (CH), 130.0 (C), 114.2 (CH), 55.3 
(CH3), 34.1 (CH2). 
IR max (cm
-1
) 3031, 2923, 1607, 1583, 1510, 1461, 1439, 1302, 1246, 1227, 1202, 1173, 
1029, 828, 591. 
Previously reported.
135 
3.9. 4-Methylbenzyl bromide 
 
To a stirred solution of diphenylcyclopropenone (0.06 g; 0.30 mmol), lithium bromide (0.521 
g; 6.0 mmol) and 4-methylbenzyl alcohol (0.24 g; 2.0 mmol) in dichloromethane (10 mL), 
was added oxalyl chloride (0.33 g; 0.22 mL; 220 µL; 2.60 mmol) dropwise through an 
addition funnel over 15 h under an inert atmosphere at rt. After this time, the reaction solution 
was filtered and then solvents removed in vacuo. The crude product was purified by flash 
chromatography (only hexane), affording the title compound. 
Rf 0.24 (100 % hexane); white solid 0.230 g, 62 % yield; mp 36 - 37 ºC; lit.,
136
 mp 34 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.16 (2H, dd, J = 7.7 and 1.7 Hz, Ar), 7.03 (2H, d, J = 7.7 
Hz, Ar), 4.36 (2H, s, CH2), 2.23 (3H, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 138.4 (C), 134.9 (C), 129.5 (CH), 129.0 (CH), 33.8 
(CH2), 21.3 (CH3). 
IR max (cm
-1
) 3016, 1614, 1513, 1225, 1094, 866, 810, 740, 588. 
Previously reported.
137 
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3.10. 2-Azidobenzyl bromide
 
 
To a stirred solution of diphenylcyclopropenone (0.06 g; 0.30 mmol), lithium bromide (0.521 
g; 6.0 mmol) and 2-azidobenzyl alcohol (0.30 g; 2.0 mmol) in dichloromethane (10 mL), was 
added oxalyl chloride (0.33 g; 0.22 mL; 220 µL; 2.60 mmol) dropwise through an addition 
funnel over 15 h under an inert atmosphere at rt. After this time, the reaction solution was 
filtered and then solvents removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.28 (100 % hexane); brown solid 0.24 g, 57 % yield; mp 78 - 79 ºC; lit.,
138
 mp 71 - 72 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.38 (2H, m, Ar), 7.20 – 7.13 (1H, m, Ar), 7.15 (1H, d, J 
= 7.5 Hz, Ar), 4.50 (2H, s, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 138.6 (C), 131.3 (CH), 130.1 (CH), 128.8 (C), 125.0 
(CH), 118.5 (CH), 28.4 (CH2). 
IR max (cm
-1
); 3024, 2929, 2118, 1579, 1484, 1285, 1160, 566, 529, 510, 477.  
The compound was previously reported.
138 
3.11. Nˈ-Hydroxypyridine-2-carboxamidine 
 
To a stirred solution of hydroxylamine hydrochloride (0.73 g; 10.5 mmol) in water (25 mL), 
was added sodium carbonate (1.12 g; 10.57 mmol) in small portions. To this, 2-cyanopyridine 
(1.0 g; 9.61 mmol) in ethanol (25 mL) was added and the reaction mixture was left to reflux 
 100 
 
for 24 h. After this, the mixture was extracted with dichloromethane (25 mL x 2) and then 
solvents were removed in vacuo to give the title compound. 
White solid 1.2 g, 91 % yield; mp 122 - 123 ºC; lit.,
139
 mp 117 - 118 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.83 (1H, br. s, OH), 8.61 - 8.58 (1H, m, Ar), 7.94 (1H, 
d, J = 8.0 Hz, Ar), 7.29 (1H, td, J = 7.7 and 1.5 Hz, Ar), 7.35 - 7.32 (1H, m, Ar), 5.76 (2H, s, 
NH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 151.1 (C), 149.0 (C), 148.4 (CH), 136.5 (CH), 124.4 
(CH), 120.0 (CH). 
IR max (cm
-1
) 3463, 3342, 1639, 1589, 1481, 1377, 1289, 1100, 888, 740. 
Previously reported.
112e 
3.12. (Z)-N-((Hydroxyimino)(pyridin-2-yl)methyl)-2-phenylacetamide  
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of phenylacetic acid (0.136 g; 1.0 mmol) and 
triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added in one 
portion to the reaction mixture. After 15 minutes, Nˈ-hydroxypyridine-2-carboxamidine 228a 
(0.15 g; 1.14 mmol) was added and the reaction mixture was left at room temperature 
overnight. The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.19 (ethyl acetate/hexane = 1:1); white solid 0.2 g, 68 % yield; mp 117 - 118 ºC. 
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1
H NMR (400 MHz, CDCl3) δ ppm 8.56 - 8.54 (1H, m, Ar), 8.15 (1H, dd, J = 7.8 and 2.5 Hz, 
Ar), 7.76 - 7.70 (1H, m, Ar), 7.38 - 7.28 (6H, m, Ar), 6.43 (1H, br. s, OH), 5.30 (1H, br. s, 
NH), 3.86 (2H, s, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.8 (C=O), 153.9 (C), 148.4 (CH), 147.5 (C), 136.8 
(CH), 133.7 (C), 129.2 (CH), 128.7 (CH), 127.2 (CH), 125.5 (CH), 121.3 (CH), 40.4 (CH2). 
IR max (cm
-1
) 3473, 3316, 1692, 1573, 1532, 1443, 1357, 1178, 1017, 771, 691. 
MS (ESI)
+
 : m/z [M+H] 256.1. 
HRMS: [M] for C14H13N3O2 calculated 255.1000, found 255.1008. 
New compound. 
3.13. 5-Benzyl-3-(pyridin-2-yl)-1,2,4-oxadiazole 
 
 
(Z)-N-((Hydroxyimino)(pyridin-2-yl)methyl)-2-phenylacetamide 242a (0.15 g; 0.59 mmol) 
was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 h with 
stirring. After this, the mixture was allowed to cool to rt and then solvents removed in vacuo. 
The crude product was purified by flash chromatography affording the title compound. 
Rf 0.5 (ethyl acetate/dichloromethane = 1:5); white solid 0.1 g, 72 % yield; mp 61 - 62 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.81 - 8.79 (1H, m, Ar), 8.12 (1H, d, J = 7.9 Hz, Ar), 
7.86 - 7.82 (1H, m, Ar), 7.44 - 7.31 (6H, m, Ar), 4.35 (2H, s, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 178.7 (C), 168.3 (C), 150.4 (CH), 146.3 (C), 137.0 (CH), 
133.3 (CH), 129.0 (CH), 128.9 (C), 127.6 (CH), 125.5 (CH), 123.1 (CH), 33.1 (CH2).  
IR max (cm
-1
) 3029, 2931, 1586, 1562, 1494, 1452, 1439, 1411, 1372, 1346, 1179, 1127, 
1074, 1020, 912, 804, 748, 734, 720, 643, 618, 595, 524. 
MS (ESI)
+
 : m/z [M + H] 238.1. 
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HRMS: [M] for C14H11N3O calculated 237.0902, found 237.0906. 
New compound. 
3.14. (Z)-N-((Hydroxyimino)(pyridin-2-yl)methyl)-2-(p-tolyl)acetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of p-tolylacetic acid (0.15 g; 0.99 mmol) and 
triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added in one 
portion to the reaction mixture. After 15 minutes, Nˈ-hydroxypyridine-2-carboxamidine 228a 
(0.15 g; 1.1 mmol) was added and the reaction mixture was left at room temperature 
overnight. The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.1(ethyl acetate/hexane = 1:1); white solid 0.21 g, 72 % yield; mp 137 - 138 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.57 – 8.55 (1H, m, Ar), 8.16 (1H, d, J = 8.0 Hz, Ar), 
7.37 (1H, td, J = 8.0 and 1.5 Hz, Ar), 7.38 - 7.35 (1H, m, Ar), 7.27 (2H, d, J = 8.0 Hz, Ar), 
7.17 (2H, d, J = 8.0 Hz, Ar), 6.42 (1H, br. s, OH), 5.30 (1H, br. s, NH), 3.82 (2H, s, CH2), 
2.35 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 169.0 (C), 153.9 (C), 148.4 (CH), 147.6 (C), 136.8 (CH), 
130.7 (C), 129.4 (CH), 129.1 (CH), 125.5 (CH), 121.4 (CH), 40.0 (CH2), 21.1 (CH3). 
 IR max (cm
-1
) 3469, 3301, 1740, 1632, 1566,1517, 1474, 1401, 1332, 1142, 900, 797, 760. 
 MS (ESI)
+
 : m/z [M + H] 270.1. 
HRMS: [M] for C15H15N3O2 calculated 269.1164, found 269.1171. 
New compound. 
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3.15. 5-(4-Methylbenzyl)-3-(pyridin-2-yl)-1,2,4-oxadiazole 
 
(Z)-N-((Hydroxyimino)(pyridin-2-yl)methyl)-2-(p-tolyl)acetamide 242b (0.15 g; 0.56 mmol) 
was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 h with 
stirring. After this, the mixture was allowed to cool to rt and then solvents removed in vacuo. 
The crude product was purified by flash chromatography affording the title compound. 
Rf 0.3(ethyl acetate/hexane = 1:1); yellow oil 0.092 g, 66 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.79 – 8.77 (1H, m, Ar), 8.09 (1H, d, J = 7.9 Hz, Ar), 
7.82 – 7.78 (1H, m, Ar), 7.40 - 7.38 (1H, m, Ar), 7.26 (2H, d, J = 7.9 Hz, Ar), 7.14 (2H, d, J = 
7.8 Hz, Ar), 4.28 (2H, s, CH2), 2.32 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 179.0 (C), 168.2 (C), 150.3 (CH), 146.3 (C), 137.3 (C), 
136.9 (CH), 130.2 (C), 129.6 (CH), 128.8 (CH), 125.4 (CH), 123.1 (CH), 32.7 (CH2), 21.0 
(CH3). 
IR max (cm
-1
) 2996, 2931, 1579, 1563, 1514, 1421, 1362, 1148, 801, 778, 743, 721. 
MS (ESI)
+
 : m/z [M + H] 252.2. 
HRMS: [M] for C15H13N3O calculated 251.1059, found 251.1066. 
New compound. 
3.16. (Z)-N-((Hydroxyimino)(pyridin-2-yl)methyl)-2-(4-methoxyphenyl)acetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
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atmosphere at rt. After 5 minutes, a mixture 4-methoxyphenylacetic acid (0.17 g; 1.0 mmol) 
and triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added in one 
portion to the reaction mixture. After 15 minutes, Nˈ-hydroxypyridine-2-carboxamidine 228a 
(0.15 g; 1.1 mmol) was added and the reaction mixture was left overnight. The solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.38 (ethyl acetate/dichloromethane = 1:5); white solid 0.24 g, 77 % yield; mp 136 - 137 
ºC.  
1
H NMR (400 MHz, CDCl3) δ ppm 8.56 - 8.54 (1H, m, Ar), 8.15 (1H, d, J = 7.9, Hz, Ar), 
7.77 - 7.71 (1H, m, Ar), 7.39 - 7.36 (1H, m, Ar), 7.29 - 7.27 (2H, m, Ar), 6.91 - 6.88 (2H, m, 
Ar), 6.41 (1H, br. s, OH), 5.31 (1H, br. s, NH), 3.82 (3H, s, CH3), 3.80 (2H, s, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 169.1 (C=O), 158.7 (C), 153.9 (C), 148.4 (CH), 147.5 
(C), 136.7 (CH), 130.3 (CH), 125.7 (C), 125.5 (CH), 121.3 (CH), 114.1 (CH), 55.2 (OCH3), 
39.5 (CH2). 
IR max (cm
-1
) 3470, 3313, 1743, 1632, 1613, 1584, 1565, 1513, 1329, 1317, 1243, 1208, 
1135, 1039, 899, 797, 769, 520.  
MS (ESI)
+
 : m/z [M + H] 286.1. 
HRMS: [M] for C15H15N3O3 calculated 285.1113, found 285.1112. 
New compound. 
3.17. 5-(4-Methoxybenzyl)-3-(pyridin-2-yl)-1,2,4-oxadiazole 
 
(Z)-N-((Hydroxyimino)(pyridin-2-yl)methyl)-2-(4-methoxyphenyl)acetamide 242c (0.15 g; 
0.53 mmol) was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 
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h with stirring. After this, the mixture was allowed to cool to rt and then solvents removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound.  
Rf 0.55 (ethyl acetate/hexane; 1:1); yellow oil 0.092 g, 66 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.71- 8.69 (1H, m, Ar), 8.01 (1H, d, J = 7.8 Hz, Ar), 7.74 
– 7.72 (1H, m, Ar), 7.33 - 7.30 (1H, m, Ar), 7.22 (2H, d, J = 8.4 Hz, Ar), 6.78 (2H, d, J = 8.4 
Hz, Ar), 4.18 (2H, s, CH2), 3.69 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 179.1 (C), 168.2 (C), 159.0 (C), 150.3 (CH), 146.3 (C), 
136.9 (CH), 130.1 (CH), 125.4 (CH), 125.2 (C), 123.1 (CH), 114.3 (CH), 55.2 (CH3), 32.2 
(CH2). 
IR max (cm
-1
) 2932, 2837, 1610, 1579, 1564, 1511, 1421, 1363, 1245, 1177, 1148, 1030, 802, 
788, 744, 721, 712. 
MS (ESI)
+
 : m/z [M + H] 268.1. 
HRMS: [M] for C15H13N3O2 calculated 267.1008, found 267.1003.  
New compound. 
3.18. (Z)-2-(4-Chlorophenyl)-N-((hydroxyimino)(pyridin-2-yl)methyl)acetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of 4-methoxyphenylacetic acid (0.17 g; 1.0 
mmol) and triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added 
in one portion to the reaction mixture. After 15 minutes, Nˈ-hydroxypyridine-2-
carboxamidine 228a (0.15 g; 1.1 mmol) was added and the reaction mixture was left at room 
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temperature overnight. The solvents were removed in vacuo. The crude product was purified 
by flash chromatography affording the title compound. 
Rf 0.31 (ethyl acetate/dichloromethane = 1:5); white solid 0.17 g, 54 % yield; mp 143 - 144 
ºC.  
1
H NMR (400 MHz, CDCl3) δ ppm 8.58 – 8.56 (1H, m, Ar), 8.15 (1H, d, J = 7.9 Hz, Ar), 
7.78 – 7.74 (1H, m, Ar), 7.39 (1H, dd, J = 6.8 and 5.2 Hz, Ar), 7.34 – 7.28 (3H, m, Ar), 7.29 
(1H, d, J = 8.3 Hz, Ar), 6.47 (1H, br. s, OH), 5.31 (1H, br. s, NH), 3.84 (2H, s, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.4 (C=O), 153.8 (C), 148.4 (CH), 147.4 (C), 136.8 
(CH), 132.2 (C), 132.1 (C), 130.6 (CH), 128.8 (CH), 125.6 (CH), 121.3 (CH), 39.6 (CH2). 
IR max (cm
-1
) 3468, 3300, 1739, 1631, 1565, 1493, 1475, 1402, 1334, 1210, 1145, 1084, 
1014, 900, 808, 741, 688, 664. 
MS (ESI)
+
 : m/z [M + H] 290.1. 
HRMS: [M] for C14H12
35
ClN3O2 calculated 289.0618, found 289.0624. 
New compound. 
3.19. 5-(4-Chlorobenzyl)-3-(pyridin-2-yl)-1,2,4-oxadiazole 
 
(Z)-2-(4-Chlorophenyl)-N-((hydroxyimino)(pyridin-2-yl)methyl)acetamide 242d (0.15 g; 0.52 
mmol) was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 h 
with stirring. After this, the mixture was allowed to cool to rt and then solvents removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.46 (ethyl acetate/dichloromethane = 1:5); yellow solid 0.16 g, 54 % yield; mp 71 - 72 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.76 – 8.74 (1H, m, Ar), 8.07 (1H, d, J = 7.8 Hz, Ar), 
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7.82 - 7.78 (1H, m, Ar), 7.39 (1H, dd, J = 7.2 and 5.1 Hz, Ar), 7.30 - 7.17 (4H, m, Ar), 4.27 
(2H, s, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 178.2 (C), 168.3 (C), 150.4 (CH), 146.1 (C), 137.0 (CH), 
133.6 (C), 131.7 (C), 130.3 (CH), 129.1 (CH), 125.5 (CH), 123.1 (CH), 32.4 (CH2). 
IR max (cm
-1
) 2929, 2880, 1589, 1576, 1562, 1488, 1444, 1375, 1346, 1141, 1091, 1014, 994, 
907, 849, 801, 769, 742, 721, 715, 640, 617, 515, 507, 427, 404. 
MS (ESI)
+
 : m/z [M + H] 272.0. 
HRMS: [M] for C14H10
35
ClN3O calculated 271.0512, found 271.0513. 
New compound. 
3.20. (Z)-N'-Hydroxypyrimidine-2-carboximidamide 
 
To a stirred solution of hydroxylamine hydrochloride (0.73 g; 10.5 mmol) in water (25 mL), 
was added sodium carbonate (1.12 g; 10.57 mmol) in small portions. To this, 2-
cyanopyrimidine (1.0 g; 9.51 mmol) in ethanol (25 mL) was added and the reaction mixture 
was left at reflux for 24 h. After this, the mixture was extracted with dichloromethane (25 mL 
x 2) and then solvents were removed in vacuo to give the title compound. 
White solid 1.2 g, 91 % yield; mp 143 - 144 ºC, not reported. 
1
H NMR (400 MHz, CDCl3) δ ppm 10.19 (1H, s, br, OH), 8.84 (2H, d, J = 4.8 Hz, Ar), 7.51 
(1H, t, J = 4.8 Hz, Ar), 5.84 (2H, s, NH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 158.7 (C), 157.7 (CH), 149.4 (C), 121.6 (CH). 
IR max (cm
-1
) 3416, 3324, 1650, 1561, 1455, 1375, 1002, 938, 808, 790, 663, 529. 
Previously reported.
112e 
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3.21. (Z)-N-((Hydroxyimino)(pyrimidin-2-yl)methyl)-2-phenylacetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of phenylacetic acid (0.136 g; 1.0 mmol) and 
triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added in one 
portion to the reaction mixture. After 15 minutes, (Z)-N'-hydroxypyrimidine-2-
carboximidamide 228b (0.15 g; 1.1 mmol) was added and the reaction mixture was left at 
room temperature overnight. The solvents were removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
Rf 0.1 (ethyl acetate/dichloromethane = 1:1); white solid 0.18 g, 64 % yield; mp 182 - 183 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.94 (2H, d, J = 4.8 Hz, Ar), 7.41 - 7.28 (6H, m, Ar), 
7.01 (1H, br. s, OH), 7.69 (1H, br. s, NH), 3.85 (2H, s, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 169.2 (C=O), 158.1 (CH), 157.9 (C), 154.5 (C), 135.0 
(C), 129.9 (CH), 128.8 (CH), 127.3 (CH), 123.0 (CH), 39.6 (CH2).  
IR max (cm
-1
) 3411, 3303, 1731, 1621, 1590, 1384, 1305, 1240, 1126, 943, 890, 819, 768, 
694, 602. 
MS (ESI)
+
 : m/z [M + H] 257.1. 
HRMS: [M] for C13H12N4O2 calculated 256.0960, found 256.0963. 
New compound. 
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3.22. 5-Benzyl-3-(pyrimidin-2-yl)-1,2,4-oxadiazole 
 
(Z)-N-((Hydroxyimino)(pyrimidin-2-yl)methyl)-2-phenylacetamide 242e (0.17 g; 0.68 mmol) 
was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 h with 
stirring. After this, the mixture was allowed to cool to rt and then solvents removed in vacuo. 
The crude product was purified by flash chromatography affording the title compound. 
Rf 0.3 (ethyl acetate/dichloromethane = 1:1); white solid 0.14 g, 86 % yield; mp 113 - 114 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.86 (2H, d, J = 4.8 Hz, Ar), 7.34 (1H, t, J = 4.8 Hz, Ar), 
7.30 - 7.23 (4H, m, Ar), 7.20 (1H, d, J = 7.1 Hz, Ar), 4.28 (2H, s, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 179.2 (C), 158.1 (CH), 159.9 (C), 154.5 (C), 135.0 (C), 
129.9 (CH), 128.8 (CH), 127.3 (CH), 123.0 (CH), 39.6 (CH2). 
IR max (cm
-1
) 2931, 1575, 1558, 1455, 1417, 1371, 1211, 1191, 903, 825, 725, 704, 692. 
MS (ESI)
+
 : m/z [M + H] 239.1. 
HRMS: [M] for C13H10N4O calculated 238.0855, found 238.0859. 
New compound. 
3.23. (Z)-N-((Hydroxyimino)(pyrimidin-2-yl)methyl)-2-(p-tolyl)acetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of p-tolylacetic acid (0.15 g; 0.99 mmol) and 
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triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added in one 
portion to the reaction mixture. After 15 minutes, (Z)-N'-hydroxypyrimidine-2-
carboximidamide 228b (0.15 g; 1.1 mmol) was added and the reaction mixture was left at 
room temperature overnight. The solvents were removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
Rf 0.1 (ethyl acetate/hexane = 1:1); white solid 0.23 g, 78 % yield; mp 183 - 184 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.83 (2H, d, J = 4.8 Hz, Ar), 7.39 (1H, t, J =  4.8 Hz, Ar), 
7.24 (2H, d, J = 7.8 Hz, Ar), 7.14 (2H, d, J = 7.8 Hz, Ar), 6.15 (1H, s, OH), 5.59 (1H, s, NH), 
3.85 (2H, s, CH2), 2.34 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.5 (C=O), 157.3 (CH), 157.0 (C), 152.7 (C), 136.7 
(C), 130.6 (C), 129.3 (CH), 129.1 (CH), 122.1 (CH), 39.9 (CH2), 21.1 (CH3). 
IR max (cm
-1
) 3424, 3318, 1741, 1625, 1556, 1377, 1332, 1187, 1127, 899, 827, 806, 769, 
670, 644, 589. 
MS (ESI)
+
 : m/z [M + H] 271.1. 
HRMS: [M] for C14H14N4O2 calculated 270.1117, found 270.1125. 
New compound. 
3.24. 5-(4-Methylbenzyl)-3-(pyrimidin-2-yl)-1,2,4-oxadiazole 
 
(Z)-N-((Hydroxyimino)(pyrimidin-2-yl)methyl)-2-(p-tolyl)acetamide 242f (0.15 g; 0.56 
mmol) was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 h 
with stirring. After this, the mixture was allowed to cool to rt and then solvents removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
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Rf 0.26 (ethyl acetate/dichloromethane = 1:1); yellow oil 0.1 g, 71 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.90 (2H, d, J = 4.9 Hz, Ar), 7.39 (1H, t, J = 4.9 Hz, Ar), 
7.23 (2H, d, J = 7.8 Hz, Ar), 7.10 (2H, d, J = 7.8 Hz, Ar), 4.29 (2H, s, CH2), 2.27 (3H, s, 
CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 179.6 (C), 167.7 (C), 157.9 (CH), 156.0 (C), 137.4 (C), 
129.9 (C), 129.6 (CH), 128.8 (CH), 122.1 (CH), 32.7 (CH2), 21.0 (CH3). 
IR max (cm
-1
) 2966, 2933, 1612, 1537, 1423, 1342, 1249, 1182, 1022, 840, 779, 750. 
MS (ESI)
+
 : m/z [M + H] 253.1. 
HRMS: [M] for C14H14N4O calculated 252.1011, found 252.1016. 
New compound. 
3.25. (Z)-N-((Hydroxyimino)(pyrimidin-2-yl)methyl)-2-(4-methoxyphenyl)acetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of 4-methoxyphenylacetic acid (0.15 g; 1.0 
mmol) and triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added 
in one portion to the reaction mixture. After 15 minutes, (Z)-N'-hydroxypyrimidine-2-
carboximidamide 228b (0.15 g; 1.1 mmol) was added and the reaction mixture was left at 
room temperature overnight. The solvents were removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
Rf 0.08 (ethyl acetate/hexane = 1:1); white solid 0.19 g, 61 % yield; mp 181 - 182 ºC. 
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1
H NMR (400 MHz, CDCl3) δ ppm 8.85 (2H, d, J = 4.8 Hz, Ar), 7.41 (1H, t, J = 4.8 Hz, Ar), 
7.29 (2H, d, J = 8.4 Hz, Ar), 6.89 (2H, d, J = 8.4 Hz, Ar), 6.15 (1H, br. s, OH), 5.32 (1H, br. 
s, NH), 3.84 (2H, s, CH2), 3.82 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.6 (C=O), 158.7 (C), 157.3 (CH), 157.0 (C), 152.7 
(C), 130.3 (CH), 125.7 (C), 122.1 (CH), 114.0 (CH), 55.2 (CH3), 39.5 (CH2).  
IR max (cm
-1
) 3424, 3318, 1784, 1615, 1589, 1440, 1337, 1310, 779, 698. 
MS (ESI)
+
 : m/z [M + H] 287.1. 
HRMS: [M] for C14H14N4O3 calculated 286.1066, found 286.1073. 
New compound. 
3.26. 5-(4-Methoxybenzyl)-3-(pyrimidin-2-yl)-1,2,4-oxadiazole 
 
(Z)-N-((Hydroxyimino)(pyrimidin-2-yl)methyl)-2-(4-methoxyphenyl)acetamide 242g (0.14 g; 
0.49 mmol) was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 
h with stirring. After this, the mixture was allowed to cool to rt and then solvents removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.32 (ethyl acetate/dichloromethane = 1:1); light yellow solid 0.09 g, 68 % yield; mp 111-
112 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.90 (2H, d, J = 4.9 Hz, Ar), 7.40 (1H, t, J = 4.9 Hz, Ar), 
7.32 - 7.28 (2H, d, J = 8.4 Hz, Ar), 6.82 (2H, d, J = 8.4 Hz, Ar), 4.27 (2H, s, CH2), 3.77 (3H, 
s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 179.8 (C), 167.7 (C), 159.0 (C), 157.9 (CH), 156.0 (C), 
130.3 (CH), 125.0 (C), 122.1 (CH), 114.3 (CH), 55.2 (CH3), 32.1 (CH2). 
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IR max (cm
-1
) 2998, 2933, 1613, 1577, 1560, 1560, 1443, 1372, 1302, 1240, 1175, 1034, 900, 
826. 
MS (ESI)
+
 : m/z [M + H] 269.1. 
HRMS: [M] for C14H12N4O2 calculated 268.0960, found 268.0964. 
New compound. 
3.27. (Z)-N'-Hydroxy-3-methylpicolinimidamide 
 
To a stirred solution of hydroxylamine hydrochloride (0.73 g; 10.5 mmol) in water (25 mL), 
was added sodium carbonate (1.12 g; 10.57 mmol) in small portions. To this, 3-
methylpicolinonitrile (1.12 g; 9.48 mmol) in ethanol (25 mL) was added and the reaction 
mixture was left to reflux for 24 h. After this, the mixture was extracted with dichloromethane 
(25 mL x 2) and then solvents were removed in vacuo to give the title compound. 
White solid 1.12 g, 78 % yield; mp 95 - 96 ºC, m.p. not reported previously. 
1
H NMR (400 MHz, CDCl3) δ ppm 9.26 (1H, br. s, OH), 8.45 - 8.43 (1H, m, Ar), 7.56 (1H, 
d, J = 7.5 Hz, Ar), 7.22 (1H, dd, J = 7.5 and 4.8 Hz), 5.72 (2H, s, NH2), 2.58 (CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 152.7 (C), 147.5 (C), 145.8 (CH), 139.8 (CH), 133.0 (C), 
123.6 (CH), 21.5 (CH3). 
IR max (cm
-1
) 3457, 3345, 1638, 1561, 1451, 1405, 1369, 1111, 920, 859, 782, 687, 651, 509. 
Previously reported.
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3.28. (Z)-N-((Hydroxyimino)(3-methylpyridin-2-yl)methyl)-2-phenylacetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of phenylacetic acid (0.136 g; 1.0 mmol) and 
triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added in one 
portion to the reaction mixture. After 15 minutes, (Z)-N'-hydroxy-3-methylpicolinimidamide 
228c (0.17 g; 1.1 mmol) was added and the reaction mixture was left at room temperature 
overnight. The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.48 (ethyl acetate/dichloromethane = 1:1); white solid 0.167 g, 56 % yield; mp 115 - 116 
ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.36 - 8.34 (1H, m, Ar), 7.50 (1H, d, J = 7.7 Hz, Ar), 
7.28 - 7.25 (3H, m, Ar), 7.26 - 7.16 (3H, m, Ar), 5.71 (1H, br. s, OH), 5.21 (1H, br. s, NH), 
3.79 (CH2), 2.59 (CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 169.1 (C=O), 155.7 (C), 146.1 (C), 145.8 (CH), 140.2 
(CH), 134.5 (C), 133.8 (C), 129.3 (CH), 128.6 (CH), 127.2 (CH), 124.6 (CH), 40.3 (CH2), 
21.7 (CH3). 
IR max (cm
-1
) 3337, 3303, 1727, 1614, 1571, 1452, 1337, 1213, 1143, 1107, 929, 882, 803, 
711. 
MS (ESI)
+
 : m/z [M + H] 270.1. 
HRMS: [M] for C15H15N3O2 calculated 269.1164, found 269.1166. 
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3.29. 5-Benzyl-3-(3-methylpyridin-2-yl)-1,2,4-oxadiazole 
 
(Z)-N-((Hydroxyimino)(3-methylpyridin-2-yl)methyl)-2-phenylacetamide 242h (0.13 g; 0.48 
mmol) was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 h 
with stirring. After this, the mixture was allowed to cool to rt and then solvents removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.54 (ethyl acetate/dichloromethane; 1:1); yellow oil 0.087 g, 72 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.68 - 8.64 (1H, m, Ar), 7.67 (1H, d, J = 7.6 Hz, Ar), 
7.42 - 7.38 (3H, m, Ar), 7.35 - 7.29 (3H, m, Ar), 4.38 (2H, s, CH2), 2.65 (3H, s, CH3).  
13
C NMR (100 MHz, CDCl3) δ ppm 177.7 (C), 168.6 (C), 147.5 (CH), 144.9 (C), 139.4 (CH), 
134.5 (C), 133.4 (C), 129.0 (CH), 128.9 (CH), 127.6 (CH), 124.7 (CH), 33.0 (CH2), 20.6 
(CH3). 
MS (ESI)
+
 : m/z [M + H] 252.1. 
HRMS: [M] for C15H13N3O calculated 251.1059, found 251.1058. 
New compound. 
3.30. (Z)-N-((Hydroxyimino)(3-methylpyridin-2-yl)methyl)-2-(p-tolyl)acetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of p-tolylacetic acid (0.15 g; 0.99 mmol) and 
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triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added in one 
portion to the reaction mixture. After 15 minutes, (Z)-N'-hydroxy-3-methylpicolinimidamide 
228c (0.17 g; 1.1 mmol) was added and the reaction mixture was left at overnight. The 
solvents were removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
Rf 0.48 (ethyl acetate/dichloromethane = 1:1); white solid 0.19 g 61 % yield; mp 125 - 126 
ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.46 - 8.44 (1H, m, Ar), 7.60 (1H, d, J = 7.5 Hz, Ar), 
7.29 - 7.25 (3H, m, Ar), 7.18 (2H, d, J = 7.8 Hz, Ar), 5.75 (1H, s, OH), 5.31 (1H, s, NH), 3.85 
(2H, s, CH2), 2.69 (3H, s, CH3), 2.36 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 169.3 (C=O), 155.7 (C), 146.1 (C), 145.8 (CH), 140.1 
(CH), 136.8 (C), 134.4 (C), 130.8 (C), 129.3 (CH), 129.1 (CH), 124.5 (CH), 39.9 (CH2), 21.7 
(CH3), 21.1 (CH3). 
IR max (cm
-1
) 3378, 3304, 1732, 1695, 1620, 1516, 1336, 1220, 1205, 1144, 1106, 889, 803, 
768.  
MS (ESI)
+
 : m/z [M + H] 284.1. 
HRMS: [M] for C16H17N3O2 calculated 283.1321, found 283.1322. 
New compound. 
3.31. 5-(4-Methylbenzyl)-3-(3-methylpyridin-2-yl)-1,2,4-oxadiazole 
 
(Z)-N-((Hydroxyimino)(3-methylpyridin-2-yl)methyl)-2-(p-tolyl)acetamide 242i (0.12 g; 0.42 
mmol) was added to xylene (10 mL) and the reaction mixture was heated at reflux for 18 h 
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with stirring. After this, the mixture was allowed to cool to rt and then solvents removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.51 (ethyl acetate/dichloromethane = 1:1); yellow oil 0.077 g, 68 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.66 - 8.64 (1H, m, Ar), 7.65 (1H, d, J = 7.7 Hz, Ar), 
7.33 - 7.28 (3H, m, Ar), 7.16 (2H, d, J = 7.7 Hz, Ar), 4.32 (2H, s, CH2), 2.63 (3H, s, CH3), 
2.33 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 177.9 (C), 168.5 (C), 147.5 (CH), 144.9 (C), 139.3 (CH), 
137.3 (C), 134.5 (C), 130.3 (C), 129.6 (CH), 128.9 (CH), 124.7 (CH), 32.6 (CH2), 21.0 (CH3), 
20.6 (CH3). 
IR max (cm
-1
) 3031, 2927, 1564, 1513, 1358, 1140, 1107, 1038, 972, 886, 803, 786, 774, 727, 
702, 677. 
MS (ESI)
+
 : m/z [M + H] 266.1. 
HRMS: [M] for C16H15N3O calculated 265.1215, found 265.1205. 
New compound. 
3.32. (Z)-N-((Hydroxyimino)(3-methylpyridin-2-yl)methyl)-2-(4-
methoxyphenyl)acetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of 4-methoxyphenylacetic acid (0.15 g; 1.0 
mmol) and triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added 
in one portion to the reaction mixture. After 15 minutes, (Z)-N'-hydroxy-3-
methylpicolinimidamide 228c (0.17 g; 1.1 mmol) was added and the reaction mixture was left 
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at room temperature overnight. The solvents were removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
Rf 0.37 (ethyl acetate/dichloromethane = 1:1); white solid 0.2 g, 61 % yield; mp 127 - 128 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.36 - 8.34 (1H, m, Ar), 7.50 (1H, d, J = 7.6 Hz, Ar), 
7.20 - 7.13 (3H, m, Ar), 6.80 (2H, d, J = 8.1 Hz, Ar), 5.67 (1H, br. s, OH), 5.43 (1H, br. s, 
NH), 3.72 (2H, s, CH2), 3.71 (3H, s, CH3), 2.58 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 169.5 (C=O), 158.7 (C), 155.6 (C), 146.1 (C), 145.8 
(CH), 140.2 (CH), 134.4 (C), 130.3 (CH), 125.9 (C), 124.6 (CH), 114.0 (CH), 55.2 (CH3), 
39.4 (CH2), 21.7 (CH3). 
IR max (cm
-1
) 3446, 3330, 1726, 1614, 1558, 1513, 1465, 1407, 1379, 1331, 1245, 1151, 
1110, 1032, 884, 804, 725, 579. 
MS (ESI)
+
 : m/z [M + H] 300.1. 
HRMS: [M] for C16H17N3O3 requires 299.1270, found 299.1262. 
New compound. 
3.33. 5-(4-Methoxybenzyl)-3-(3-methylpyridin-2-yl)-1,2,4-oxadiazole 
 
(Z)-N-((Hydroxyimino)(3-methylpyridin-2-yl)methyl)-2-(4-methoxyphenyl)acetamide 242j 
(0.16 g; 0.53 mmol) was added to xylene (10 mL) and the reaction mixture was heated at 
reflux for 18 h with stirring. After this, the mixture was allowed to cool to rt and then solvents 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.47 (ethyl acetate/dichloromethane = 1:1); yellow oil 0.13 g, 86 % yield. 
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1
H NMR (400 MHz, CDCl3) δ ppm 8.90 (2H, d, J = 4.8 Hz, Ar), 7.40 - 7.38 (1H, dd, J = 4.8 
and 4.8 Hz, Ar), 7.26 (2H, d, J = 8.4 Hz, Ar), 6.82 (2H, d, J = 8.4 Hz, Ar), 4.26 (2H, s, CH2), 
3.73 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 178.0 (C), 168.5 (C), 159.0 (C), 147.5 (CH), 144.9 (C), 
139.4 (CH), 134.5 (C), 130.1 (CH), 125.4 (C), 124.7 (CH), 114.3 (CH), 55.2 (OCH3), 32.1 
(CH2), 20.6 (CH3). 
IR max (cm
-1
) 2981, 2937, 1726, 1614, 1558, 1513, 1465, 1407, 1379, 1331, 1245, 1151, 
1110, 1032, 884, 804, 725. 
MS (ESI)
+
 : m/z [M + H] 282.1. 
HRMS: [M] for C16H15N3O2 calculated 281.1164, found 281.1163. 
New compound. 
3.34. (Z)-2-(4-Chlorophenyl)-N-((hydroxyimino)(3-methylpyridin-2-yl)methyl)acetamide 
 
To a stirred solution of diphenylcyclopropenone (0.23 g; 1.1 mmol) in dichloromethane (15 
mL), was added oxalyl chloride (0.13 g; 0.084 mL; 1.0 mmol) dropwise under an inert 
atmosphere at rt. After 5 minutes, a mixture of 4-methoxyphenylacetic acid (0.17 g; 1.0 
mmol) and triethylamine (0.22 g; 0.31 mL; 2.2 mmol) in dichloromethane (15 mL) was added 
in one portion to the reaction mixture. After 15 minutes, Nˈ-hydroxypyridine-2-
carboxamidine 228c (0.17 g; 1.1 mmol) was added and the reaction mixture was left at room 
temperature overnight. The solvents were removed in vacuo. The crude product was purified 
by flash chromatography affording the title compound. 
Rf 0.39 (ethyl acetate/dichloromethane = 1:5); white solid 0.19 g, 57 % yield; mp 137 - 138 
ºC.  
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1
H NMR (400 MHz, CDCl3) δ ppm 8.46 (1H, d, J = 4.9 Hz, Ar), 7.61 (1H, d, J = 7.7 Hz, Ar), 
7.36 - 7.31 (3H, m, Ar), 7.30 - 7.27 (2H, m, Ar), 5.75 (1H, br. s, OH), 5.39 (1H, br. s, NH), 
3.87 (2H, s, CH2), 2.69 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.8 (C=O), 155.7 (C), 145.9 (C), 145.8 (CH), 140.2 
(CH), 134.4 (C), 133.1 (C), 132.2 (C), 130.7 (CH), 128.8 (CH), 124.6 (CH), 39.5 (CH2), 21.8 
(CH3). 
IR max (cm
-1
) 3381, 3304, 1730, 1621, 1607, 1568, 1492, 1446, 1406, 1381, 1335, 1211, 
1155 MS (ESI)
+
 : m/z [M+H] 230.1., 1108, 1088, 1012, 884, 804, 764, 732, 684, 666, 642.  
MS (ESI)
+
 : m/z [M + H] 304.1. 
HRMS: C15H14
35
ClN3O2 calculated 303.0775, found 303.0772. 
New compound. 
3.35. 5-(4-Chlorobenzyl)-3-(3-methylpyridin-2-yl)-1,2,4-oxadiazole 
 
(Z)-2-(4-Chlorophenyl)-N-((hydroxyimino)(3-methylpyridin-2-yl)methyl)acetamide 242k 
(0.15 g; 0.53 mmol) was added to xylene (10 mL) and the reaction mixture was heated at 
reflux for 18 h with stirring. After this, the mixture was allowed to cool to rt and then solvents 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.47 (ethyl acetate/dichloromethane = 1:1); yellow oil 0.11 g, 70 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.68 -8.64 (1H, d, J = 4.4 Hz, Ar), 7.67 (1H, d, J = 7.7 
Hz, Ar), 7.36 - 7.28 (5H, m, Ar), 4.34 (2H, s, CH2), 2.64 (3H, s, CH3). 
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13
C NMR (100 MHz, CDCl3) δ ppm 177.2 (C), 168.6 (C), 147.6 (CH), 144.7 (C), 139.4 (CH), 
134.6 (C), 133.7 (C), 131.8 (C), 130.4 (CH), 129.1 (CH), 124.8 (CH), 32.3 (CH2), 20.7 (CH3). 
IR max (cm
-1
) 2931, 1556, 1491, 1454, 1416, 1350, 1091, 1015, 895, 801, 784, 772, 722, 701. 
MS (ESI)
+
 : m/z [M + H] 286.1. 
 HRMS: [M] for C15H12
35
ClN3O calculated 285.0669, found 285.0666. 
New compound. 
3.36. 4-Phenylazetidin-2-one 
 
To a stirred solution of styrene (3.70; 31.90 mmol) in dry diethyl ether (15 mL), N-
chlorosulfonyl isocyanate (3.20 mL; 37.10 mmol) was added dropwise at rt under an inert N2 
atmosphere over 10 min. The reaction mixture was kept at rt for 2 h with stirring, and then 
solvent was removed in vacuo to give an oily residue. After that diethyl ether (20 mL) was 
added and this solution was added dropwise to a vigorously stirred solution of water (30 mL), 
sodium carbonate (9.00 g; 107.10 mmol), sodium sulfite (6.01 g, 47.60 mmol) and ice (40 g) 
over 10 min. The reaction mixture was kept at rt for 1 h with stirring and filtered under 
vacuum. After separation, the aqueous phase was washed with dichloromethane (10 mL x 5), 
and then the combined organic extracts were dried (MgSO4) and the solvents were removed in 
vacuo.  The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.65 (ethyl acetate/petroleum ether = 3:1); white solid 0.75 g, 57 % yield; mp 111 - 112 ºC; 
lit.,
8
 mp 102 - 103 ºC. 
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1
H NMR (400 MHz, CDCl3) δ ppm 7.42 - 7.30 (5H, m, Ph), 6.15 (1H, br. s, NH), 4.75 (1H, 
dd, J = 5.3 Hz and 2.3 Hz, CH), 3.47 (1H, ddd, J = 14.9, 5.3 and 2.3 Hz, CH2), 2.92 (1H, dd, J 
= 14.9 and 2.3 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.0 (C=O), 140.2 (C), 128.9 (CH), 128.3 (CH), 125.7 
(CH), 50.4 (CH), 48.1 (CH2). 
IR max (cm
-1
) 3208, 1706, 1677, 1453, 1367, 1170, 961, 695. 
As reported previously.
8 
2.37. 4-Phenylazetidin-2-thione 
 
To a stirred solution of 4-phenylazetidin-2-one 255a (1.07 g; 7.31 mmol) in dry 
tetrahydrofuran (15 mL), was added Lawesson’s reagent (1.54 g; 3.80 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was heated at reflux for 2 h. After this time, the 
reaction mixture was allowed to cool to rt and the solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound. 
Rf 0.65 (ethyl acetate/petroleum ether = 1:3); white solid 0.91 g, 66 % yield; mp 113-114 ºC; 
lit.,
8
 mp 117-118 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.19 (1H, br. s, NH), 7.44 – 7.36 (5H, m, Ph), 5.20 (1H, 
dd, J = 4.6 Hz and 2.1 Hz, CH), 3.53 (1H, ddd, J = 15.5, 4.6, and 2.1 Hz, CH2), 3.08 (1H, dd, 
J = 15.5 and 2.1 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 204.5 (C=S), 138.1 (C), 129.1 (CH), 128.9 (CH), 125.8 
(CH), 58.9 (CH), 51.3 (CH2). 
 IR max (cm
-1
) 3136, 2926, 1486, 1489, 1235, 979, 754, 684.  
As reported previously.
8 
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3.38. 2-Methylthio-4-phenyl-1-azetine 
 
Trimethyloxonium tetrafluoroborate (0.16 g; 1.06 mmol) was added in one portion to 4-
phenylazetidin-2-thione 256a (0.10 g; 0.61 mmol) in anhydrous dichloromethane (3.5 mL). 
The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at reflux for 
1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % aqueous 
solution of potassium carbonate (10 mL) added dropwise at - 78 ºC. The solution was filtered 
through Celite
®
 and the organic layer was separated. The water phase was washed with 
dichloromethane (10 mL x 2), and the combined organic extracts were dried over (MgSO4). 
The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.67 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.055 g, 51 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.30 - 7.17 (5H, m, Ph), 4.93 (1H, dd, J = 4.3 and 2.1 Hz, 
CH), 4.28 (1H, dd, J = 14.6 and 4.3 Hz, CH2), 2.90 (1H, dd, J = 14.6 and 2.1 Hz, CH2), 2.39 
(3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 183.9 (C), 140.8 (C), 128.5 (CH), 127.5 (CH), 126.1 
(CH), 64.9 (CH), 43.1 (CH2), 11.5 (CH3). 
IR max (cm
-1
)  3031, 2943, 1516, 1437, 1264, 1029, 859, 755, 688. 
As reported previously.
8 
3.39. 2-Ethylthio-4-phenyl-1-azetine 
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Triethyloxonium tetrafluoroborate (0.20 g; 1.06 mmol) was added in one portion to 4-
phenylazetidin-2-thione 256a (0.10 g; 0.61 mmol) in anhydrous dichloromethane (3.5 mL). 
The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at reflux for 
1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % aqueous 
solution of potassium carbonate (10 mL) was added dropwise at - 78 ºC. The solution was 
then filtered through Celite
® 
and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried 
(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.66 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.074 g, 63 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.43 - 7.20 (5H, m, Ph), 5.05 (1H, dd, J = 4.3 and 2.1 Hz, 
CH), 3.59 (1H, dd, J = 14.7 and 4.3 Hz, CH2), 3.08 (2H, q, J = 7.5 Hz, CH2), 2.99 (1H, dd, J 
= 14.7 and 2.1 Hz, CH2), 1.43 (3H, t, J = 7.5, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm, 183.7 (C), 140.9 (C), 128.5 (CH), 127.4 (CH), 126.1 
(CH), 65.2 (CH), 43.7 (CH2), 23.5 (CH2), 11.5 (CH3). 
IR max (cm
-1
) 3021, 2961, 1522, 1419, 1224, 1067, 887, 757, 697. 
As reported previously.
8 
3.40. 5-Methylthio-7-phenyl-2,3-bis(p-tolyl)-1-azabicyclo[3.2.0]hept-2-en-4-one 
 
To a stirred solution of 2-methylthio-4-phenyl-1-azetine 257a (0.04 g; 0.21 mmol) in 
anhydrous acetonitrile (5 mL), was added 2,3-bis(p-tolyl)cycloprop-2-ene-1-one 241 (0.05 g; 
0.21 mmol) at rt under an inert N2 atmosphere. The reaction mixture was stirred at rt for 72 h 
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and then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound as a mixture of diastereoisomers (1:1).  
Rf 0.58 (ethyl acetate/petroleum ether = 1:5); orange yellow solid 0.045 g, 65 % yield; mp 
138-139 ºC. 
 1
H NMR (400 MHz, CDCl3) δ ppm 7.53 (2 x diastereo, 2H, d, J = 7.3, Ar), 7.37 – 6.82 (2 x 
diastereo, 22H, m, Ar), 6.66 (2 x diastereo, 2H, d, J = 8.0 Hz, Ar), 5.45 (1 x diastereo, 1H, t, J 
= 8.3 Hz, PhCH), 4.15 (1 x diastereo, 1H, dd, J = 9.6 and 5.6 Hz, PhCH), 3.06 (1 x diastereo, 
1H, dd, J = 12.6 and 9.6 Hz, CH2), 2.93 – 2.83 (2 x diastereo, 2H, m, CH2), 2.38 (1 x 
diastereo, 1H, dd, J = 12.6 and 5.6 Hz, CH2), 2.31 (3H, s, CH3), 2.22 (3H, s, CH3), 2.17 (3H, 
s, CH3), 2.11 (3H, s, CH3), 2.02, (3H, s, CH3), 1.97 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 202.7, 202.5 (C=O), 177.2 (C), 174.9 (C), 142.5 (C), 
141.1 (C), 141.5 (C), 137.1 (C), 136.7 (C), 135.3 (C), 130.1 (CH), 129.5 (CH), 129.3 (CH), 
129.2 (CH), 129.1 (C), 129.0 (CH), 128.9 (CH), 128.7 (CH), 128.6 (CH), 128.5 (CH), 128.4 
(CH), 128.3 (CH), 128.2 (C), 128.1 (C), 127.8 (CH), 127.7 (CH), 127.2 (C), 126.9 (CH), 
125.8 (C), 123.4 (C), 76.6 (C), 76.5 (C), 66.4 (CH), 65.9 (CH), 34.5 (CH2), 31.2 (CH2), 21.6 
(CH3), 21.5 (CH3), 21.3 (CH3), 21.2 (CH3), 11.7 (CH3), 11.5 (CH3). 
IR max (cm
-1
) 2986, 2906, 1675, 1579, 1496, 1372, 1182, 1018, 821, 758, 733, 696, 517. 
MS (ESI)
+
 : m/z [M+H] 412.2. 
 HRMS: [M] for C27H25NOS calculated 411.1657, found 411.1664.  
New compound. 
3.41. 6-Methylthio-4-phenyl-2,3-bis(p-tolyl)pyridine 
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5-Methylthio-7-phenyl-2,3-bis(p-tolyl)-1-azabicyclo[3.2.0]hept-2-en-4-one 269a (0.03 g; 0.08 
mmol) was added to toluene (10 mL) and the reaction mixture was heated at reflux for 16 h 
with stirring. After this, the mixture was allowed to cool to rt and then solvents removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.48 (ethyl acetate/petroleum ether = 1:5); brown solid 0.019 g, 58 % yield; mp 180-181 
ºC. 
 
1
H NMR (400 MHz, CDCl3) δ ppm 7.20 - 7.11 (5H, m, Ar), 7.09 (1H, s, pyrid H), 6.97 – 
6.95 (2H, m, Ar), 6.91 (2H, d, J = 7.8 Hz, Ar), 6.77 (2H, d, J = 7.8 Hz, Ar), 6.65 (2H, d, J = 
7.8 Hz, Ar), 2.57 (3H, s, SCH3), 2.21 (3H, s, PhCH3), 1.15 (3H, s, PhCH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 157.5 (C), 157.4 (C), 150.2 (C), 139.5 (C), 137.6 (C), 
137.1 (C), 135.9 (C), 134.6 (C), 131.2 (CH), 129.9 (CH), 129.2 (CH), 129.0 (C), 128.4 (CH), 
128.2 (CH), 127.8 (CH), 127.2 (CH), 120.8 (CH), 21.2 (CH3), 21.1 (CH3), 13.3 (CH3). 
IR max (cm
-1
) 2955, 1555, 1510, 1491, 1354, 1159, 830, 815, 726, 701, 611. 
MS (ESI)
+
 : m/z [M + H] 382.2. 
HRMS: [M] for C26H23NS calculated 381.1551, found 381.1581. 
New compound 
3.42. 5-Ethylthio-7-phenyl-2,3-bis(p-tolyl)-1-azabicyclo[3.2.0]hept-2-en-4-one 
 
To a stirred solution of 2-ethylthio-4-phenyl-1-azetine 257b (0.04 g; 0.21 mmol) in anhydrous 
acetonitrile (5 mL), was added 2,3-bis(p-tolyl)cyclopropenone 241 (0.05 g; 0.21 mmol) at rt 
under an inert N2 atmosphere. The reaction mixture was stirred at rt for 72 h and then solvents 
were removed in vacuo. The crude product was purified by flash chromatography affording 
the title compound as a mixture of diastereoisomers (2:1). 
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Rf 0.29 (ethyl acetate/petroleum ether = 1:5); orange yellow solid 0.070 g, 67 % yield; mp 
143 - 144 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.53 (2 x  diastereo, 2H, d, J = 7.4, Ar), 7.34 – 6.81 (2 x 
diastereo, 22H, m, Ar), 6.65 (2 x diastereo, 2H, d, J = 8.1 Hz, Ar), 5.45 (1 x diastereo, 1H, t, J 
= 8.3 Hz, PhCH), 4.15 (1 x diastereo, 1H, dd, J = 9.7 and 5.5 Hz, PhCH), 3.06 (1 x diastereo, 
1H, dd, J = 12.7 and 9.7 Hz, CHCH2), 2.92 – 2.81 (2 x diastereo, 2H, m, CHCH2), 2.35 – 2.44 
(1 x diastereo, 1H, m, CHCH2), 2.45 – 2.76 (2 x diastereo, 4H, m, CH3CH2), 2.27 (3H, s, 
CH3), 2.17 (3H, s, CH3), 2.14 (3H, s, CH3), 2.08, (3H, s, CH3), 1.12 – 1.17 (6H, m, 2 x CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 203.0, 202.4 (C=O), 176.7 (C), 174.6 (C), 142.4 (C), 
141.6 (C), 141.0 (C), 137.0 (C), 136.6 (C), 135.4 (C), 130.1 (CH), 129.5 (CH), 129.4 (CH), 
129.3 (C), 129.3 (CH), 128.2 (CH), 129.0 (CH), 128.9 (CH), 128.8 (CH), 128.7 (CH), 128.6 
(CH), 128.4 (C), 128.2 (C), 127.8 (CH), 127.7 (CH), 127.1 (C), 125.7 (C), 123.3 (C), 76.8 
(C), 76.7 (C), 66.6 (CH), 65.9 (CH), 35.3 (CH2), 31.9 (CH2), 23.7 (CH2), 23.6 (CH2), 21.6 
(CH3), 21.5 (CH3), 21.4 (CH3), 21.3 (CH3), 14.6 (CH3), 14.5 (CH3). 
IR max (cm
-1
) 2988, 2945, 1677, 1608, 1495, 1374, 1242, 1013, 821, 757, 743, 696. 
MS (ESI)
+
 : m/z [M + H] 426.2. 
HRMS: [M + H] for C28H28NOS calculated 426.1813, found 426.1886. 
New compound. 
3.43. 6-Ethylthio-4-phenyl-2,3-bis(p-tolyl)pyridine 
 
5-Ethylthio-7-phenyl-2,3-bis(p-tolyl)-1-azabicyclo[3.2.0]hept-2-en-4-one 269b (0.03 g; 0.08 
mmol) was added to toluene (10 mL) and the reaction mixture was heated at reflux for 16 h 
with stirring. After this, the mixture was allowed to cool to rt and then solvents removed in 
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vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.49 (ethyl acetate/petroleum ether = 1:5); brown solid 0.022 g, 67 % yield; mp 189 - 190 
ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.15 – 7.08 (5H, m, Ar), 7.07 (1H, s, pyrid H), 6.97 - 
6.94 (2H, m, Ar), 6.90 (2H, d, J = 8.0 Hz, Ar), 6.77 (2H, d, J = 8.0 Hz, Ar), 6.65 (2H, d, J = 
8.0, Hz, Ar), 3.19 (2H, q, J = 7.3 Hz, CH2), 2.22 (3H, s, PhCH3), 2.16 (3H, s, PhCH3), 1.36 
(3H, t, J = 7.3 Hz, CH2CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 157.4 (C), 157.0 (C), 149.7 (C), 139.2 (C), 137.5 (C), 
136.6 (C), 135.5 (C), 134.3 (C), 130.9 (CH), 129.6 (CH), 128.8 (CH), 128.4 (C), 127.9 (CH), 
127.7 (CH), 127.4 (CH), 126.7 (CH), 121.0 (CH), 20.9 (CH3), 20.8 (CH3), 24.1 (CH2), 14.6 
(CH3). 
IR max (cm
-1
) 2966, 1554, 1510, 906, 812, 765, 727, 710, 611. 
MS (ESI)
+
 : m/z [M + H] 396.2. 
HRMS: [M] for C27H25NS calculated 395.1708, found 395.1726. 
New compound. 
3.44. 5-Methylthio-7-phenyl-2,3-bis(p-methoxyphenyl)-1-azabicyclo[3.2.0]hept-2-en-4-
one 
 
To a stirred solution of 2-methylthio-4-phenyl-1-azetine 257a (0.03 g; 0.19 mmol) in 
anhydrous acetonitrile (5 mL), was added 2,3-bis(p-methoxyphenyl)cycloprop-2-en-1-one 
237 (0.05 g; 0.19 mmol) at rt under an inert N2 atmosphere. The reaction mixture was stirred 
at rt for 72 h and then solvents were removed in vacuo. The crude product was purified by 
flash chromatography affording the title compound as a single diastereoisomer. The crude 
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material was observed as a mixture of diastereoisomers (4:1) but unfortunately we could not 
obtain the second diastereoisomer in pure form. 
Rf 0.41 (ethyl acetate/petroleum ether = 1:5); orange yellow solid 0.035 g, 42 % yield; mp 
113-114 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.54 (2H, d, J = 7.4, Ar), 7.35 – 7.25 (7H, m, Ar), 6.81 
(2H, d, J = 8.6 Hz, Ar), 6.61 (2H, d, J = 8.6 Hz, Ar), 4.16 (1H, dd, J = 9.6 and 5.6 Hz, PhCH), 
3.75 (3H, s, OCH3), 3.69 (3H, s, OCH3), 3.69 (1H, dd, J = 12.6 and 9.6 Hz, CH2), 2.38 (1H, 
dd, J = 12.6 Hz and 5.6 Hz, CH2), 1.97 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 202.2 (C=O), 176.6 (C), 162.4 (C), 158.8 (C), 141.5 (C), 
132.0 (CH), 130.1 (CH), 128.6 (CH), 127.9 (CH), 127.1 (CH), 123.7 (C), 122.3 (C), 122.2 
(C), 114.0 (CH), 113.9 (CH), 76.4 (C), 66.6 (CH), 55.3 (OCH3), 55.2 (OCH3), 34.7 (CH2), 
11.5 (CH3). 
IR max (cm
-1
) 1673, 1601, 1496, 1370, 1241, 1171, 1024, 832, 761, 697. 
MS (ESI)
+
 : m/z [M + H] 444.1. 
HRMS: [M] for C27H25NO3S calculated 443.1555, found 443.1563. 
New compound. 
3.45. 6-Methylthio-4-phenyl-2,3-bis(p-methoxyphenyl)pyridine 
 
2,3-Bis(4-methoxyphenyl)-5-methylthio-7-phenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 269c 
(0.03 g; 0.06 mmol) was added to toluene (10 mL) and the reaction mixture was heated at 
reflux for 16 h with stirring. After this, the mixture was allowed to cool to rt and then solvents 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
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Rf 0.45 (ethyl acetate/petroleum ether = 1:5); brown solid 0.014 g, 61 % yield; mp 167 - 168 
ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.27 – 7.20 (5H, m, Ar), 7.17 (1H, s, pyrid-H), 7.08 – 
7.04 (2H, m, Ar), 6.77 (2H, d, J = 8.7 Hz, Ar), 6.74 (2H, d, J = 8.7 Hz, Ar), 6.63 (2H, d, J = 
8.7 Hz, Ar), 3.79 (3H, s, CH3), 3.74 (3H, s, CH3), 2.67 (3H, s, SCH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 158.9 (C), 158.1 (C), 157.4 (C), 157.1 (C), 150.2 (C), 
139.6 (C), 133.2 (C), 132.5 (CH), 131.4 (CH), 130.1 (C), 129.5 (C), 129.2 (CH), 127.8 (CH), 
127.2 (CH), 120.6 (CH), 113.3 (CH), 112.9 (CH), 55.2 (CH3), 55.1 (CH3), 13.4 (CH3). 
IR max (cm
-1
) 2958, 2933, 1607, 1556, 1510, 1246, 1177, 1033, 836, 700. 
MS (ESI)
+
 : m/z [M + H] 414.1. 
HRMS [M] for C26H23NO2S calculated 413.1449, found 413.1453. 
3.46. 5-Ethylthio-7-phenyl-2,3-bis(p-methoxyphenyl)-1-azabicyclo[3.2.0]hept-2-en-4-one 
 
To a stirred solution of 2-ethylthio-4-phenyl-1-azetine 257b (0.05 g; 0.26 mmol) in anhydrous 
acetonitrile (5 mL), was added 2,3-bis(4-methoxyphenyl)cycloprop-2-en-1-one 237 (0.07 g; 
0.26 mmol) at rt under an inert N2 atmosphere. The reaction mixture was stirred at rt for 72 h 
and then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound as a mixture of diastereoisomers. 
Rf 0.26 (ethyl acetate/petroleum ether; 1:5); orange yellow solid 0.047 g, 39 % yield; mp 136 
- 137 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.65 (2 x diastereo, 2H, d, J = 7.5 Hz, Ar), 7.45 - 6.90 (2 
x diastereo, 14H, m, Ar), 6.84 (2 x diastereo, 4H, d, J = 7.5 Hz, Ar), 6.48 (2 x diastereo, 4H, d, 
J = 7.5 Hz, Ar), 6.48 (2 x diastereo, 2H, J = 7.5 Hz, Ar), 5.46 -5.44 (1 x diastereo, 1H, m, J = 
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8.0 Hz, PhCH), 4.15 (1 x diastereo, 1H, dd, J = 9.2 and 5.4 Hz, PhCH), 3.84 (3H, s, OCH3), 
3.79 (3H, s, OCH3), 3.78 (3H, s, OCH3), 3.72 (3H, s, OCH3), 3.17 (1 x diastereo, 1H, dd, J = 
12.7 and 9.2 Hz, CHCH2), 3.02 – 2.85 (2 x diastereo, 2H, m, CHCH2), 2.74 – 2.53 (2 x 
diastereo, 4H, m, CH2), 2.48 (1 x diastereo, 1H, dd, J = 12.7 and 5.4 Hz, CH2), 2.53 – 2.74 (2 
x diastereo, 6H, s, 2 x CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 202.8, 202.3 (C=O), 176.1 (C), 173.8 (C), 162.3 (C), 
161.4 (C), 158.8 (C), 158.6 (C), 141.6 (C), 135.4 (C), 131.9 (CH), 131.2 (CH), 130.0 (CH), 
129.7 (CH), 128.8 (CH), 128.9 (CH), 129.0 (CH), 128.7 (CH), 128.5 (CH), 128.4 (CH), 128.3 
(CH), 128.2 (C), 128.1 (C), 128.6 (CH), 127.8 (CH), 127.7 (CH), 127.1 (CH), 124.8 (C), 
124.5 (C), 123.8 (C), 123.7 (C), 122.3 (C), 122.2 (C), 114.0 (CH), 113.9 (CH), 113.8 (CH), 
113.1 (CH), 76.8 (C), 76.7 (C), 66.7 (CH), 65.8 (CH), 55.3 (CH3), 55.2 (CH3), 55.1 (CH3), 
55.0 (CH3), 35.5 (CH2), 31.1 (CH2), 23.6 (CH2), 23.5 (CH2), 14.6 (CH3), 14.5 (CH3). 
IR max (cm
-1
) 2932, 1673, 1602, 1515, 1496, 1372, 1244, 1171, 833, 755, 697. 
MS (ESI)
+
 : m/z [M + H] 458.2. 
HRMS [M] for C28H27NO3S calculated 457.1712, found 457.1716. 
New compound. 
3.47. 6-Ethylthio-4-phenyl-2,3-bis(p-methoxyphenyl)pyridine 
 
5-Ethylthio-2,3-bis(4-methoxyphenyl)-7-phenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 269d 
(0.035 g; 0.06 mmol) was added to toluene (10 mL) and the reaction mixture was heated at 
reflux for 16 h with stirring. After this, the mixture was allowed to cool to rt and then solvents 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
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Rf 0.45 (ethyl acetate/petroleum ether; 1:5); brown solid 0.022 g, 55 % yield; mp 173 - 174 
ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.17 – 7.09 (5H, m, Ar), 7.06 (1H, s, pyrid-H), 6.97 – 
6.92 (2H, m, Ar), 6.68 (2H, d, J = 8.6, Ar), 6.64 (2H, d, J = 8.6, Ar), 6.53 (2H, d, J = 8.6, Ar), 
3.70 (3H, s, CH3), 3.65 (3H, s, CH3), 3.19 (2H, q, J = 7.3 Hz, CH2), 1.37 (3H, t, J = 7.3 Hz, 
CH2CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 158.9 (C), 158.1 (C), 157.2 (C), 156.9 (C), 150.2 (C), 
139.6 (C), 133.3 (C), 132.5 (CH), 131.4 (CH), 130.2 (C), 129.5 (C), 129.2 (CH), 127.8 (CH), 
127.2 (CH), 121.2 (CH), 113.3 (CH), 112.9 (CH), 55.2 (CH3), 55.1 (CH3), 24.5 (CH2), 14.9 
(CH3). 
IR max (cm
-1
) 1607, 1556, 1510, 1245, 1176, 1034, 836, 821, 700. 
MS (ESI)
+
 : m/z [M + H] 428.2. 
HRMS [M] for C27H25NO2S calculated 427.1606, found 427.1609. 
New compound. 
3.48. 4-(2ʹ-Naphthyl)-1-azetidin-2-one 
 
To a stirred solution of 2-vinylnaphthalene (1.00 g; 6.48 mmol) in dry diethyl ether (15 mL), 
N-chlorosulfonyl isocyanate (0.68 mL; 7.78 mmol) was added dropwise at rt under an inert N2 
atmosphere over 10 min. The reaction mixture was kept at rt for 2 h with stirring, and then 
solvent was removed in vacuo to give an oily residue. After that diethyl ether (20 mL) was 
added and this solution was added dropwise to a vigorously stirred solution of water (30 mL), 
sodium carbonate (2.30 g, 21.39 mmol), sodium sulfite (1.21 g, 9.72 mmol) and ice (15 g) 
over 10 min. The reaction mixture was kept at rt for 1 h with stirring and filtered under 
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vacuum. After separation, the water phase was washed with dichloromethane (10 mL x 5), 
and then the combined organic extracts were dried (MgSO4) and the solvents were removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.22 (ethyl acetate/petroleum ether = 3:1); white solid 0.66 g, 48 % yield; mp 160 - 161 ºC 
lit.,
106
 153 - 155 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.91 – 7.84 (5H, m, Ar), 7.55 – 7.49 (2H, m, Ar), 6.29 
(1H, br. s, NH), 4.90 (1H, dd, J = 5.2 Hz and 2.4 Hz, CH), 3.54 (1H, ddd, J = 14.9, 5.2 and 
2.4 Hz, CH2), 2.97 (1H, dd, J = 14.9 and 1.9 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 167.9 (C=O), 137.4 (C), 133.1 (C), 128.9 (C), 127.8 
(CH), 127.7 (CH), 126.6 (CH), 126.3 (CH), 124.8 (CH), 123.1 (CH), 50.0 (CH), 48.0 (CH2); 
IR max (cm
-1
) 3234, 3053, 1760, 1563, 1506, 1354, 1268, 1180, 968, 885, 853, 740. 
As reported previously.
106, 140 
3.49. 4-(2ʹ-Naphthyl)-1-azetidin-2-thione 
 
To a stirred solution of 4-(2ʹ-naphthyl)-1-azetidin-2-one 255b (1.08 g; 5.49 mmol) in dry 
tetrahydrofuran (15 mL), was added Lawesson’s reagent (1.12 g; 2.74 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was heated at reflux for 2 h. After this time, the 
reaction mixture was allowed to cool to rt and the solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound. 
Rf 0.48 (ethyl acetate/petroleum ether = 1:3); white solid 0.72 g, 67 % yield; mp 161-162 ºC 
lit., not reported. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.55 (1H, br. s, NH), 7.90 (1H, d, J = 8.6 Hz, Ar), 7.85 
(2H, dd, J = 9.3 and 5.1 Hz, Ar), 7.81 (1H, s, Ar), 7.56 – 7.52 (2H, m, Ar), 7.48 (1H, dd, J = 
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8.5 Hz and 1.6 Hz, CH), 4.35 (1H, dd, J = 4.6 and 1.6 Hz, CH), 3.61 (1H, ddd, J = 15.6, 4.6, 
and 2.0 Hz, CH2), 3.10 (1H, dd, J = 15.6 and 1.2 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 204.4 (C=S), 135.3 (C), 133.3 (C), 133.1 (C), 129.1 
(CH), 127.9 (CH), 127.8 (CH), 126.8 (CH), 126.6 (CH), 125.2 (CH), 122.9 (CH), 59.1 (CH), 
51.2 (CH2). 
IR max (cm
-1
) 3114, 2950, 1598, 1480, 1401, 1336, 1248, 1167, 973, 895, 865, 819, 766, 705. 
As reported previously.
82, 106 
3.50. 4-Ethylthio-2-(2ʹ-naphthyl)-1-azetine 
 
Triethyloxonium tetrafluoroborate (0.24 g; 1.27 mmol) was added in one portion to 4-(2ʹ-
naphthyl)-1-azetidine-2-thione 256b (0.16 g; 0.75 mmol) in anhydrous dichloromethane (5 
mL). The mixture was stirred at rt for 1 h under an inert N2 atmosphere then heated at reflux 
for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) was added dropwise at - 78 ºC. The solution 
was then filtered through Celite
® 
and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried over 
(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.29 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.11 g, 59 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.87 – 7.82 (4H, m, Ar), 7.51 – 7.44 (3H, m, Ar), 5.22 
(1H, dd, J = 4.4 and 2.1 Hz, CH), 3.66 (1H, dd, J = 14.6 and 4.2 Hz, CH2), 3.13 (2H, q, J = 
7.4 Hz, SCH2CH3) 3.06 (1H, dd, J = 14.6 and 2.1 Hz, CH2), 1.46 (3H, t, J = 7.4, CH3). 
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13
C NMR (100 MHz, CDCl3) δ ppm 183.8 (C), 138.5 (C), 133.3 (C), 132.8 (C), 128.3 (CH), 
127.9 (CH), 127.6 (CH), 126.1 (CH), 125.8 (CH), 124.8 (CH), 123.9 (CH), 65.2 (CH), 43.6 
(CH2), 23.5 (CH2), 14.7 (CH3). 
IR max (cm
-1
) 3030, 1567, 1429, 1403, 1309, 1227, 1073, 963, 710. 
HRMS: Mass spectrometry data could not be obtained due to the degradation of the title 
compound at rt. 
New compound. 
3.51. 2-Ethylthiobenzo[f]isoquinoline 
 
Triethyloxonium tetrafluoroborate (0.24 g; 1.27 mmol) was added in one portion to 4-(2ʹ-
naphthyl)-1-azetidin-2-thione 256b (0.16 g; 0.75 mmol) in anhydrous dichloromethane (5 
mL). The mixture was stirred at rt for 1 h under an inert N2 atmosphere then heated at reflux 
for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) was added dropwise at - 78 ºC. The solution 
was then filtered through Celite
® 
and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried over 
(MgSO4). The solvents were removed in vacuo and the crude product was kept at rt in 
deuterated chloroform for 7-days and after that it was purified by flash chromatography 
affording the title compound. 
Rf 0.48 (ethyl acetate/petroleum ether; 1:3); light yellow oil 0.13 g, 73 % yield. 
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1
H NMR (400 MHz, CDCl3) δ ppm 9.30 (1H, d, J = 7.6 Hz, Ar), 7.96 – 7.90 (2H, m, Ar), 
7.75 - 7.68 (3H, m, Ar), 7.64 (1H, d, J = 8.7, Ar), 7.37 (1H, d, J = 8.4, Ar), 3.52 (2H, q, J = 
7.3 Hz, SCH2CH3) 1.59 (3H, t, J = 7.3, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 158.1 (C), 146.2 (C), 135.3 (CH), 133.9 (C), 130.9 (C), 
128.0 (CH), 127.7 (CH), 126.7 (CH), 126.0 (CH), 125.2 (CH), 124.3 (CH), 123.2 (C), 121.2 
(CH), 24.5 (CH2), 14.6 (CH3). 
IR max (cm
-1
) 3051, 2922, 2022, 1586, 1556, 1493, 1123, 1074, 836, 747. 
MS (ESI)
+
 : m/z [M + H] 240.1. 
HRMS: [M] for C15H13NS calculated 239.0769, found 239.0779. 
New compound. 
3.52. 5-Ethylthio-7-methyl-2,3-bis(p-tolyl)-7-naphthyl-1-azabicyclo[3.2.0]hept-2-en-4-one 
 
To a stirred solution of 4-ethylthio-2-(2-naphthyl)-1-azetine 257c (0.09 g; 0.13 mmol) in 
anhydrous acetonitrile (5 mL), was added 2,3-bis(p-tolyl)cyclopropenone 241 (0.09 g; 0.13 
mmol) at rt under an inert N2 atmosphere. The reaction mixture was stirred at rt for 72 h and 
then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound as a mixture of diastereoisomers (1:1). 
Rf 0.4 (ethyl acetate/petroleum ether = 1:5); orange yellow solid 0.077 g, 42 % yield; mp 180 
- 181 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.01 – 7.88 (2 x diastereo, 5H, m, Ar), 7.61 – 7.44 (4 x 
diastereo, 5H, m, Ar), 7.38 – 7.24 (2 x diastereo, 10H, m, Ar), 7.19 (2 x diastereo, 2H, d, J = 
7.7, Ar), 7.08 (2 x diastereo, 2H, d, J = 7.7, Ar), 7.04 – 6.91 (2 x diastereo, 2H, m, Ar), 6.80 (2 
x diastereo, 2H, d, J= 7.7 Hz, Ar), 6.76 (2 x diastereo, 2H, d,  J = 7.7 Hz, Ar), 5.74 (1 x 
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diastereo, 1H, t, J = 8.1 Hz, PhCH), 4.42 (1 x diastereo, 1H, dd, J = 9.3 and 5.4 Hz, PhCH), 
3.23 (1 x diastereo, 1H, dd, J = 12.2 and 9.9 Hz, CHCH2), 3.15 (1 x diastereo, 1H, dd, J = 13.1 
and 8.1 Hz, CHCH2), 3.01 (1 x diastereo, 1H, dd, J = 13.1 and 8.5 Hz, CHCH2), 2.81 – 2.59 
(2 x diastereo, 4H, m, CH3CH2), 2.54 (1 x diastereo, 1H, dd, J = 13.1 and 5.4 Hz, CHCH2), 
2.39 (3H, s, CH3), 2.30 (3H, s, CH3), 2.28 (3H, s, CH3), 1.98 (3H, s, CH3), 1.30 – 1.24 ((6H, 
m, 2 x CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 202.9, 202.4 (C=O), 176.6 (C), 174.8 (C), 142.4 (C), 
140.9 (C), 138.9 (C), 137.0 (C), 136.6 (C), 133.1 (C), 133.0 (C), 132.8 (C), 132.4 (C), 132.3 
(C), 130.1 (CH), 129.3 (CH), 129.2 (CH), 128.9 (C), 128.7 (CH), 128.6 (CH), 128.3 (CH), 
128.2 (C), 128.1 (CH), 128.0 (CH), 127.8 (CH), 128.7 (CH), 127.3 (CH), 127.2 (CH), 127.1 
(C), 126.3 (CH), 126.2 (CH), 126.1 (CH), 126.0 (CH), 125.9 (CH), 125.7 (CH), 125.5 (C), 
124.9 (CH), 123.3 (C), 76.9 (C), 76.8 (C), 66.7 (CH), 66.1 (CH), 35.3 (CH2), 31.5 (CH2), 23.7 
(CH2), 23.6 (CH2), 21.5 (CH3), 21.3 (CH3), 21.2 (CH3), 21.1 (CH3), 14.6 (CH3), 14.5 (CH3); 
IR max (cm
-1
) 3011, 1673, 1574, 1496, 1370, 1258, 1015, 790, 737. 
MS (ESI)
+
 : m/z [M + H] 276.2. 
HRMS: [M] for C32H29NOS calculated 475.1970, found 475.1981. 
New compound. 
3.53. 5-Ethylthio-2,3-bis(p-methoxyphenyl)-7-naphthyl-1-azabicyclo[3.2.0]hept-2-en-4-
one 
 
To a stirred solution of 4-ethylthio-2-(2-naphthyl)-1-azetine 257c (0.09 g; 0.13 mmol) in 
anhydrous acetonitrile (5 mL), was added 2,3-bis(4-methoxyphenyl)cycloprop-2-en-1-one 
237 (0.09 g; 0.13 mmol) at rt under an inert N2 atmosphere. The reaction mixture was stirred 
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at rt for 72 h and then solvents were removed in vacuo. The crude product was purified by 
flash chromatography affording the title compound as a mixture of diastereoisomers (1.5:1). 
Rf 0.39 (ethyl acetate/petroleum ether = 1:5); orange yellow solid 0.065 g, 33 % yield; mp 
174 - 175 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.91 – 7.78 (2 x diastereo, 5H, m, Ar), 7.52 – 7.43 (4 x 
diastereo, 5H, m, Ar), 7.33 – 7.21 (2 x diastereo, 8H, m, Ar), 7.94 – 6.89 (2 x diastereo, 2H, 
m, Ar), 6.83 (2 x diastereo, 2H, d, J = 8.6, Ar), 6.77 (2 x diastereo, 2H, d, J = 8.6, Ar), 6.72 (2 
x diastereo, 2H, d, J = 8.6 Hz, Ar), 6.57 (2 x diastereo, 2H, d, J = 8.6 Hz, Ar), 6.11 (2 x 
diastereo, 2H, d, J = 8.6 Hz, Ar), 5.63 (1 x  diastereo, 1H, t, J = 8.1 Hz, PhCH), 4.30 (1 x 
diastereo, 1H, dd, J = 9.5 and 5.4 Hz, PhCH), 3.76 (3H, s, OCH3), 3.71 (3H, s, OCH3), 3.62 
(3H, s, OCH3), 3.40 (3H, s, OCH3), 3.14 (1 x diastereo, 1H, dd, J = 12.4 and 9.6 Hz, CHCH2), 
3.05 (1 x diastereo, 1H, dd, J = 13.1 and 7.9 Hz, CHCH2), 2.92 (1 x diastereo, 1H, dd, J = 13.1 
and 8.5 Hz, CHCH2), 2.64 – 2.49 (2 x diastereo, 4H, m, CH3CH2), 2.45 (1 x diastereo, 1H, dd, 
J = 12.4 and 5.4 Hz, CHCH2), 1.30 – 1.24 (6H, m, 2 x CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 202.8, 202.2 (C=O), 176.0 (C), 174.1 (C), 162.3 (C), 
161.2 (C), 158.8 (C), 158.5 (C), 139.0 (C), 133.2 (C), 132.6 (C), 132.3 (C), 131.9 (C), 131.0 
(CH), 130.0 (CH), 129.6 (CH), 128.8 (CH), 128.6 (CH), 127.8 (CH), 127.7 (CH), 127.3 (CH), 
127.2 (C), 126.3 (CH), 126.1 (CH), 126.0 (CH), 125.7 (CH), 125.0 (CH), 124.6 (C), 124.5 
(C), 123.8 (C), 123.7 (C), 122.3 (C), 122.2 (C), 114.1 (CH), 114.0 (CH), 113.8 (C), 112.8 
(CH), 71.1 (C), 77.0 (C), 66.8 (CH), 66.1 (CH), 55.3 (OCH3), 55.2 (OCH3), 55.1 (OCH3), 
55.0 (OCH3), 35.5 (CH2), 31.7 (CH2), 23.7 (CH2), 23.6 (CH2), 14.6 (CH3), 14.5 (CH3). 
IR max (cm
-1
) 3037, 2941, 1605, 1443, 1249, 1177, 1031, 834. 
MS (ESI)
+
 : m/z [M+H] 508.2. 
HRMS: [M] for C32H29NO3S calculated 507.1868, found 507.1876. 
New compound. 
 139 
 
3.54. 4-(1ˈ-Naphthyl)-1-azetidin-2-one 
 
To a stirred solution of 1-vinylnaphthalene (1.00 g; 6.48 mmol) in dry diethyl ether (15 mL), 
N-chlorosulfonyl isocyanate (0.68 mL; 7.78 mmol) was added dropwise at rt under an inert N2 
atmosphere over 10 min. The reaction mixture was kept at rt for 2 h with stirring, and then 
solvent was removed in vacuo to give an oily residue whivh was dissolved in rther (20 mL). 
The ethereal solution was added dropwise to a vigorously stirred solution of water (30 mL), 
sodium carbonate (2.30 g, 21.39 mmol), sodium sulfite (1.21 g, 9.72 mmol) and ice (15 g) 
over 10 min. The reaction mixture was kept for 1 h with stirring at rt and filtered under 
vacuum. After separation, the water phase was washed with dichloromethane (10 mL x 5), 
and then the combined organic extracts were dried (MgSO4) and the solvents were removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.22 (ethyl acetate/petroleum ether = 3:1); white solid 0.57 g, 53 % yield; mp 155-156 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.95 - 7.93 (2H, m, Ar), 7.87 - 7.84 (2H, m, Ar), 7.60 - 
7.49 (3H, m, Ar), 6.53 (1H, br. s, NH), 5.44 (1H, dd, J = 4.9 and 2.5 Hz, CH), 3.70 (1H, ddd, 
J = 14.6, 5.4 and 2.7 Hz, CH2), 2.92 (1H, dd, 14.6 and 2.5 Hz, CH2).  
13
C NMR (100 MHz, CDCl3) δ ppm 167.8 (C=O), 135.7 (C), 133.6 (C), 130.0 (C), 129.0 
(CH), 128.3 (CH), 126.5 (CH), 126.1 (CH), 125.4 (CH), 122.3 (CH), 121.6 (CH), 48.1 (CH), 
47.0 (CH2). 
IR max (cm
-1
) 3183, 2931, 1751, 1665, 1594, 1505, 1354, 1284, 1190, 971, 798. 
MS (ESI)
+
 : m/z [M + H] 198.1. 
HRMS: [M ] for C13H11NO calculated 197.0841, found 197.0854. 
 140 
 
Previously unreported. 
3.55. 4-(1ˈ-Naphthyl)-1-azetidine-2-thione 
 
To a stirred solution of 4-(1ʹ-naphthyl)-1-azetidin-2-one 255c (1.08 g; 5.49 mmol) in dry 
tetrahydrofuran (15 mL), was added Lawesson’s reagent (1.12 g; 2.74 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was heated at reflux for 2 h. After this time, the 
reaction mixture was allowed to cool to rt and the solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound. 
Rf 0.48 (ethyl acetate/petroleum ether = 1:3); white solid 0.72 g, 67 % yield; mp 156 - 157 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.52 (1H, br. s, NH), 7.96 - 7.77 (3H, m, Ar), 7.62 - 7.51 
(4H, m, Ar), 5.94 (1H, dd, J = 4.7 and 2.1 Hz, CH), 3.61 (1H, ddd, J = 15.3, 4.7, and 2.4 Hz, 
CH2), 3.10 (1H, dd, J = 15.3 and 2.1 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 204.1 (C=S), 133.8 (C), 133.6 (C), 129.5 (C), 129.1 
(CH), 128.8 (CH), 126.8 (CH), 126.3 (CH), 125.4 (CH), 122.1 (CH), 122.0 (CH), 56.5 (CH), 
50.3 (CH2). 
IR max (cm
-1
) 3028, 2913, 1573, 1487, 1417, 1338, 1246, 1164, 972, 893, 821, 765, 706. 
MS (ESI)
+
 : m/z [M + H] 214.1. 
HRMS: [M ] for C13H11NS calculated 213.0610, found 213.0615 
Previously unreported. 
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3.56. 4-Methylthio-2-(1ˈ-naphthyl)-1-azetine 
 
Trimethyloxonium tetrafluoroborate (0.14 g; 1.01 mmol) was added in one portion to 4-(1ʹ-
naphthyl)-1-azetidin-2-thione 256c (0.13 g; 0.56 mmol) in anhydrous dichloromethane (10 
mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) added dropwise at - 78 ºC. The solution was 
then filtered through Celite
® 
and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried 
(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.29 (ethyl acetate/petroleum ether; 1:3); yellow oil 0.053 g, 40 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.82 – 7.69 (3H, m, Ar), 7.53 (1H, d, J = 6.9 Hz, Ar), 
7.46 – 7.38 (3H, m, Ar), 5.56 (1H, dd, J = 4.2 and 2.0 Hz, CH), 3.68 (1H, dd, J = 14.4 and 4.2 
Hz, CH2), 2.89 (1H, dd, J = 14.4 and 2.0 Hz, CH2), 2.44 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 183.6 (C), 137.0 (C), 133.5 (C), 130.1 (C), 128.9 (CH), 
127.5 (CH), 126.1 (CH), 125.7 (CH), 125.5 (CH), 123.1 (CH), 122.6 (CH), 62.0 (CH), 43.2 
(CH2), 11.6 (CH3). 
IR max (cm
-1
) 3016, 2929, 1727, 1431, 1329, 1241, 1173, 97, 890, 609. 
HRMS: Mass spectrometry data could not be obtained due to the degradation of the title 
compound at rt. 
New compound. 
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3.57. 2-Methylthiobenzo[f]isoquinoline 
 
Trimethyloxonium tetrafluoroborate (0.14 g; 1.01 mmol) was added in one portion to 4-(1ʹ-
naphthyl)-1-azetidin-2-thione 256c (0.13 g; 0.56 mmol) in anhydrous dichloromethane (10 
mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) added dropwise at - 78 ºC. The solution was 
then filtered through Celite
® 
and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried 
(MgSO4). The solvents were removed in vacuo and the crude product was kept at rt in 
deuterated chloroform for 7-days and after that it was purified by flash chromatography 
affording the title compound. 
Rf 0.66 (ethyl acetate/petroleum ether = 1:3); light yellow solid 0.11 g, 87 % yield; mp 93 - 
94 ºC. 
 
1
H NMR (400 MHz, CDCl3) δ ppm 8.62 (1H, d, J = 8.8 Hz, Ar), 8.46 (1H, d, J = 8.2 Hz, Ar) 
7.89 - 7.81 (3H, m, Ar), 7.61 - 7.50 (2H, m, Ar), 7.34 (1H, d, J = 8.8 Hz, Ar), 2.66 (3H, s, 
CH3). 
 
13
C NMR (100 MHz, CDCl3) δ ppm 159.5 (C), 148.2 (C), 131.1 (C), 130.9 (CH), 130.2 
(CH), 129.8 (C), 128.7 (CH), 127.5 (CH), 127.0 (CH), 126.5 (CH), 122.2 (CH), 122.1 (C), 
120.2 (CH), 13.1 (CH3). 
IR max (cm
-1
) 3047, 2923, 1574, 1562, 1445, 1166, 1141, 1077, 869, 838, 747. 
MS (ESI)
+
 : m/z [M + H] 226.1. 
HRMS: [M ] for C14H11NS calculated 225.0612, found 225.0620. 
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Novel compound. 
3.58. 2-Ethylthio-4-(1ˈ-naphthyl)-1-azetine 
 
Triethyloxonium tetrafluoroborate (0.24 g; 1.28 mmol) was added in one portion to 4-(1-
naphthyl)-1-azetidine-2-thione 256c (0.16 g; 0.54 mmol) in anhydrous dichloromethane (5 
mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50% 
aqueous solution of potassium carbonate (10 mL) added dropwise at - 78 ºC. The solution was 
filtered through Celite
® 
and the organic layer was separated. The water phase was washed 
with dichloromethane (10 mL x 2), and the combined organic extracts were dried over 
(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.35 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.091 g, 51 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.93 - 7.79 (3H, m, Ar), 7.43 (1H, d, J = 7.0 Hz, Ar), 
7.56 - 7.49 (3H, m, Ar), 5.69 (1H, d, J = 1.8 Hz, CH), 3.66 (1H, dd, J = 14.3 and 4.2 Hz, 
CHCH2), 3.21 - 3.11 (2H, m, CH2CH3) 2.99 (1H, dd, J = 14.3 and 4.2 Hz, CHCH2), 1.48 (3H, 
t, J = 7.4, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 183.4 (C), 137.1 (C), 133.5 (C), 130.1 (C), 128.9 (CH), 
127.5 (CH), 126.1 (CH), 125.7 (CH), 125.5 (CH), 123.1 (CH), 122.6 (CH), 62.3 (CH), 43.7 
(CH2), 23.6 (CH2), 14.8 (CH3). 
HRMS: Mass spectrometry data could not be obtained due to the degradation of the title 
compound at rt. 
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New compound. 
3.59. 2-Ethylthiobenzo[f]isoquinoline 
 
Triethyloxonium tetrafluoroborate (0.24 g; 1.28 mmol) was added in one portion to 4-(1ʹ-
naphthyl)-1-azetidine-2-thione 256c (0.16 g; 0.54 mmol) in anhydrous dichloromethane (5 
mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) added dropwise at - 78 ºC. The solution was 
filtered through Celite
® 
and the organic layer was separated. The water phase was washed 
with dichloromethane (10 mL x 2), and the combined organic extracts were dried over 
(MgSO4). The solvents were removed in vacuo and the crude product was kept at rt in 
deuterated chloroform for 7-days and after that it was purified by flash chromatography 
affording the title compound. 
Rf 0.61 (ethylacetate/hexane = 1:3); light yellow solid 0.11 g, 78 % yield; mp 94 - 95 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.61 (1H, d, J = 8.7 Hz, Ar), 8.45 (1H, d, J = 8.2 Hz, Ar) 
7.88 - 7.80 (3H, m, Ar), 7.60 - 7.50 (2H, m, Ar), 7.31 (1H, d, J = 8.7 Hz, Ar), 3.29 (2H, q, J = 
7.3 Hz, CH2), 1.39 (3H, t, J = 7.3, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 159.1 (C), 148.3 (C), 131.1 (C), 130.8 (CH), 130.3 (CH), 
129.8 (C), 128.6 (CH), 127.6 (CH), 127.0 (CH), 126.5 (CH), 122.3 (CH), 122.2 (C), 120.3 
(CH), 24.4 (CH2), 14.7 (CH3). 
IR max (cm
-1
) 3049, 2920, 1581, 1573, 1562, 1445, 1144, 1129, 1078, 838, 774, 749. 
MS (ESI)
+
 : m/z [M + H] 240.1. 
HRMS: [M] for C15H13NS calculated 239.0769, found 239.0776. 
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New compound. 
3.60. 4-Biphenyl-1-azetidin-2-one 
 
To a stirred solution of 4-vinylbiphenyl (1.00 g; 5.55 mmol) in dry diethyl ether (15 mL), N-
chlorosulfonyl isocyanate (0.58 mL; 6.66 mmol) was added dropwise at rt under an inert N2 
atmosphere over 10 min. The reaction mixture was kept at rt for 2 h with stirring, and then 
solvent was removed in vacuo to give an oily residue. After that, diethyl ether (20 mL) was 
added and the solution was added dropwise to a vigorously stirred solution of water (30 mL), 
sodium carbonate (2.31 g, 21.39 mmol), sodium sulfite (1.20 g, 9.72 mmol) and ice (15 g) 
over 10 min. The reaction mixture was kept at rt for 1 h with stirring and filtered under 
vacuum. The water phase was washed with dichloromethane (10 mL x 5), and then the 
combined organic extracts were dried (MgSO4) and the solvents were removed in vacuo. The 
crude product was purified by flash chromatography affording the title compound. 
Rf (ethyl acetate/petroleum ether = 3:1); white solid 0.50 g, 47 % yield; mp 178 - 179 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.63 (2H, d, J = 8.3 Hz, Ar), 7.61 (2H, d, J = 8.0 Hz, Ar), 
7.49 - 7.45 (4H, m, Ar), 7.39 (1H, t, J = 7.3 Hz, Ar), 6.18 (1H, br. s, NH), 4.80 (1H, dd, J = 
5.3 Hz and 2.4 Hz, CH), 3.51 (1H, ddd, J = 14.9, 5.3 and 2.4 Hz, CH2), 2.96 (1H, dd, J = 14.9 
and 2.4 Hz, CH2).  
13
C NMR (100 MHz, CDCl3) δ ppm 167.8 (C=O), 141.3 (C), 140.4 (C), 139.1 (C), 128.8 
(CH), 127.6 (CH), 127.5 (CH), 127.0 (CH), 126.1 (CH), 50.1 (CH), 48.1 (CH2). 
IR max (cm
-1
) 3189, 3021, 2913, 4, 1348, 1272, 1187, 1171, 1005, 970, 833, 759, 730, 699. 
MS (ESI)
+
 : m/z [M + H] 224.1. 
HRMS: [M] for C15H13NO calculated 223.0997, found 223.0998. 
New compound. 
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3.61. 4-Biphenyl-1-azetidin-2-thione 
 
To a stirred solution of 4-biphenyl-1-azetidin-2-one 255d (0.27 g; 1.21 mmol) in dry 
tetrahydrofuran (5 mL), was added Lawesson’s reagent (0.24 g; 0.60 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was heated at reflux for 2 h. After this time, the 
reaction mixture was allowed to cool to rt and the solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound. 
Rf 0.52 (ethyl acetate/petroleum ether = 1:3); white solid 0.16 g, 54 % yield; mp 180 - 181 ºC; 
1
H NMR (400 MHz, CDCl3) δ ppm 8.08 (1H, br. s, NH), 7.55 (2H, d, J = 8.1 Hz, Ar), 7.52 
(2H, d, J = 7.4 Hz, Ar), 7.40 - 7.35 (4H, m, Ar), 7.30 (1H, t, J = 7.3 Hz, Ar), 5.15 (1H, dd, J = 
4.6 and 2.1 Hz, CH), 2.47 (1H, ddd, J = 14.6, 4.6, and 2.1 Hz, CH2), 2.99 (1H, dd, J = 14.6 
and 2.1 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 204.4 (C=S), 141.9 (C), 140.2 (C), 137.0 (C), 128.9 
(CH), 127.8 (CH), 127.7 (CH), 127.1 (CH), 126.3 (CH), 58.7 (CH), 51.4 (CH2). 
IR max (cm
-1
) 3157, 3030, 1681, 1479, 1402, 1359, 1235, 1196, 1166, 1133, 1005, 963, 837, 
764, 727, 690. 
MS (ESI)
+
 : m/z [M + H] 240.1. 
HRMS: [M] for C15H13NS calculated 239.0769, found 239.0773. 
New compound. 
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3.62. 2-Ethylthio-4-biphenyl-1-azetine 
 
Triethyloxonium tetrafluoroborate (0.09 g; 0.45 mmol) was added in one portion to 4-
biphenyl-1-azetidin-2-thione 256d (0.06 g; 0.26 mmol) in anhydrous dichloromethane (5 
mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) added dropwise at - 78 ºC. The solution was 
then filtered through Celite
®
 and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried 
(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.29 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.04 g, 52 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.51 (4H, d, J = 8.0 Hz, Ar), 7.37 (2H, d, J = 7.4 Hz, Ar), 
7.33 (2H, d, J = 8.0 Hz, Ar), 7.26 (1H, t, J = 7.3 Hz, Ar), 4.99 (1H, dd, J = 4.2 and 1.9 Hz, 
CH), 3.52 (1H, dd, J = 14.6 and 4.2 Hz, CH2), 3.01 (2H, q, J = 7.4 CH3CH2), 2.93 (1H, dd, J 
= 14.6 and 1.9 Hz, CH2), 1.34 (3H, t, J = 7.4, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 183.7 (C), 140.9 (C), 140.3 (C), 139.9 (C), 128.7 (CH), 
127.3 (CH), 127.2 (CH), 127.1 (CH), 126.5 (CH), 64.9 (CH), 43.6 (CH2), 23.4 (CH2), 14.7 
(CH3). 
MS (ESI)
+
 : m/z [M + H] 268.1. 
HRMS: [M] for C17H17NS calculated 267.1082, found 267.1084. 
IR max (cm
-1
) 3029, 1657, 1543, 1449, 1367, 1237, 1144, 1168, 1041, 964, 836, 762, 690. 
New compound. 
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3.63. 4-Methyl-4-vinyl-1-azetidin-2-one 
 
To a stirred solution of isoprene (2.33 g; 3.43 mL; 34.41 mmol) in dry diethyl ether (15 mL), 
N-chlorosulfonyl isocyanate (4.88 g; 3.01 mL; 34.01 mmol) in dry diethyl ether (10 mL) was 
added dropwise at - 78 ºC under an inert N2 atmosphere over 1 h. After this, the reaction 
mixture was allowed to warm to - 10 ºC, and then the reaction flask was transferred to an ice-
salt bath. This solution was added dropwise to a vigorously stirred solution of water (50 mL), 
sodium carbonate (9.00 g; 107.10 mmol) sodium sulfite (6.01 g; 47.60 mmol) and ice (30 g) 
over 10 min. The reaction mixture was kept for 1 h at -10 ºC with stirring. After this, the 
reaction mixture was allowed to warm to ambient temperature and then extracted with diethyl 
ether (20 mL x 6). The combined organic extracts were dried (MgSO4) and the solvents were 
removed in vacuo to obtain the title compound. 
Yellow oil 2.2 g, 58 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 6.75 (1H, s, NH), 6.03 (1H, dd, J = 17.2 and 10.6 Hz, 
CH), 5.24 (1H, d, J = 17.2 Hz, CH=CH2), 5.11 (1H, d, J = 10.6 Hz, CH=CH2), 2.81 (2H, s, 
CH2), 1.51 (CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 167.5 (C=O), 114.1 (CH), 113.8 (CH2), 54.5 (C), 50.8 
(CH2), 24.8 (CH3). 
Previously reported.
82 
3.64. 4-Methyl-4-vinyl-1-azetidin-2-thione 
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To a stirred solution of 4-methyl-4ˈ-vinyl-azetidin-2-one 275 (0.55 g; 4.97 mmol) in dry 
tetrahydrofuran (15 mL), was added Lawesson’s reagent (1.01 g; 2.48 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was heated at reflux for 2 h. After this time, the 
reaction mixture was allowed to cool to rt and the solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound. 
Rf 0.51 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.35 g, 56 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 9.38 (1H, s, NH), 5.97 (1H, dd, J = 17.2 and 10.6 Hz, 
CH), 5.24 (1H, d, J = 17.2 Hz, CH=CH2), 5.11 (1H, d, J = 10.6 Hz, CH=CH2), 2.89 (2H, s, 
CH2), 1.51 (CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 202.2 (C=S), 139.9 (CH), 115.1 (CH2), 63.6 (C), 54.6 
(CH2), 23.7 (CH3). 
IR max (cm
-1
) 3235, 2970, 1720, 1643, 1412, 1372, 1304, 12074, 1226, 1188, 1153, 923. 
MS (ES)
+
: m/z [M + H]
  
134.1.
 
Previously reported.
82 
3.65. 2-Methylthio-4-methyl-4-vinyl-1-azetidine 
 
Trimethyloxonium tetrafluoroborate (0.059 g; 0.41 mmol) was added in one portion to 4-
methyl-4-vinyl-azetidine-2-thione 276 (0.31 g; 0.24 mmol) in anhydrous dichloromethane (5 
mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) was added dropwise at -78 ºC. The solution 
was then filtered through Celite
®
 and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried 
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(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. The product was used in next step without 
NMR analysis. 
Rf 0.25 (ethyl acetate/petroleum ether = 1:2); yellow oil 0.03 g, 87 % yield. 
Previously reported.
28a 
3.66. 4-Methyl-6-methylthio-1,8-diphenyl-7-azabicyclo[4.2.1]non-3-en-9-one 
 
To a stirred solution of 2-methylthio-4-methyl-4-vinyl-1-azetidine 277 (0.04 g; 0.27 mmol) in 
anhydrous acetonitrile (5 mL), was added diphenylcyclopropenone (0.05 g; 0.27 mmol) at rt 
under an inert N2 atmosphere. The reaction mixture was stirred at rt for 24 h and then solvents 
were removed in vacuo. The crude product was purified by flash chromatography affording 
the title compound. 
Rf 0.48 (ethyl acetate/ hexane; 1:3); white solid 0.05 g, 52 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.57 (2H, d, J = 7.5 Hz, Ar), 7.28 - 7.22 (4H, m, Ar), 
7.20 - 7.14 (2H, m, Ar), 7.06 (2H, d, J = 6.7 Hz, Ar), 5.32 (1H, dd, J = 6.5 and 1.3 Hz, 
H3CC=CH), 3.04 (1H, dd, J = 16.6 Hz and 1.3 Hz, CH2), 2.90 (1H, dd, J = 16.6 and 6.5 Hz, 
CH2), 2.71 (1H, d, J = 17.0 Hz, CH2), 2.56 (1H, d, J = 17.0 Hz, CH2), 2.03 (CH3), 1.65 (CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 214.4 (C=O), 174.4 (C), 136.5 (C), 132.3 (C), 131.9 (C), 
131.1 (CH), 129.1 (CH), 128.5 (CH), 128.4 (CH), 128.0 (CH), 127.1 (CH), 118.6 (CH), 82.4 
(C), 64.1 (C), 42.7 (CH2), 34.9 (CH2), 27.7 (CH3), 12.5 (CH3). 
Novel compound. 
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3.67. (E)-N-(p-methoxybenzyl)-1-phenylmethanimine 
 
To the stirred solution of anhydrous magnesium sulfate (2.00 g; 16.60 mmol) and 
benzaldehyde (1.06 g; 1.01 mL; 10.01 mmol) in dry dichloromethane (10 mL) was added 4-
methoxybenzylamine (1.37 g; 1.31 mL; 10.01 mmol) dropwise at rt under an inert N2 
atmosphere. The reaction mixture was kept for 12 h with stirring at rt and then filtered under 
vacuum. The filtrate was washed with dichloromethane (20 mL x 2) and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.55 (ethyl acetate/petroleum ether = 1:1); yellow oil 1.90 g, 89 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.40 (1H, s, CH), 7.82 - 7.79 (2H, m, Ar), 7.45 - 4.41 
(3H, m, Ar), 7.29 (2H, d, J = 8.1 Hz, Ar), 6.92 (2H, d, J = 8.1 Hz, Ar), 4.80 (2H, s, CH2), 3.83 
(2H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 161.6 (CH), 158.7 (C), 136.2 (C), 131.3 (C), 130.7 (CH), 
129.2 (CH), 128.6 (CH), 128.2 (CH), 113.9 (CH), 64.5 (CH2), 55.3 (OCH3). 
IR (neat) max 2833, 1641, 1609, 1579, 1509, 1450, 1300, 1242, 1172, 1031, 814, 760, 744, 
692. 
Previously reported.
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3.68. 3,3-Difluoro-1-(p-methoxybenzyl)-4-phenyl-1-azetidin-2-one 
 
To a stirred solution of (E)-N-(p-methoxybenzyl)-1-phenylmethanimine 281 (1.50 g; 6.67 
mmol) and ethyl bromodifluoroacetate (2.70 g; 1.71 mL; 13.22 mmol) in dry tetrahydrofuran 
(10 mL) was added laboratory prepared activated zinc dust (1.37 g; 1.31 mL; 10.01 mmol) 
gradually under inert N2 atmosphere. The reaction mixture was heated at reflux for 1 h with 
stirring. After this, the mixture was allowed to cool to rt and then quenched with saturated 
aqueous ammonium chloride (20 mL). The water phase was washed with dichloromethane 
(20 mL x 2) and the combined organic extracts were dried (MgSO4) and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.36 (ethyl acetate/petroleum ether = 1:1); yellow oil 1.3 g, 67 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.46 - 7.41 (2H, m, Ar), 7.28 - 4.25 (3H, m, Ar), 7.05 
(2H, d, J = 7.7 Hz, Ar), 6.85 (2H, d, J = 7.7 Hz, Ar), 4.91 (1H, d, J = 14.7 Hz, NCH2), 4.70 
(1H, d, J = 7.3 Hz, PhCH), 4.70 (1H, d, J = 14.7 Hz, NCH2), 3.77 (3H, s, OCH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 159.6 (C=O), 130.1 (C), 130.0 (CH), 129.8 (C), 129.5 
(C), 129.0 (CH), 128.0 (CH), 125.3 (CH), 120.2 (CF2, dd, J = 293 and 287 Hz), 114.4 (CH), 
67.8 (CH, dd, J = 26.4 and 23.9 Hz), 55.3 (CH3), 43.7 (CH2). 
Previously reported.
114 
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3.69. 3,3-Difluoro-4-phenyl-azetidin-2-one 
 
To a stirred solution of 3,3-difluoro-1-(p-methoxybenzyl)-4-phenyl-1-azetidin-2-one 283 
(1.22 g; 4.03 mmol) in acetonitrile/water (9:1; 25 mL) at 0 ºC was added ceric ammonium 
nitrate (6.62 g; 12.11 mmol) slowly in small portions. After 20 min, the reaction mixture was 
left at rt for 6 h with stirring and the reaction mixture was poured into water (50 mL). The 
aqueous phase was washed with ethyl acetate (20 mL x 2) and the combined organic extracts 
were washed with 5 % NaHCO3 (10 mL), 10 % Na2SO3 (10 mL), 5 % NaHCO3 (10 mL) and 
brine (10 mL). The organic layers were dried (MgSO4) and then solvents were removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.28 (ethyl acetate/petroleum ether = 1:5); yellow solid 0.6 g, 79 % yield; mp 96-97 ºC lit., 
not reported. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.50 - 7.44 (3H, m, Ph), 7.39 - 7.35 (2H, m, Ph), 6.82 
(1H, br, s, NH), 5.08 (1H, dd, J = 7.5 and 2.5 Hz, PhCH). 
13
C NMR (100 MHz, CDCl3) δ ppm 161.4 (C=O, t, J = 29.9 Hz), 131.8 (C), 129.6 (CH), 
128.9 (CH), 127.1 (CH), 120.2 (CF2, dd, J = 293 and 287 Hz), 67.8 (CH, dd, J = 26.5 and 
24.4 Hz). 
Consistent with values reported in the literature.
114 
3.70. 3,3-Difluoro-4-phenyl-1-azetidin-2-thione 
 
To a stirred solution of 3,3-difluoro-4-phenyl-1-azetidin-2-one 284 (0.20 g; 1.09 mmol) in dry 
tetrahydrofuran (5 mL), was added Lawesson’s reagent (0.22 g; 0.55 mmol) at rt under an 
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inert N2 atmosphere. The reaction mixture was heated at reflux for 2 h. After this time, the 
reaction mixture was allowed to cool to rt and the solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound. 
Rf 0.38 (ethyl acetate/petroleum ether = 1:3); white solid 0.13 g, 59 % yield; mp 98 - 99 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.40 (1H, br. s, NH), 7.40 - 7.37 (3H, m, Ph), 7.28 - 7.26 
(2H, m, Ph), 5.44 (1H, dd, J = 6.9 and 2.5 Hz, PhCH). 
13
C NMR (100 MHz, CDCl3) δ ppm 194.7 (C=S, t, J = 30.3 Hz), 130.9 (C), 130.0 (CH), 
129.1 (CH), 127.3 (CH), 113.9 (CF2, dd, J = 293 and 287 Hz), 73.8 (CH, dd, J = 27.8 and 
26.0 Hz). 
IR max (cm
-1
) 3289, 1496, 1453, 1289, 1197, 1115, 707, 691, 647, 564, 499. 
MS (ES)
+
 : m/z [M + H] 200.0. 
HRMS: could not find due to decomposition of compound during MS.  
Previously unreported. 
2.71. 2-Ethylthio-3,3-difluoro-4-phenyl-1-azetine 
 
Triethyloxonium tetrafluoroborate (0.11 g; 0.60 mmol) was added in one portion to 3,3-
difluoro-4-phenyl-azetidine-2-thione 285 (0.07 g; 0.35 mmol) in anhydrous dichloromethane 
(5 mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 1 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) was added dropwise at -78 ºC. The solution 
was then filtered through Celite
® 
and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried 
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(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.66 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.04 g, 44 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.45 - 7.33 (3H, m, Ph), 7.28 - 7.24 (2H, m, Ph), 4.55 - 
4.39 (1H, m, PhCH), 2.96 - 2.88 (2H, dd, J = 7.4 and 1.8 Hz, CH2), 1.16 (3H, t, J = 7.4 Hz, 
CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 163.8 (C), 136.1 (C), 128.6 (CH), 128.5 (CH), 128.1 
(CH), 116.7 (CF2, dd, J = 298 and 17.3 Hz), 58.0 (CH, t, J = 23.5 Hz), 23.1 (CH2), 13.9 
(CH3). 
IR max (cm
-1
) 2989, 1514, 1449, 1274, 1171, 1098, 1033, 923, 698, 631. 
MS (ES)
+
: m/z [M + H]
 
228.1. 
HRMS: Could not find by MS. 
Previously unreported. 
2.72. 5-Ethylthio-6,6-difluoro-2-(p-methoxyphenyl)-7-phenyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene 
 
To a stirred solution of 2-ethylthio-3,3-difluoro-4-phenyl-1-azetine 286 (0.10 g; 0.44 mmol) 
and 4-methoxybenzohydroximoylchloride (0.08 g; 0.44 mmol) in dry diethyl ether (20 mL) 
was added triethylamine (0.06 g; 0.09 mL) in dry diethyl ether (25 mL) dropwise at rt under 
an inert N2 atmosphere over 7 h. The reaction mixture was stirred at rt overnight. After that, 
the precipitates were filtered and the solvent was removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
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Rf 0.56 (ethyl acetate/petroleum ether = 3:1); yellow oil 0.10 g, 60 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.47 (2H, d, J = 6.6 Hz, Ar), 7.43 (2H, d, J = 8.9 Hz, Ar), 
7.40 - 7.32 (3H, m, Ar), 6.71 (2H, d, J = 8.9 Hz, Ar), 5.03 (1H, dd, J = 16.3 and 3.5 Hz, 
PhCH), 3.67 (3H, s, CH3), 2.87 - 2.72 (2H, m, CH2), 1.29 (3H, t, J = 7.5 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 162.3 (C), 160.8 (C), 131.8 (C), 131.7 (C), 129.5 (CH), 
129.3 (CH), 128.9 (CH), 127.6 (CH), 117.3 (C, dd, J = 29.4 and 23.8 Hz), 115.4 (C, dd, J = 
295.1 and 6.3 Hz), 114.6 (CH), 79.4 (CH, dd, J = 27.1 and 24.7 Hz), 55.4 (CH3), 21.9 (CH2), 
14.9 (CH3). 
IR max (cm
-1
) 2983, 2950, 1606, 1511, 1256, 1222, 1172, 1087, 1027, 834, 703. 
MS (ESI)
+
 : m/z [M + H] 377.1. 
HRMS: [M] for C19H18F2N2O2S calculated 376.1057, found 376.1055. 
New compound. 
2.73. 5-Ethylthio-3-(p-methoxyphenyl)-1,2,4-oxadiazole 
 
5-Ethylthio-6,6-difluoro-2-(p-methoxyphenyl)-7-phenyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-
ene 289 (0.085 g; 0.23 mmol) was added to toluene (10 mL) and the reaction mixture was 
heated at reflux for 22 h with stirring. After this, the mixture was allowed to cool to rt and 
then solvents removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
Rf 0.45 (ethyl acetate/petroleum ether = 1:2); white solid 0.045 g, 83 % yield; mp 71 - 72 ºC 
lit., not reported. 
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1
H NMR (400 MHz, CDCl3) δ ppm 7.91 (2H, d, J = 8.8 Hz, Ar), 6.88 (2H, d, J = 8.8 Hz, Ar), 
3.77 (CH3), 3.23 (2H, q, J = 7.3 Hz, CH2), 1.43 (3H, t, J = 7.3 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 178.2 (C), 168.8 (C), 162.5 (C), 129.6 (CH), 119.6 (C), 
114.8 (CH), 55.9 (CH3), 27.8 (CH2), 15.4 (CH3). 
IR max (cm
-1
) 2966, 2935, 1612, 1509,1424, 1342, 1305, 1250, 1182, 1022, 879, 839, 779, 
749, 710, 635, 628. 
Consistent with the previously reported data.
106 
3.74. Pyrrolidine-2-thione 
 
To a stirred solution of 2-pyrrolidinone (0.90 mL; 16.40 mmol) in dry tetrahydrofuran (15 
mL), was added Lawesson’s reagent (2.43 g; 5.98 mmol) at rt under an inert N2 atmosphere. 
The reaction mixture was heated at reflux for 2 h. After this time, the reaction mixture was 
allowed to cool to rt and the solvents were removed in vacuo. The crude product was purified 
by flash chromatography affording the title compound. 
Rf 0.23 (ethyl acetate/petroleum ether = 2:3); white solid 0.91 g, 76 % yield; mp 112 - 113 ºC 
lit.,
113
 112 - 115 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.74 (1H, s, NH), 3.63 (2H, t, J = 7.3 Hz, NCH2), 2.92 
(2H, t, J = 7.9 Hz, SCCH2), 2.18-2.11 (2H, m, CH2CH2CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 206.07 (C), 49.9 (CH2), 43.2 (CH2), 22.9 (CH2). 
As reported previously.
28b 
3.75. 2-Methylthio-1-pyrrolidine 
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Dimethyl sulfate (0.41 g; 4.33 mmol) was added in one portion to pyrrolidin-2-one 394 (0.40 
g; 3.94 mmol) and the reaction mixture was stirred at rt for 16 h under an inert N2 atmosphere. 
After this time, ether (10 mL) was added and the resulting mixture was washed with 10 % 
aqueous potassium carbonate (20 mL) and then extracted with dichloromethane (25 mL x 3). 
The organic layer was dried (MgSO4) and the solvents were removed in vacuo to leave 2 mL 
of liquid product as dark orange oil which was used crude in the next step. 
As reported previously.
28b 
3.76. 5-Methylthio-2,3-diphenyl-1-azabicyclo[3.3.0]oct-2-en-4-one 
 
To a stirred solution of 2-methylthio-1-pyrrolidine 291 (0.43 g; 3.75 mmol) in anhydrous 
acetonitrile (10 mL), was added diphenylcyclopropenone (0.77 g; 3.75 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was stirred at rt for 12 h and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography to afford the title 
compound. 
Rf 0.31 (ethyl acetate/petroleum ether = 1:5); orange yellow solid 0.54 g, 65 % yield; mp 114 
- 115 ºC lit., not reported. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.47 - 7.43 (3H, m, Ph), 7.39 - 7.35 (2H, m, Ph), 7.26 - 
7.18 (4H, m, Ph), 7.17 - 7.12 (1H, m, Ph), 3.56 - 3.52 (1H, m, NCH2), 3.36 - 3.30 (1H, m, 
NCH2), 2.28 - 2.20 (2H, m, SCCH2), 2.05 (3H, s, CH3), 1.89 - 1.79 (2H, m, CH2CH2CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 198.9 (C=O), 175.3 (C), 131.3(C), 131.2 (C), 131.0 
(CH), 129.6 (CH), 128.8 (CH), 128.7 (CH), 128.1 (CH), 126.2 (CH), 116.6 (C), 80.3 (C), 48.6 
(CH2), 32.3 (CH2), 26.6 (CH2), 11.7 (CH3). 
IR max (cm
-1
) 2955, 2888, 1657, 1651, 1599, 1547, 1538, 1402, 1302, 1279, 1047, 782, 794. 
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As reported previously.
28b 
3.77. Piperidone-2-thione 
 
To a stirred solution of 2-piperidone (1.00 g; 10.01 mmol) in dry tetrahydrofuran (15 mL), 
was added Lawesson’s reagent (2.03 g; 5.02 mmol) at rt under an inert N2 atmosphere. The 
reaction mixture was heated at reflux for 2 h. After this time, the reaction mixture was 
allowed to cool to rt and the solvents were removed in vacuo. The crude product was purified 
by flash chromatography affording the title compound. 
Rf 0.22 (ethyl acetate/petroleum ether = 2:3); white solid 0.91 g, 66 % yield; mp 92-93 ºC; 
lit.,
112f
: 92-93 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.56 (1H, s, NH), 3.31 (2H, td, J = 5.8 Hz and 2.7 Hz, 
NCH2), 2.84 (2H, t, J = 6.2 Hz, SCCH2), 1.66 - 1.79 (4H, m, CH2CH2CH2CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 203.1 (C=S), 44.9 (CH2), 39.1 (CH2), 20.8 (CH2) 20.2 
(CH2). 
IR max (cm
-1
) 3308, 2949, 1673, 1530, 1497, 1453, 1426, 1333, 1213, 1126, 1040, 973, 909, 
730, 695. 
As reported previously.
113 
3.78. 2-Methylthio-1-piperidine 
 
Dimethyl sulfate (0.34 g; 3.61 mmol) was added in one portion to piperidone-2-thione 395 
(0.40 g; 3.84 mmol) and the reaction mixture was stirred at rt for 16 h under an inert N2 
atmosphere. After this time, ether (10 mL) was added and the resulting mixture was washed 
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with 10 % aqueous potassium carbonate (20 mL) and then extracted with DCM (25 mL x 3). 
The organic layer was dried (MgSO4) and the solvents were removed in vacuo to leave 2 mL 
of liquid product as dark orange oil which was used crude in the next step. 
As reprted previously.
28b 
3.79. 5-Methylthio-2,3-diphenyl-1-azabicyclo[4.3.0]non-2-ene-4-one 
 
To a stirred solution of 2-methylthio-1-piperidine 293 (0.35 g; 2.70 mmol) in anhydrous 
acetonitrile (10 mL), was added diphenylcyclopropenone (0.56 g; 0.77 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was stirred ar rt for 12 h and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.31 (ethyl acetate/petroleum ether = 1:5); orange yellow solid 0.54 g, 65 % yield; mp 117-
118 ºC lit., not reported. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.44 - 7.39 (3H, m, Ph), 7.22 - 7.19 (2H, m, Ph), 7.07 - 
7.02 (4H, m, Ph), 6.99 - 6.95 (1H, m, Ph), 3.57 (1H, ddd, J = 13.4, 12 and 4.7 Hz, NCH2), 
3.43 (1H, td, J = 13.4 and 3.2 Hz, NCH2), 2.18 - 2.14 (1H, m, SCCH2), 1.92 (3H, s, CH3), 
1.89 – 1.80 (1H, m, SCCH2), 1.79 – 1.60 (2H, - 1.60 (2H, m, CH2) 1.33 - 1.20 - (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 198.7 (C=O), 170.5 (C), 131.6 (C), 130.4 (C), 130.3 
(CH), 129.1 (CH), 128.5 (CH), 128.2 (CH), 127.8 (CH), 125.2 (CH), 109.9 (C), 72.1 (C), 41.4 
(CH2), 32.6 (CH2), 27.4 (CH2), 20.4 (CH2), 10.5 (CH3).  
As reported previously.
28b 
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3.80. 2-Azabicyclo[2.2.1]hept-5-en-3-thione 
 
To a stirred solution of 2-azabicyclo[2.2.1]hept-5-en-2-one (0.50 g; 4.58 mmol) in dry 
tetrahydrofuran (10 mL), was added Lawesson’s reagent (0.93 g; 2.29 mmol) at rt under an 
inert N2 atmosphere. The mixture was stirred at rt for 0.5 h and then at reflux for 4 h. After 
this time, the reaction mixture was allowed to cool to rt and the solvents were removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.51 (ethyl acetate/petroleum ether = 1:2); white solid 0.33 g, 58 % yield; mp 102 - 103 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.17 (1H, s, NH), 6.81 (1H, td, J = 5.1 and 1.2 Hz, 
CH=CH), 6.72 (1H, dd, J = 5.1 and 1.6 Hz, CH=CH), 4.77 - 4.73 (1H, m, NCH), 3.95 - 4.73 
(1H, m, SCCH), 2.39 (1H, dt, J = 7.7 and 1.6 Hz CH2), 2.24 (1H, dd, J = 7.7 and 1.2 Hz, 
CH2).  
13
C NMR (100 MHz, CDCl3) δ ppm 211.8 (C=S), 139.3 (CH), 137.7 (CH), 65.6 (CH), 65.0 
(CH), 63.7 (CH2). 
 IR max (cm
-1
) 3319, 3029, 2928, 1661, 1528, 1494, 1337, 1218, 1124, 1044, 968. 
New compound. 
3.81. 3-Ethylthio-2-azabicyclo[2.2.1]hept-2,5-diene 
 
Triethyloxonium tetrafluoroborate (0.51 g; 2.71 mmol) was added in one portion to 1-
azabicyclo[2.2.1]hept-4-en-2-thione 296 (0.20 g; 1.60 mmol) in anhydrous dichloromethane 
(10 mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 1 hour. After this time, the reaction mixture was allowed to cool to rt and then 50 % 
 162 
 
aqueous solution of potassium carbonate (10 mL) added dropwise at - 78 ºC. The solution was 
then filtered through Celite
®
 and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried over 
(MgSO4) and then solvents removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.49 (ethyl acetate/petroleum ether = 1:2); yellow oil 0.15 g, 61 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 6.81 (1H, dd, J = 5.1 and 1.6 Hz, CH=CH), 6.67(1H, td, J 
= 5.1 and 1.2 Hz, CH=CH), 5.20 - 5.15 (1H, m, NCH), 3.80 - 3.76 (1H, m, SCCH), 3.07 - 
2.93 (2H, m, CH3CH2), 2.12 (1H, dt, J = 7.3 and 1.6 Hz, CH2), 1.93 – 1.88 (1H, m, CH2), 1.32 
(3H, t, J = 7.3 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 185.3 (C–S), 141.7 (CH), 137.6 (CH), 74.2 (CH), 68.6 
(CH), 58.7 (CH2), 25.1 (CH2), 14.1 (CH3). 
IR max (cm
-1
) 3021, 2931, 1680, 1578, 1372, 1240, 1029, 768, 688. 
MS : Could not obtain due to the decomposition of the tiltle compound at rt. 
New compound. 
3.82. 8a-(Ethylthio)-2,3-diphenyl-8,8a-dihydro-5,8-methanoindolizin-1-one 
 
To a stirred solution of 3-ethylthio-2-azabicyclo[2.2.1]hept-2,5-diene 297 (0.08 g; 0.52 mmol) 
in anhydrous acetonitrile (5 mL), was added diphenylcyclopropenone (0.11 g; 0.52 mmol) at 
rt under an inert N2 atmosphere. The reaction mixture was stirred at rt for 24 h and then 
solvents were removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
 163 
 
Rf 0.27 (ethyl acetate/petroleum ether = 1:5); orange yellow solid 0.12 g, 61 % yield; mp 109-
110 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.52 (2H, d, J = 7.2 Hz, Ar), 7.46 – 7.44 (2H, m, Ar), 
7.38 - 7.34 (3H, m, Ar), 7.31 - 7.15 (3H, m, Ar), 6.69 (1H, dd, J = 5.3 and 2.9 Hz, CH=CH), 
6.50 (1H, dd, J = 5.3 and 2.9 Hz, CH=CH), 4.01-3.94 (1H, m, NCH), 3.54 - 3.43 (1H, m, 
SCCH), 2.76 - 2.53 (2H, m, CH3CH2), 1.82 (1H, d, J = 9.4 Hz, CH2), 1.69 (1H, d, J = 9.4 Hz, 
CH2), 1.34 (3H, t, J = 7.3 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 201.0 (C=O), 175.3 (C), 140.6 (CH), 134.2 (CH), 131.6 
(C), 131.2 (CH), 129.4 (CH), 128.7 (CH), 128.6 (CH), 128.2 (CH), 127.1 (C), 126.9 (CH), 
126.3 (C), 79.8 (C), 66.7 (CH), 47.2 (CH), 44.1 (CH2), 22.9 (CH2), 14.1 (CH3). 
IR max (cm
-1
) 3027, 2931, 1736, 1681, 1579, 1431, 1373, 1238, 1043, 751, 723, 695. 
MS (ESI)
+
 : m/z [M + K] 398.1. 
HRMS: [M+Na] for C23H21NOSNa calculated 382.1230, found 382.1236. 
New compound. 
3.83. Benzyl 3-thioxopiperazine-1-carboxylate 
 
To a stirred solution of benzyl 3-oxopiperazine-1-carboxylate (0.50 g; 2.13 mmol) in dry 
tetrahydrofuran (10 mL), was added Lawesson’s reagent (0.43 g; 1.07 mmol) at rt under an 
inert N2 atmosphere. The mixture was stirred at rt for 0.5 h and then at reflux for 2.5 h. After 
this time, the reaction mixture was allowed to cool to rt and the solvents were removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
 164 
 
Rf 0.38 (ethyl acetate/petroleum ether = 1:2); white solid 0.27 g, 51 % yield; mp 131 - 132 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 9.01 (1H, br. s, NH), 7.32 - 7.24 (5H, m, Ph), 5.07 (2H, s, 
CH2), 4.53 (2H, s, CH2), 3.66 (2H, t, J = 5.2 Hz, CH2), 3.35-3.38 (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 199.8 (C=S), 154.2 (C=O), 135.8 (C), 128.6 (CH), 128.4 
(CH), 128.2 (CH), 67.9 (CH2), 53.2 (CH2), 43.7 (CH2), 38.9 (CH2). 
IR max (cm
-1
) 3334, 3168, 3085, 2968, 1698, 1569, 1453, 1405, 1339, 1322, 1286, 1232, 
1197, 1110, 763. 
MS (ESI)
+
 : m/z [M + H] 251.1. 
HRMS: [M] for C11H12N2OS calculated 250.0766, found 250.0772. 
New compound. 
3.84. Benzyl 6-methyl-3,5-dihydro-2H-pyrazine-4-carboxylate 
 
Trimethyloxonium tetrafluoroborate (0.14 g; 0.95 mmol) was added in one portion to benzyl 
3-thioxopiperazine-1-carboxylate 301 (0.14 g; 0.56 mmol) in anhydrous dichloromethane (5 
mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 4 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) was added dropwise at - 78 ºC. The solution 
was then filtered through Celite
® 
and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and the combined organic extracts were dried over 
(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
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Rf 0.35 (ethyl acetate/petroleum ether = 1:2); yellow oil 0.087 g, 60 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.27 – 7.12 (5H, m, Ph), 5.08 (2H, s, PhCH2), 4.01 (2H, 
s, SCCH2), 3.75 - 3.66 (2H, m, CH2), 3.41 (2H, t, J = 5.2 Hz, CH2), 2.25 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 163.4 (C), 154.7 (C=O), 136.3 (C), 128.5 (CH), 128.2 
(CH), 128.1 (CH), 67.5 (CH2), 53.5 (CH2), 49.7 (CH2), 46.6 (CH2), 11.8 (CH3). 
IR max (cm
-1
) 3034, 2962, 1664, 1529, 1436, 1328, 1228, 1026. 
MS (ESI)
+
 : Could not obtain due to the degradation of the title compound at rt. 
New compound. 
3.85. Benzyl 6-ethylsulfanyl-3,5-dihydro-2H-pyrazine-4-carboxylate 
 
Triethyloxonium tetrafluoroborate (0.26 g; 1.36 mmol) was added in one portion to benzyl 3-
thioxopiperazine-1-carboxylate 301 (0.20 g; 0.80 mmol) in anhydrous dichloromethane (5 
mL). The mixture was stirred at rt for 1 hour under an inert N2 atmosphere then heated at 
reflux for 4 h. After this time, the reaction mixture was allowed to cool to rt and then a 50 % 
aqueous solution of potassium carbonate (10 mL) added dropwise at -78 ºC. The solution was 
then filtered through Celite
®
 and the organic layer was separated. The water phase was 
washed with dichloromethane (10 mL x 2), and then the combined organic extracts were dried 
over (MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.36 (ethyl acetate/petroleum ether = 1:2); yellow oil 0.087 g, 62 % yield. 
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1
H NMR (400 MHz, CDCl3) δ ppm 7.29 – 7.12 (5H, m, Ar), 5.08 (2H, s, PhCH2), 3.97 (2H, 
s, SCCH2), 3.68 - 3.56 (2H, m, CH2), 3.42 (2H, t, J = 5.3 Hz, SCNCH2), 2.87 (2H, q, J = 7.4 
Hz, CH2),  1.20 (3H, t, J = 7.4, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 163.7 (C), 154.7 (C=O), 136.3 (C), 128.5 (CH), 128.2 
(CH), 128.1 (CH), 67.4 (CH2), 49.6 (CH2), 46.6 (CH2), 32.9 (CH2), 23.1 (CH2), 14.3 (CH3). 
IR max (cm
-1
) 3023, 2941, 1653, 1543, 1441, 1329, 1244, 968. 
MS (ESI)
+
 : Could not obtain due to the degradation of the title compound at rt. 
New compound. 
3.86. 1-Benzylpiperazin-2,5-dione 
 
To a stirred solution of N-azidoacetyl-N-benzylglycine ethyl ester (0.50 g; 1.91 mmol) in wet 
tetrahydrofuran (15 mL), was added triphenylphosphine (0.75 g; 2.86 mmol) at rt. The 
reaction mixture was left to stir for 45 min at the same temperature. After this, solvent was 
removed in vacuo and the crude product was purified by flash chromatography affording the 
title compound. 
Rf 0.22 (dichloromethane/methanol = 10:1); white solid 0.33 g, 82 % yield; mp 219 - 220 ºC 
lit.,
73
 208 - 210 ºC. 
1
H NMR (400 MHz, DMSO-d6) δ ppm 8.17 (1H, br. s, NH), 7.37 - 7.34 (2H, m, Ph), 7.31 - 
7.26 (3H, m, Ph), 4.51 (2H, s, CH2), 3.88 (2H, s, CH2), 3.78 (2H, s, CH2). 
13
C NMR (100 MHz, DMSO-d6) δ ppm 166.0 (C=O), 164.9 (C=O), 136.7 (C), 129.0 (CH), 
128.3 (CH), 127.9 (CH), 49.5 (CH2), 48.6 (CH2), 44.9 (CH2). 
IR max (cm
-1
) 3239, 1684, 1650, 1639, 1472, 1454, 1431, 1322, 1273, 1255, 1114, 1049, 937. 
Previously reported.
73
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3.87. 1-Benzyl-5-thioxopiperazin-2-one 
 
To a stirred solution of 1-benzylpiperazine-2,5-dione 308 (0.12 g; 0.61 mmol) in dry 
tetrahydrofuran (5 mL), was added Lawesson’s reagent (0.12 g; 0.31 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was heated at reflux for 2 h. After this time, the 
reaction mixture was allowed to cool to rt and the solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound. 
Rf 0.28 (ethyl acetate/petroleum ether = 1:3); white solid 0.05 g, 37 % yield; mp 230 - 231 ºC. 
1
H NMR (400 MHz, DMSO-d6) δ ppm 10.67 (1H, br. s, NH), 7.37 - 7.34 (2H, m, Ph), 7.31 - 
7.26 (3H, m, Ph), 4.54 (2H, s, CH2), 4.24 (2H, s, CH2), 3.97 (2H, s, CH2). 
13
C NMR (100 MHz, DMSO-d6) δ ppm 193.2 (C=S), 163.6 (C=O), 136.6 (C), 129.0 (CH), 
128.3 (CH), 127.9 (CH), 57.1 (CH2), 48.1 (CH2), 47.5 (CH2). 
IR max (cm
-1
) 3327, 3110, 2998, 1643, 1597, 1495, 1320, 1249, 1144, 1042, 940, 768, 695. 
MS (ESI)
+
 : m/z [M + H] 221.1. 
 HRMS: [M] for C11H12N2OS calculated 220.0670, found 220.0677. 
Previously unreported. 
3.88. 1-Benzylpiperazin-2,5-dithione 
 
To a stirred solution of 1-benzylpiperazine-2,5-dione 308 (0.12 g; 0.61 mmol) in dry 
tetrahydrofuran (5 mL), was added Lawesson’s reagent (0.12 g; 0.31 mmol) at rt under an 
inert N2 atmosphere. The reaction mixture was heated at reflux for 2 h. After this time, the 
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reaction mixture was allowed to cool to rt and the solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound 
Rf 0.59 (ethyl acetate/ petroleum ether; 1:3); light yellow solid 0.02 g, 15 % yield; mp 245 - 
246 ºC. 
1
H NMR (400 MHz, DMSO-d6) δ ppm 10.88 (1H, br. s, NH), 7.39 - 7.30 (5H, m, Ph), 5.22 
(2H, s, CH2), 4.44 (2H, s, CH2), 4.42 (2H, s, CH2). 
13
C NMR (100 MHz, DMSO-d6) δ ppm 196.8 (C=S), 195.5 (C=S), 139.9 (C), 133.9 (CH), 
133.0 (CH), 132.9 (CH), 64.8 (CH2), 60.8 (CH2), 59.8 (CH2). 
IR max (cm
-1
) 3214, 3089, 2899, 1598, 1532, 1313, 1188, 1144, 1074, 1025, 932, 752, 707, 
591. 
MS (ESI)
+
 : m/z [M + H] 237.1. 
HRMS: [M] for C11H12N2S2 calculated 236.0442, found 236.0453. 
Previously unreported. 
3.89. 5-Ethoxy-3,6-dihydro-1-benzyl-2(1H)-pyrazinone 
 
Triethyloxonium tetrafluoroborate (0.05 g; 0.26 mmol) was added in one portion 1-benzyl-
piperazine-2,5-dione 308 (0.03 g; 0.15 mmol) in anhydrous dichloromethane (5 mL). The 
mixture was stirred at rt for 1 h under an inert N2 atmosphere then heated at reflux for 1 h. 
After this time, the reaction mixture was allowed to cool to rt and then a 50 % aqueous 
solution of potassium carbonate (10 mL) added dropwise at - 78 ºC. The solution was then 
filtered through Celite
® 
and the organic layer was separated. The water phase was washed 
with dichloromethane (10 mL x 2), and then the combined organic extracts were dried over 
(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
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Rf 0.24 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.014 g, 40 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.29 - 7.23 (3H, m, Ph), 7.21 - 7.19 (2H, m, Ph), 4.54 
(2H, s, CH2), 4.14 (2H, s, CH2), 4.01 (2H, q, J = 7.1 Hz, CH2), 3.72 (2H, s, CH2), 1.16 (3H, t, 
J = 7.1 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 166.2 (C), 157.2 (C=O), 135.4 (C), 128.8 (CH), 128.4 
(CH), 127.9 (CH), 61.4 (CH2), 50.3 (CH2), 49.1 (CH2), 45.6 (CH2), 14.1 (CH3). 
IR max (cm
-1
) 2999, 1703, 1645, 1389, 1227, 943, 790, 730, 699. 
MS (ESI)
+
 : m/z [M + H] 233.1. 
HRMS: [M] for C13H16N2O2 calculated 232.1212, found 232.1206. 
Previously reported.
142 
3.90. 5-Ethylthio-3,6-dihydro-1-benzyl-2(1H)-pyrazinone 
 
Triethyloxonium tetrafluoroborate (0.04 g; 0.22 mmol) was added in one portion to 1-benzyl-
5-thioxopiperazin-2-one 309 (0.03 g; 0.13 mmol) in anhydrous dichloromethane (5 mL). The 
mixture was stirred at rt for 1 h under an inert N2 atmosphere then heated at reflux for 1 h. 
After this time, the reaction mixture was allowed to cool to rt and then a 50 % aqueous 
solution of potassium carbonate (10 mL) added dropwise at -78 ºC. The solution was then 
filtered through Celite
® 
and the organic layer was separated. The water phase was washed 
with dichloromethane (10 mL x 2), and then the combined organic extracts were dried over 
(MgSO4). The solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.66 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.035 g, 44 % yield. 
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1
H NMR (400 MHz, CDCl3) δ ppm 7.29 - 7.21 (3H, m, Ph), 7.20 - 7.17 (2H, m, Ph), 4.55 
(2H, s, CH2), 4.27 (2H, s, CH2), 3.77 (2H, s, CH2), 2.87 (2H, q, J = 7.3 Hz, CH2), 1.19 (3H, t, 
J = 7.3 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 166.1 (C=O), 161.0 (C-S), 135.4 (C), 128.9 (CH), 128.2 
(CH), 128.0 (CH), 54.2 (CH2), 50.1 (CH2), 49.0 (CH2), 23.7 (CH2), 14.2 (CH3). 
IR max (cm
-1
) 2979, 1650, 1494, 1453, 1263, 1111, 1068, 941, 736, 698. 
MS (ESI)
+
 : m/z [M + H] 249.1. 
HRMS: [M] for C13H16N2OS calculated 248.0983, found 248.0989. 
Previously unreported. 
3.91. Benzo[e][1,2,3]oxathiazine 2,2-dioxide 
 
To a stirred solution of salicylaldehyde (0.78 g; 0.68 mL; 6.39 mmol) in anhydrous N, N-
dimethylacetamide (12 mL), was added freshly prepared* sulfamoyl chloride (2.22 g; 19.2 
mmol) under an inert N2 atmosphere at rt. The reaction mixture was allowed to stir at rt for 16 
h. After this, the reaction mixture was quenched with buffer solution at pH 7 (3 g of NaH2PO4 
in 25 mL H2O /15 mL of 0.1 NaOH; 10 mL) and then aqueous solution was extracted with 
diethyl ether (20 mL x 2). The combined organic layers were washed successively with water 
(10 mL x 2) and brine (10 mL x 2). The combined organic extracts were dried (MgSO4) and 
then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.17 (ethyl acetate/hexane = 3:7); white solid 0.9 g, 75 % yield; mp 87-88 ºC lit.,
116c
 92 - 
94 ºC. 
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1
H NMR (400 MHz, CDCl3) δ ppm 8.94 (1H, s, NCH), 7.78 (1H, t, J = 8.0 Hz, Ar), 7.73 (1H, 
d, J = 7.6 Hz, Ar), 7.45 (1H, t, J = 7.6 Hz, Ar), 7.28 (1H, d, J = 8.1 Hz, Ar). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.1 (CH), 154.1 (C), 137.8 (CH), 131.1 (CH), 126.4 
(CH), 118.5 (CH), 115.3 (C). 
IR max (cm
-1
) 3031, 2926, 1600, 1560, 1373, 1201, 1177, 905, 819, 768, 755. 
* A solution of formic acid (1.28 g; 1.045 mL; 27.72 mmol) in anhydrous DCM (7 mL) was 
added dropwise to a solution of N-chlorosulfonyl isocyanate (3.93 g; 2.41 mL; 27.69 mmol) 
in anhydrous DCM (7 mL)  and allowed to heat for reflux for 15 min to yield sulfamoyl 
chloride (1.6 g, 50 %).
 
Consistent with the previously reported data.
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3.92. 3,4-Dihydroisoquinoline 
 
To a stirred solution of 1,2,3,4-tetrahydroisoquinoline (3.33 g; 3.12 mL; 25.01 mmol) in 
anhydrous dichloromethane (50 mL), was slowly added N-bromosuccinimide (5.01 g; 27.51 
mmol) at rt under an inert N2 atmosphere. The reaction mixture was stirred at rt for 0.5 h. An 
aqueous solution of 30 % sodium hydroxide (16.7 mL) was added to the reaction mixture. 
After this, the resulting reaction mixture was stirred at rt for 1 h, and then the mixture was 
washed with water (70 mL) and then 1 M HCl (70 mL). The acid extracts were basified with 1 
M sodium hydroxide until the pH of the solution reached a value greater than 9.0. The water 
phase was washed with dichloromethane (150 mL x 2) and then finally washed with brine 
(100 mL). The combined organic extracts were dried (MgSO4) and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
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Rf 0.41 (dichloromethane/methanol = 15:1); yellow oil 2.0 g, 61 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.32 (1H, s, NCH), 7.35 - 7.24 (3H, m, Ar), 7.14 (1H, d, 
J = 7.2 Hz, Ar), 3.76 (2H, td, J = 7.6 and 1.9 Hz, CH2), 2.73 (2H, t, J = 7.6 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 160.3 (CH), 136.3 (C), 131.1 (CH), 128.5 (C), 127.4 
(CH), 127.2 (CH), 127.1 (CH), 47.4 (CH2), 25.0 (CH2). 
Previously reported.
117 
3.93. 10b-Hydroxy-2,3-diphenyl-5,6-dihydropyrrolo[2,1-a]isoquinolin-1-one 
 
To a stirred solution of 3,4-dihydroisoquinoline 321 (0.03 g; 0.24 mmol) in CDCl3 (5 mL), 
was added diphenylcyclopropenone (0.05 g; 0.24 mmol) at rt under an air atmosphere. The 
reaction mixture was stirred at rt for 3 h and then solvents were removed in vacuo. The crude 
product was purified by flash chromatography affording the title compound. 
Rf 0.42 (ethyl acetate/hexane = 1:1); orange yellow solid 0.05 g, 59 % yield; mp 169 - 170 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.07 (1H, d, J = 7.7 Hz, Ar), 7.45 - 7.38 (3H, m, Ar), 
7.31 (2H, t, J = 7.5 Hz, Ar), 7.22 (2H, t, J = 7.5 Hz, Ar), 7.04 - 6.96 (4H, m, Ar), 6.91 (2H, 
dd, J = 7.7 and 1.4 Hz, Ar), 3.82 (1H, dd, J = 5.1 and 1.7 Hz, CH2), 3.78 (1H, dd, J = 5.1 and 
1.7 Hz, CH2), 3.54 (1H, td, J = 13.7 and 3.8 Hz, CH2), 2.63 - 2.47 (2H, m, CH2 & OH). 
13
C NMR (100 MHz, CDCl3) δ ppm 198.1 (C=O), 174.2 (C), 133.9 (C), 133.3 (C), 130.7 
(CH), 130.6 (C), 130.4 (C), 129.2 (CH), 128.8 (CH), 128.7 (CH), 128.6 (CH), 128.5 (CH), 
128.2 (CH), 127.9 (CH), 127.5 (CH), 125.9 (CH), 113.3 (C), 85.7 (C), 40.7 (CH2), 29.3 
(CH2). 
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 IR max (cm
-1
) 3256, 3019, 2921, 1657, 1601, 1542, 1427, 1350, 1121, 1074, 973, 791, 767, 
720, 527. 
MS (ESI)
+
 : m/z [M + H] 354.1. 
HRMS: [M] for C24H19NO2 calculated 353.1416, found 353.1420. 
Previously not reported. 
3.94. 10b-Hydroxy-2,3-bis(4-methoxyphenyl)-5,6-dihydropyrrolo[2,1-a]isoquiolin-1-one 
 
To a stirred solution of 3,4-dihydroisoquinoline 321 (0.03 g; 0.19 mmol) in CDCl3 (5 mL), 
was added 2,3-bis(4-methoxyphenyl)cycloprop-2-en-1-one 237 (0.05 g; 0.19 mmol) at rt 
under an air atmosphere. The reaction mixture was stirred at rt for 3 h and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.35 (ethyl acetate/petroleum ether = 1:5); yellow solid 0.04 g, 52 % yield; mp 86 - 87 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.05 (1H, d, J = 8.0 Hz, Ar), 7.30 - 7.16 (4H, m, Ar), 
6.99 (1H, d, J = 7.2 Hz, Ar), 6.89 - 6.79 (4H, m, Ar), 6.58 (2H, d, J = 8.7 Hz, Ar), 3.89 - 3.66 
(2H, m, CH2), 3.58 - 3.23 (1H, m, CH2), 3.78 (OCH3), 3.65 (OCH3), 2.59-2.43 (2H, m, CH2 & 
OH). 
13
C NMR (100 MHz, CDCl3) δ ppm 198.2 (C=O), 173.5 (C), 161.4 (C), 157.7 (C), 134.1 (C), 
133.5 (C), 130.1 (CH), 128.6 (CH), 128.4 (CH), 128.3 (CH), 128.2 (CH), 127.5 (CH), 123.3 
(C), 122.4 (C), 114.5 (CH), 113.4 (CH), 112.9 (C), 85.7 (C), 55.4 (OCH3), 55.1 (OCH3), 40.9 
(CH2), 28.1 (CH2). 
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IR max (cm
-1
) 3341, 1668, 1604, 1518, 1456, 1289, 1243, 1173, 1110, 1024, 832, 747, 581, 
531. 
MS (ESI)
+
 : m/z [M + H] 414.2. 
HRMS: [M] for C26H23NO4 calculated 413.1627, found 413.1627. 
Previously not reported. 
3.95. 6,7-Dimethoxy-3,4-dihydroisoquinoline 
 
To a stirred solution of hexamethylenetetramine (3.87 g; 27.61 mmol) and 2-
(dimethoxyphenyl) ethylamine (2.51 g; 2.33 mL; 13.81 mmol) in acetic acid (15 mL) was 
added trifluoroacetic acid (5.58 g; 3.75 mL; 48.94 mmol) dropwise under an inert N2 
atmosphere. The reaction mixture was heated at 90 ºC for 0.5 h with stirring. After this time, 
the reaction mixture was allowed to cool to rt. The reaction was quenched with water (15 mL) 
and then solid potassium carbonate was added gradually until the pH of the solution reached a 
value greater than 9.0. The water phase was washed with dichloromethane (20 mL x 2) and 
the combined organic extracts were dried (MgSO4) and then solvents were removed in vacuo. 
The crude product was purified by flash chromatography affording the title compound. 
Rf 0.36 (ethyl acetate/methanol = 5:1); yellow oil 2.5 g, 94 % yield; Rf = 0.36). 
1
H NMR (400 MHz, CDCl3) δ ppm 8.14 (1H, s, NCH), 6.72 (1H, s, Ar), 6.59 (1H, s, Ar), 
3.83 (3H, s, CH3), 3.81 (3H, s, CH3), 3.64 (2H, td, J = 7.8 and 1.9 Hz, CH2), 2.58 (2H, t, J = 
7.8 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 159.5 (CH), 151.1 (C), 147.7 (C), 129.7 (C), 121.4 (C), 
110.3 (CH), 110.2 (CH), 56.0 (CH3), 55.9 (CH3), 47.3 (CH2), 24.6 (CH2). 
Previously reported.
44 
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3.96. 8,9-Dimethoxy-10b-hydroxy-2,3-diphenyl-5,6-dihydropyrrolo[2,1-a]isoquinolin-1-
one 
 
To a stirred solution of 6,7-dimethoxy-3,4-dihydroisiquinoline 85 (0.09 g; 0.48 mmol) in 
CDCl3 (5 mL), was added diphenylcyclopropenone (0.10 g; 0.48 mmol) at rt under an air 
atmosphere. The reaction mixture was stirred at rt for 3 h and then solvents were removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.25 (ethyl acetate/hexane = 1:1); orange yellow solid 0.13 g, 65 % yield; mp 86 - 87 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.57 (1H, s, Ar), 7.48 - 7.22 (5H, m, Ar), 7.14 - 6.97 (3H, 
m, Ar), 6.92 (2H, d, J = 7.5 Hz, Ar), 6.47 (1H, s, Ar), 3.93 (3H, s, CH3), 3.79 (3H, s, CH3), 
3.75 - 3.49 (3H, m, OH and CH2), 2.57 - 2.49 (1H, m, CH2), 2.39 (1H, dd, J = 15.3 and 2.3 
Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 198.1 (C=O), 173.8 (C), 149.4 (C), 148.5 (C), 130.7 
(CH), 130.6 (C), 130.4 (C), 129.8 (CH), 129.1 (CH), 128.7 (CH), 127.9 (CH), 126.6 (C), 
125.9 (CH), 124.9 (C), 113.2 (C), 110.3 (CH), 110.2 (CH), 85.4 (C), 56.1 (CH3), 55.9 (CH3), 
40.7 (CH2), 28.9 (CH2). 
IR max (cm
-1
) 3361, 1842, 1615, 1513, 1444, 1338, 1258, 1224, 1106, 781, 760, 726, 684. 
MS (ESI)
+
 : m/z [M + H] 414.2. 
HRMS: [M] for C26H23NO4 calculated 413.1627, found 413.1617. 
New compound. 
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3.97. 8,9-Dimethoxy-10b-hydroxy-2,3-bis(4-methoxyphenyl)-5,6-dihydropyrrolo[2,1-
a]isoquinolin-1-one 
 
To a stirred solution of 6,7-dimethoxy-3,4-dihydroisoquinoline 85 (0.15 g; 0.78 mmol) in 
CDCl3 (5 mL), was added 2,3-bis(4-methoxyphenyl)cycloprop-2-en-1-one 237 (0.21 g; 0.78 
mmol) at rt under an air atmosphere. The reaction mixture was stirred at rt for 3 h and then 
solvents were removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
Rf 0.25 (ethyl acetate/hexane = 2:1); orange yellow solid 0.16 g, 69 % yield; mp 142-143 ºC. 
1
H NMR (400 MHz, DMSO-d6) δ ppm 7.51 (1H, s, Ar), 7.32 (2H, d, J = 8.5 Hz, Ar), 7.07 
(2H, d, J = 7.8 Hz, Ar), 6.85 (2H, d, J = 7.8 Hz, Ar), 6.68 (2H, d, J = 8.5 Hz, Ar), 6.67 (1H, s, 
Ar), 3.82 (3H, s, CH3), 3.80 (3H, s, CH3), 3.72 (3H, s, CH3), 3.66 (3H, s, CH3), 3.72 - 3.29 
(3H, m, OH and CH2), 2.72-2.43 (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 197.7 (C=O), 172.6 (C), 161.1 (CH), 157.4 (C), 149.1 
(C), 147.9 (C), 130.5 (C), 129.9 (CH), 127.2 (C), 126.6 (C), 124.4 (C), 122.9 (C), 115.1 (CH), 
113.6 (CH), 111.9 (CH), 111.3 (C), 111.2 (CH), 85.5 (C), 56.0 (OCH3), 55.9 (OCH3), 55.7 
(OCH3), 55.3 (OCH3), 40.9 (CH2), 28.7 (CH2). 
IR max (cm
-1
) 3318, 1644, 1604, 1517, 2492, 1337, 1248, 1172, 1113, 1014, 1001, 828, 725, 
583, 561, 540, 528. 
MS (ESI)
+
 : m/z [M + H] 274.2. 
HRMS: [M] for C28H27NO6 calculated 473.1838, found 473.1837. 
New compound. 
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3.98. 7-Nitro-3,4-dihydroisoquinoline 
 
To a stirred solution of potassium nitrate (0.71 g; 6.78 mmol) in sulfuric acid (4.6 mL), was 
added 3,4-dihydroisoquinoline in one portion at 0 ºC and the mixture was gradually warmed 
up to rt over 2 h. The reaction mixture was heated at 60 ºC for 4 h and then allowed to cool to 
rt. After this, the reaction mixture was basified with an aqueous solution of 3 M NaOH until 
the pH of the solution reached a value greater than 9.0. The water phase was washed with 
dichloromethane (20 mL x 3) and finally washed with brine (20 mL). The combined organic 
extracts were dried (MgSO4) and then solvents were removed in vacuo. The crude product 
was purified by flash chromatography affording the title compound. 
Rf 0.14 (ethyl acetate/hexane = 2:1); yellow oil 0.6 g, 76 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 8.36 (1H, s, NCH), 7.16 (1H, dd, J = 8.3 and 2.2 Hz, Ar), 
8.08 (1H, d, J = 2.2 Hz, Ar), 7.29 (1H, d, J = 8.3 Hz, Ar), 3.79 (2H, td, J = 7.6 and 2.1 Hz, 
NCH2), 2.80 (2H, t, J = 7.6 Hz, NCH2CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 158.2 (CH), 143.6 (C), 158.3 (C), 143.6 (C), 128.6 (CH), 
125.7 (CH), 121.8 (CH), 46.8 (CH2), 25.1 (CH2). 
Previously reported.
117 
3.99. Methyl 5-((2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoate 
 
To a stirred solution of of tryptamine (0.400 g, 2.51 mmol) in dichloromethane (5 mL), was 
added glutaric anhydride (0.254 g, 2.51 mmol) in CH2Cl2 (1.1 mL). The reaction mixture was 
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kept at rt with stirring. After 20 minutes, the solvent was removed under reduced pressure. 
The residue was dissolved in methanol (4.0 mL) and then thionyl chloride (0.2 mL, 2.8 mmol) 
was added dropwise. The reaction mixture was stirred for 3h at rt. The solvents were removed 
in vacuo and the crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.52 (ethyl acetate/petroleum ether/methanol = 2:1:0.1); white solid 0.59 g, 83 % yield;  
mp 121 - 122 ºC; lit.,
122 
: 102 - 103 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 9.76 (1H, br. s, NH), 7.56 (1H, d, J = 7.8 Hz, Ar), 7.33 
(1H, d, J = 8.1 Hz, Ar), 7.11 - 6.99 (3H, m, Ar), 3.64 (CH3), 3.49 (2H, dd, J = 13.1 and 7.0 
Hz, CH2), 2.94 (2H, t, J = 7.3 Hz, CH2), 2.29 (2H, t, J = 7.4 Hz, CH2), 2.19 (2H, t, J = 7.4 Hz, 
CH2), 1.86 (2H, qd, J = 7.4 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 173.8 (C=O), 173.7 (C=O), 136.7 (C), 127.4 (C), 122.0 
(CH), 120.9 (CH), 118.2 (CH), 117.9 (CH), 111.8 (C), 110.8 (CH), 50.6 (CH3), 40.1 (CH2), 
34.7 (CH2), 32.5 (CH2), 24.8 (CH2), 20.8 (CH2). 
IR max (cm
-1
) 3357, 3311, 1712, 1626, 1536, 1415, 1309, 1180, 728, 645.  
Previously reported.
122 
3.100. Methyl 4-(4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)butanoate 
 
To a stirred solution of of methyl 5-((2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoate 345 
(0.320 g, 1.11 mmol) in toluene (7 mL) and acetonitrile (3 mL), was added phosphorous 
oxychloride (0.3 mL, 3 mmol) dropwise under an inert N2 atmosphere. The reaction mixture 
was heated at reflux for 5 h. After this time, the mixture was cooled to rt and the solvent was 
removed under reduced pressure. The crude product was dissolved in dichloromethane (20 
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mL) and the resulting mixture was washed with 1 M aqueous sodium hydrogen carbonate (15 
mL). The organic layer was dried (MgSO4) and the solvents were removed in vacuo to give 
the title product. 
Rf 0.32 (ethyl acetate/petroleum ether/methanol = 1:1); yellow oil 0.29 g, 97 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 9.92 (NH), 7.48 (1H, d, J = 7.9 Hz, Ar), 7.36 (1H, d, J = 
8.2 Hz, Ar), 7.18 (1H, dd, J = 7.5 and 7.5 Hz, Ar), 7.03 (1H, dd, J = 7.5 and 7.5 Hz, Ar), 3.78 
(2H, t, J = 8.4 Hz, CH2), 3.64 (3H, s, CH3), 2.79 (2H, t, J = 8.4 Hz, CH2), 2.62 (2H, t, J =7.9 
Hz, CH2), 2.40 (2H, t, J = 6.4 Hz, CH2), 1.96 - 1.82 (1H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 175.4 (C=O), 161.4 (C), 137.2 (C), 128.3 (C), 125.3 (C), 
124.7 (CH), 120.2 (CH), 120.0 (CH), 117.1 (C), 112.4 (CH), 51.9 (CH3), 47.8 (CH2), 34.8 
(CH2), 32.8 (CH2), 22.1 (CH2), 19.3 (CH2). 
Previously reported.
122 
3.101. Methyl 4-(1-oxo-2,3-diphenyl-6,11-dihydro-1H-indolizino[8,7-b]indol-11b(5H)-
yl)butanoate 
 
To a stirred solution of methyl 4-(4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)butanoate 346 
(0.12 g; 0.44 mmol) in acetonitrile (5 mL), was added diphenylcyclopropenone (0.09 g; 0.44 
mmol) at rt under an inert N2 atmosphere. The reaction mixture was stirred at rt for 24 h and 
then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.78 (ethyl acetate/hexane = 1:1); orange yellow solid 0.169 g, 80 % yield; mp 180 - 181 
ºC. 
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1
H NMR (400 MHz, CDCl3) δ ppm 8.97 (NH), 7.55 - 7.44 (4H, m, Ar), 7.43 (1H, d, J = 7.8 
Hz, Ar), 7.41 (1H, d, J = 8.1 Hz, Ar), 7.21 (1H, t, J = 7.5 Hz, Ar), 7.15 - 7.05 (7H, m, Ar), 
4.11 (1H, dd, J = 13.9 and 5.6 Hz, CH2), 3.69 (3H, s, CH3), 3.63 - 3.55 (1H, m, CH2), 2.76 
(1H, dd, J = 15.4 and 4.1 Hz, CH2), 2.63 - 2.55 (1H, m, CH2), 2.52 - 2.32 (3H, m, CH2), 2.24 
(1H, ddd, J = 12.8 and 4.3 Hz, CH2), 1.92 - 1.81 (1H, m, CH2), 1.79 - 1.70 (1H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 197.9 (C=O), 175.4 (C=O), 173.6 (C), 136.7 (C), 131.7 
(C), 131.1 (C), 130.7 (C), 130.6 (CH), 130.4 (CH), 129.1 (CH) 128.4 (CH), 127.8 (CH), 126.4 
(C), 125.6 (CH), 122.3 (CH), 119.7 (CH), 118.3 (CH), 114.9 (C), 111.7 (CH), 106.9 (C), 69.9 
(C), 51.6 (CH3), 41.6 (CH2), 36.7 (CH2), 33.7 (CH2), 22.3 (CH2), 19.1 (CH2). 
IR max (cm
-1
) 3246, 1731, 1644, 1538, 1422, 1351, 1315, 1254, 1083, 988, 908, 769, 696. 
MS (ESI)
+
 : m/z [M + H] 477.2. 
HRMS: [M] for C31H28N2O3 calculated 476.2100, found 476.2089. 
Novel compound. 
3.102. Methyl 4-(2,3-bis(4-methoxyphenyl)-1-oxo-6,11-dihydro-1H-indolizino[8,7-
b]indol-11b(5H)-yl)butanoate 
 
To a stirred solution of methyl 4-(4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)butanoate 346 
(0.15 g; 0.55 mmol) in acetonitile (5 mL), was added 2,3-bis(4-methoxyphenyl)cycloprop-2-
en-1-one 237 (0.15 g; 0.55 mmol) at rt under an inert N2 atmosphere. The reaction mixture 
was stirred at rt for 24 h and then solvents were removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
Rf 0.72 (ethyl acetate/hexane = 1:1); orange yellow solid 0.22 g, 74 % yield; mp 188 - 189 ºC. 
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1
H NMR (400 MHz, CDCl3) δ ppm 9.11 (NH), 7.44 (1H, d, J = 7.8 Hz, Ar), 7.40 (1H, d, J = 
8.2 Hz, Ar), 7.34 – 7.16 (3H, m, Ar), 7.11 (1H, t, J = 7.4 Hz, Ar), 7.08 - 7.00 (4H, m, Ar), 
6.72 (2H, d, J = 8.8 Hz, Ar), 4.20 – 4.15 (1H, m, CH2), 3.90 (3H, s, CH3), 3.74 (3H, s, CH3), 
3.68 (3H, s, CH3), 3.60 – 3.53 (1H, m, CH2), 2.74 – 2.69 (1H, m, CH2), 2.60 – 2.30 (4H, m, 
CH2), 2.25 – 2.17 (1H, m, CH2), 1.90 – 1.68 (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 197.9 (C=O), 174.8 (C=O), 173.6 (C), 161.1 (C), 157.5 
(C), 136.6 (C), 131.9 (C), 130.6 (CH), 130.3 (C), 129.7 (CH), 126.4 (C), 123.8 (C), 122.6 (C), 
122.1 (CH), 119.5 (CH), 118.2 (CH), 114.5 (CH), 113.4 (CH), 111.6 (CH), 106.8 (C), 69.8 
(C), 55.3 (CH3), 55.1 (CH3), 51.6 (CH3), 41.7 (CH2), 36.6 (CH2), 33.7 (CH2), 22.2 (CH2), 
19.2 (CH2). 
IR max (cm
-1
) 3270, 2929, 2839, 1742, 1635, 1606, 1577, 1519, 1462, 1437, 1344, 1295, 
1243, 1171, 1023, 829, 759. 
MS (ESI)
+
 : m/z [M + H] 537.2. 
HRMS: [M] for C33H32N2O5 calculated 536.2311, found 536.2308. 
Novel compound. 
3.103. Methyl 4-((2-(1H-indol-3-yl)ethyl)amino)-4-oxobutanoate 
 
To a stirred solution of of tryptamine (0.400 g, 2.50 mmol) in dichloromethane (10 mL), was 
added succinic anhydride (0.25 g, 2.50 mmol). The reaction mixture was kept at rt with 
stirring. After 20 minutes, the solvent was removed under reduced pressure. The residue was 
dissolved in methanol (4.0 mL) and then thionyl chloride (0.2 mL, 2.8 mmol) was added 
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dropwise. The reaction mixture was stirred at rt for 3 h. The solvents were removed in vacuo 
and the crude product was purified by flash chromatography affording the title compound. 
Rf 0.56 (ethyl acetate/petroleum ether/methanol = 2:1:0.1); white solid 0.57 g, 83 % yield; mp 
115-116 ºC lit.,
122
 102-103 ºC. 
1
H NMR (400 MHz, DMSO-d6) δ ppm 10.82 (1H, s, NH), 8.01 (1H, s, NH), 7.52 (1H, d, J = 
7.6 Hz, Ar), 7.33 (1H, d, J = 7.8 Hz, Ar), 7.15 (1H, s, CH), 7.08 – 6.96 (2H, m, Ar), 3.58 (3H, 
s, CH3), 3.31 (2H, t, J = 6.4 Hz, CH2), 2.81 (2H, t, J = 7.33 Hz, CH2), 2.61 - 2.51 (2H, m, 
CH2), 2.36 (2H, t, J = 6.8 Hz, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 173.3 (C=O), 170.9 (C=O), 136.6 (C), 127.6 (C), 123.0 
(CH), 121.3 (CH), 118.6 (CH), 112.2 (C), 111.8 (CH), 51.7 (CH3), 40.0 (CH2), 30.3 (CH2), 
29.2 (CH2), 25.6 (CH2). 
IR max (cm
-1
) 3331, 2928, 2839, 1721, 1651, 1536, 1432, 1368, 1213, 1171, 988, 738, 670. 
Previously reported.
122 
3.104. Methyl 3-(4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)propanoate 
 
To a stirred solution of methyl 4-((2-(1H-indol-3-yl)ethyl)amino)-4-oxobutanoate 359 (0.15 
g, 0.55 mmol) in 1,2-dichloroethane (7 mL), was added phosphorus (V) oxychloride (0.3 mL, 
0.50 g, 3.23 mmol) dropwise at rt under an inert N2 atmosphere. The resulting solution was 
heated to reflux for 40 min. After that the reaction mixture was allowed to cool to rt and the 
solvents were removed under reduced pressure. The crude product was dissolved in 
dichloromethane (10 mL) and the resulting mixture was washed with 1 M aqueous sodium 
hydrogen carbonate (15 mL). The organic layer was dried (MgSO4) and the solvents were 
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removed in vacuo to give the title product as yellow solid (0.098 g, 70 %). The residue was 
used for next step without further purification. Previously reported.
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3.105. Methyl 3-(1-oxo-2,3-diphenyl-6,11-dihydro-1H-indolizino[8,7-b]indol-11b(5H)-
yl)propanoate 
 
To a stirred solution of methyl 3-(4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)propanoate 360 
(0.06 g; 0.24 mmol) in acetonitrile (5 mL), was added diphenycyclopropenone (0.05 g; 0.24 
mmol) at rt under an inert N2 atmosphere. The reaction mixture was stirred at rt for 24 h and 
then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.77 (ethyl acetate/hexane = 1:1); orange yellow solid 0.09 g, 81 % yield; mp 182 - 183 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 9.27 (NH), 7.57 - 7.53 (2H, m, Ar), 7.47 (2H, d, J = 7.8 
Hz, Ar), 7.43 (2H, d, J = 8.3 Hz, Ar), 7.24 – 7.10 (8H, m, Ar), 4.06 (1H, dd, J = 5.5 and 3.9 
Hz, CH2), 3.62 – 3.55 (1H, m, CH2), 3.75 (3H, s, CH3), 2.86 – 2.81 (1H, m, CH2), 2.75 (1H, 
dd, J = 15.5 and 4.0 Hz, CH2), 2.70 – 2.55 (3H, m, CH2), 2.53 – 2.43 (1H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 197.6 (C=O), 175.8 (C=O), 173.2 (C), 136.8 (C), 131.2 
(C), 130.9 (C), 130.7 (CH), 130.6 (C), 130.5 (CH), 129.1 (CH), 128.5 (CH), 127.8 (CH), 
126.3 (CH), 125.8 (CH), 122.4 (CH), 119.6 (CH), 118.2 (CH), 115.6 (C), 111.8 (C), 107.0 
(C), 69.6 (C), 51.8 (CH3), 41.6 (CH2), 31.8 (CH2), 28.7 (CH2), 22.3 (CH2). 
IR max (cm
-1
) 3269, 2928, 2839, 1744, 1639, 1601, 1536, 1469, 1428, 1351, 1171, 1060, 859, 
736, 694, 511. 
MS (ESI)
+
 : m/z [M + H] 463.2. 
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HRMS: [M] for C30H26N2O3 calculated 462.1943, found 462.1939. 
New compound. 
3.106. 2-Chloro-N-ethyl-N-phenylacetamide 
 
To a stirred solution of chloroacetyl chloride (1.05 g; 0.49 mL; 9.31 mmol) in dry 
dichloromethane (60 mL), were added N-ethylaniline (0.94 g; 0.97 mL; 7.74 mmol) and 
tetrabutylammonium hydrogen sulfate (0.31 g; 0.90 mmol) in dry dichloromethane (60 mL) at 
rt under an inert N2 atmosphere. A solution of potassium carbonate (1.61 g; 11.59 mmol) in 
water (30 mL) was added slowly in small portions. After this, the reaction mixture was stirred 
for 45 min at rt, and then the mixture was washed with 5 % aqueous HCl (40 mL x 2), 10 % 
aqueous NaOH (40 mL x 2) and brine (40 mL). The organic layers were dried (MgSO4) and 
then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.22 (ethyl acetate/petroleum ether = 1:4); colorless oil 1.7 g, 92 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.39 - 7.30 (3H, m, Ph), 7.14 (2H, d, J = 7.5 Hz, Ph), 
3.72 (2H, s, CH2), 3.67 (2H, q, J = 7.2 Hz, CH2), 1.04 (3H, t, J = 7.2 Hz, CH3).  
13
C NMR (100 MHz, CDCl3) δ ppm 165.5 (C=O), 140.8 (C), 129.9 (CH), 128.6 (CH), 128.1 
(CH), 44.8 (CH2), 42.1 (CH2), 12.7 (CH3). 
Consistent with the previously reported data.
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3.107. 2-Azido-N-ethyl-N-phenylacetamide 
 
To a stirred solution of 2-chloro-N-ethyl-N-phenylacetamide 362 (1.01 g; 5.07 mmol) in dry 
dimethylformamide (15 mL), was added sodium azide (0.82 g; 12.68 mmol) under an inert N2 
atmosphere at rt. The reaction mixture was heated at 90 ºC for 1 h. After this, the reaction 
mixture was allowed to cool to rt and the organic layer was extracted with dichloromethane 
(50 mL x 3). The combined organic extracts were dried (MgSO4) and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.41 (ethyl acetate/petroleum ether = 1:3); yellow oil 0.9 g, 93 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.40 - 7.28 (3H, m, Ph), 7.11 (2H, d, J = 7.5 Hz, Ph), 
3.71 (2H, q, J = 7.2 Hz, CH2), 3.48 (2H, s, CH2), 1.06 (3H, t, J = 7.2 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 166.7 (C=O), 140.3 (C), 130.0 (CH), 128.7 (CH), 128.1 
(CH), 50.8 (CH2), 44.4 (CH2), 12.8 (CH3). 
IR max (cm
-1
) 2976, 2942, 2099, 1663, 1595, 1494, 1404, 1254, 1133, 1090, 1074, 948, 889. 
MS (ESI)
+
 : Mass spectrometry did not give the required MS spectrum due to the degradation 
of the title compound. 
New compound. 
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3.108. (E)-N-(2-((2,3-diphenylcycloprop-1-en-1-yl)imino)-N-ethyl-N-phenylacetamide 
 
To a stirred solution of ethyl 2-azido-N-ethyl-N-phenylacetamide 363 (0.25 g; 1.31 mmol) in 
dry tetrahydrofuran (5 mL), was added triphenylphosphine (0.52 g; 0.97 mmol) at rt. The 
reaction mixture was left to stir for 45 min at rt. After this time, diphenylcyclopropenone 
(0.26 g; 1.28 mmol) in acetonitrile (2.5 mL) was added dropwise under an inert N2 
atmosphere at the same temperature. The reaction mixture was left overnight at rt and then the 
solvents were removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
Rf 0.51 (ethyl acetate/petroleum ether; 1:3); yellow oil 0.27 g, 57 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.56 (2H, d, J = 7.4 Hz, Ph), 7.48-7.41 (3H, m, CH and 
Ph), 7.39 - 7.32 (4H, m, Ph), 7.29 - 7.23 (4H, m, Ph), 7.01 - 6.95 (3H, m, Ph), 6.74 (1H, s, 
CH), 3.59 (2H, q, J = 7.2 Hz, CH2), 1.17 (3H, t, J = 7.2 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 155.4 (C=O), 152.2 (C), 144.9 (C), 139.5 (C), 136.9 (C), 
134.0 (CH), 129.8 (C), 129.2 (CH), 128.9 (CH), 128.5 (CH), 128.4 (CH), 128.3 (CH), 127.8 
(CH), 127.7 (CH), 121.5 (CH), 117.7 (CH), 113.7 (CH), 46.0 (CH2), 12.9 (CH3). 
 IR max (cm
-1
) 2987, 1731, 1586, 1495, 1445, 1258, 1091, 1070, 907, 750, 728, 690, 669. 
MS (ESI)
+
 : m/z [M + H] 367.2. 
 HRMS: [M] for C25H22N2O calculated 366.1732, found 366.1756.  
New Compound. 
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3.109. 2-(((2,3-Bis(4-methoxyphenyl)cycloprop-1-en-1-yl)oxy)amino)-N-ethyl-N-
phenylacetamide 
 
To a stirred solution of 2-azido-N-ethyl-N-phenyl-acetamide 363 (0.15 g; 0.79 mmol) in dry 
tetrahydrofuran (5 mL), was added triphenylphosphine (0.31 g; 1.18 mmol) at rt. The reaction 
mixture was left to stir for 45 min at rt. After this time, 2,3-bis(4-methoxyphenyl)cycloprop-
2-en-1-one 237 (0.21 g; 0.75 mmol) in acetonitrile (2.5 mL) was added dropwise under an 
inert N2 atmosphere at the same temperature. The reaction mixture was left overnight at rt and 
then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.29 (ethyl acetate/petroleum ether = 1:1); white solid 0.19 g, 56 % yield; mp 128-129 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.69 (1H, s, CH), 7.43 - 7.37 (3H, m, Ar), 7.17 (2H, d, J 
= 8.3 Hz, Ar), 7.13 (2H, d, J = 7.2 Hz, Ar), 6.97 (2H, d, J = 8.3 Hz, Ar), 6.93 (2H, d, J = 8.4 
Hz, Ar), 6.63 (2H, d, J = 8.4 Hz, Ar), 6.51 (1H, br. s, NH), 3.69 - 3.60 (4H, m, 2 x CH2), 3.64 
(3H, s, CH3), 3.66 (3H, s, CH3), 1.17 (3H, t, J = 7.2 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 167.7 (C=O), 167.4 (C), 159.7 (C), 159.6 (C), 140.0 (C), 
136.5 (CH), 132.0 (CH), 131.7 (C), 131.1 (CH), 130.1 (CH), 128.8 (CH), 128.3 (CH), 128.0 
(C), 127.7 (C), 115.1 (CH), 113.6 (CH), 55.2 (CH3), 55.1 (CH3), 44.3 (CH2), 42.8 (CH2), 12.9 
(CH3). 
IR max (cm
-1
) 3369, 3029, 2929, 1653, 1606, 1507, 1489, 1416, 1286, 1250, 1171, 1022, 832, 
767, 699, 555. 
MS (ESI)
+
 : m/z [M + H] 445.2. 
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HRMS: [M] for C27H28N2O4 calculated 444.2049, found 444.2047. 
Previously unreported. 
3.110. 1-(2-Chloroacetyl)pyrrolidin-2-one 
 
To a stirred solution of 2-pyrrolidinone (1.11 g; 0.99 mL; 12.93 mmol) in dry benzene (5 
mL), was added chloroacetyl chloride (1.75 g; 1.23 mL; 15.51 mmol) dropwise over 0.5 h at 0 
ºC under an inert N2 atmosphere and the reaction mixture was left to stir at the same 
temperature for 1 h. After completion of this time, the reaction mixture was allowed to warm 
to ambient temperature and then left for 24 h with stirring at the same temperature. The 
resulting reaction mixture was filtered free of pyrrolidone hydrochloride and solvents were 
removed in vacuo to obtain the desired compound as a colorless oil (1.4 g, 67 %). 
1
H NMR (400 MHz, CDCl3) δ ppm 5.25 (2H, s, CH2), 3.79 (2H, t, J = 7.2 Hz, CH2), 2.56 
(2H, t, J = 8.1 Hz, CH2), 2.12-2.01 (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 174.8 (C=O), 165.9 (C=O), 44.6 (CH2), 44.2 (CH2), 32.0 
(CH2), 16.5 (CH2). 
IR max (cm
-1
)  2986, 2947, 1720, 1643, 1412, 1372, 1273, 1225, 1186, 1153, 1091, 992, 922. 
Previously reported.
123 
3.111. 1-(2-Azidoacetyl)pyrrolidin-2-one 
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To a stirred solution of 1-(2-chloroacetyl)pyrrolidin-2-one 367 (0.91 g; 5.59 mmol) in dry 
dimethylformamide (10 mL), was added sodium azide (0.54 g; 8.38 mmol) under an inert N2 
atmosphere at rt. The reaction mixture was heated at 90 ºC for 1 h. After this, the reaction 
mixture was allowed to cool to rt and the organic layer was extracted with dichloromethane 
(25 mL x 3). The combined organic extracts were dried (MgSO4) and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.34 (ethyl acetate/petroleum ether = 1:3); colorless oil 0.7 g, 89 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 4.42 (2H, s, CH2), 3.82 (2H, t, J = 7.2 Hz, CH2), 2.58 
(2H, t, J = 8.1 Hz, CH2), 2.15-2.05 (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 175.9 (C=O), 168.7 (C=O), 53.8 (CH2), 45.1 (CH2), 32.9 
(CH2), 17.6 (CH2). 
IR max (cm
-1
)  2983, 2943, 2094, 1715, 1634, 1417, 1289, 1259, 1198, 1063, 993, 789, 683, 
495. 
Previously reported.
124 
3.112. 1-(2-((2,3-Diphenylcycloprop-1-en-1-yl)imino)acetyl)pyrrolidin-2-one 
 
To a stirred solution of 1-(2-azidoacetyl)pyrrolidin-2-one 368 (0.07 g; 0.49 mmol) in dry 
tetrahydrofuran (5 mL), was added triphenylphosphine (0.19 g; 0.74 mmol) at rt. The reaction 
mixture was left to stir for 45 min at rt. After this time, diphenylcyclopropenone (0.09 g; 0.46 
mmol) in acetonitrile (2.5 mL) was added dropwise under an inert N2 atmosphere at the same 
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temperature. The reaction mixture was left overnight at rt and then the solvents were removed 
in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.16 (ethyl acetate/petroleum ether = 1:2); white solid 0.1 g, 46 % yield; mp 154-155 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.48 (2H, dd, J = 8.1 and 1.5 Hz, Ph), 7.43 - 7.37 (3H, m, 
CH and Ph), 7.35 - 7.25 (4H, m, Ar), 7.20 - 7.18 (2H, m, Ph), 7.17 (1H, s, CH), 3.47 (2H, t, J 
= 7.2 Hz, CH2), 2.55 (2H, t, J = 8.2 Hz, CH2), 2.16 - 2.07 (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 172.3 (C=O), 153.6 (C=O), 144.9 (C), 139.1 (C), 136.8 
(C), 134.6 (CH), 129.0 (C), 128.9 (CH), 128.5 (CH), 128.4 (CH), 128.2 (CH), 127.9 (CH), 
127.8 (CH), 112.4 (CH), 46.3 (CH2), 31.0 (CH2), 18.5 (CH2). 
IR max (cm
-1
) 2980, 2359, 1711, 1587, 1487, 1458, 1407, 1226, 760, 726, 649. 
MS (ESI)
+
 : m/z [M + H] 331.1. 
HRMS: [M] for C21H18N2O2 requires 330.1368, found 330.1355. 
Previously unreported. 
3.113. 2-Chloro-1-(1-piperidin-1-yl)ethan-1-one 
 
To a stirred solution of chloroacetyl chloride (1.75 g; 1.23 mL; 15.51 mmol) in dry 
dichloromethane (100 mL), were added piperidine (1.11 g; 1.33 mL; 12.93 mmol) and 
tetrabutylammonium hydrogen sulfate (0.72 g; 4.59 mmol) in dry dichloromethane (100 mL) 
at rt under an inert N2 atmosphere. A solution of potassium carbonate (2.68 g; 19.39 mmol) in 
water (50 mL) was added slowly in small portions. After this, the reaction mixture was stirred 
for 45 min at rt, and then the mixture was washed with 5 % aqueous HCl (100 mL x 2), 10 % 
aqueous NaOH (100 mL x 2) and brine (100 mL). The organic layers were dried (MgSO4) and 
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then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.53 (ethyl acetate/petroleum ether = 1:1); colourless oil 1.7 g, 82 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 4.06 (2H, s, CH2), 3.47 (2H, t, J = 5.7 Hz, CH2), 3.37 
(2H, t, J = 5.7 Hz, CH2), 1.61 - 2.1.56 (4H, m, CH2), 1.50 - 1.46 (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 164.7 (C=O), 47.3 (CH2), 43.2 (CH2), 41.2 (CH2), 26.2 
(CH2), 25.3 (CH2), 24.2 (CH2). 
IR (neat) max 2936, 2856, 1637, 1443, 1277, 1249, 1222, 1132, 1119, 1022, 953, 852, 785, 
651, 563. 
Consistent with the previously reported data.
145 
3.114. 2-Azido-1-(1-piperidin-1-yl)ethan-1-one 
 
To a stirred solution of 2-chloro-1-(1-piperidin-1-yl)ethan-1-one 371 (0.85 g; 5.28 mmol) in 
dry dimethylformamide (10 mL), was added sodium azide (0.51 g; 7.92 mmol) under an inert 
N2 atmosphere at rt. The reaction mixture was heated at 90 ºC for 1 h. After this, the reaction 
mixture was allowed to cool to rt and the organic layer was extracted with dichloromethane 
(25 mL x 3). The combined organic extracts were dried (MgSO4) and then solvents were 
removed in vacuo. The crude product was purified by flash chromatography affording the title 
compound. 
Rf 0.51 (ethyl acetate/petroleum ether = 1:1); colourless oil 0.7 g, 85 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 3.76 (2H, s, CH2), 3.38 - 3.35 (2H, m, CH2), 3.14 - 3.11 
(2H, m, CH2), 1.48 - 1.45 (2H, m, CH2), 1.40 - 1.36 ((4H, m, 2 x CH2). 
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13
C NMR (100 MHz, CDCl3) δ ppm 165.2 (C=O), 50.4 (CH2), 45.8 (CH2), 42.9 (CH2), 26.1 
(CH2), 25.3 (CH2), 24.1 (CH2).  
IR max (cm
-1
) 2937, 2857, 2099, 1644, 1443, 1427, 1281, 1249, 1222, 1138, 1016, 953, 920, 
852, 787, 552. 
Consistent with the previously reported data.
145 
3.115. (E)-2-((2,3-dipheylcycloprop-1-en-1-yl)imino)-1-(piperidin-1-yl)ethan-1-one 
 
To a stirred solution of 2-azido-1-(1-piperidin-1-yl)ethan-1-one 372 (0.15 g; 0.97 mmol) in 
dry tetrahydrofuran (5 mL), was added triphenylphosphine (0.38 g; 1.45 mmol) at rt. The 
reaction mixture was left to stir for 45 min at rt. After this time, diphenylcyclopropenone 
(0.21 g; 0.97 mmol) in acetonitrile (2.5 mL) was added dropwise under an inert N2 
atmosphere at the same temperature. The reaction mixture was left overnight at rt and then the 
solvents were removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
Rf 0.51(ethyl acetate/petroleum ether = 1:1); yellow solid 0.2 g, 63 % yield; mp 137-138 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.50 (2H, dd, J = 8.1 and 1.5 Hz, Ph), 7.43 - 7.31 (5H, m, 
Ph), 7.28 - 7.20 (3H, m, Ph), 7.06 (1H, s, CH), 6.15 (1H, s, CH), 2.93 - 2.90 ((4H, m, 2 x 
CH2), 1.62 - 1.52 (6H, m, 3 x CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 157.6 (C=O), 152.6 (C), 139.9 (C), 137.2 (C), 132.7 
(CH), 129.6 (C), 129.0 (CH), 128.4 (CH), 128.2 (CH), 128.1 (CH), 128.0 (CH), 127.4 (CH), 
103.2 (CH), 48.8 (2 x CH2), 24.7 (2 x CH2), 23.9 (CH2). 
IR max (cm
-1
) 2939, 2359, 1644, 1594, 1444, 1250, 905, 725, 693, 645. 
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MS (ESI)
+
 : m/z [M + H] 331.2. 
HRMS: [M] for C22H22N2O calculated 330.1732, found 330.1736. 
Previously unreported. 
3.116. 2-(((2,3-Bis(4-methoxyphenyl)cycloprop-1-en-1-yl)oxy)amino-1-(piperidin-1-
yl)ethan-1-one 
 
To a stirred solution of 2-azido-1-(1-piperidin-1-yl)ethan-1-one 372 (0.15 g; 0.97 mmol) in 
dry tetrahydrofuran (5 mL) was added triphenylphosphine (0.31 g; 1.18 mmol) at rt. The 
reaction mixture was left to stir for 45 min at rt. After this time, 2,3-bis(4-
methoxyphenyl)cycloprop-2-en-1-one 239 (0.26 g; 0.97 mmol) in acetonitrile (2.5 mL) was 
added dropwise under an inert N2 atmosphere at the same temperature. The reaction mixture 
was left overnight at rt and then solvents were removed in vacuo. The crude product was 
purified by flash chromatography affording the title compound. 
Rf 0.31 (ethyl acetate/petroleum ether = 1:1); white solid 0.14 g, 36 % yield; mp 127-128 ºC. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.28 (2H, d, J = 8.7 Hz, Ar), 7.01 (2H, d, J = 8.7 Hz, Ar), 
6.74 (2H, d, J = 8.7 Hz, Ar), 6.83 (1H, s, CH), 6.81 (2H, d, J = 8.7 Hz, Ar), 6.04 (1H, s, NH), 
3.74 (3H, s, CH3), 3.72 (3H, s, CH3), 3.66 (2H, s, CH2), 2.87 - 2.84 (4H, m, 2 x CH2), 1.51-
1.46 (6H, m, 3 x CH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 159.4 (C=O), 158.9 (C), 157.5 (C), 153.1 (C), 132.8 (C), 
130.3 (CH), 129.8 (C), 129.1 (CH), 127.2 (C), 113.7 (CH), 113.5 (CH), 103.2 (CH), 55.4 
(CH3), 55.3 (CH3), 48.9 (2 x CH2), 29.7 (CH2), 24.7 (2 x CH2), 23.9 (CH2). 
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IR max (cm
-1
) 3321, 2934, 2359, 1644, 1604, 1512, 1463, 1247, 1176, 1033, 903, 723, 648, 
539. 
Previously unreported. 
3.117. N-Chloroacetyl-N-benzylglycine ethyl ester
 
 
To a stirred solution of chloroacetyl chloride (0.70 g; 0.49 mL) in dry dichloromethane (20 
mL), were added N-benzylglycine ethyl ester (1.00 g; 0.97 mL) and tetrabutyl ammonium 
hydrogen sulfate (0.20 g; 0.60 mmol) in dry dichloromethane (20 mL) at rt under an inert N2 
atmosphere. A solution of potassium carbonate (1.07 g; 7.74 mmol) in water (20 mL) was 
added slowly in small portions. After this, the reaction mixture was stirred for 45 min at rt, 
and then the mixture was washed with 5 % aqueous HCl (40 mL x 2), 10 % aqueous NaOH 
(40 mL x 2) and brine (40 mL). The organic layers were dried (MgSO4) and then solvents 
were removed in vacuo. The crude product was purified by flash chromatography affording 
the title compound. 
Rf 0.51 (ethyl acetate/petroleum ether = 1:4); yellow oil 1.20 g, 86 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.40 - 7.32 (2 x rotamers, 6H, m, Ph), 7.28 - 7.24 (2 x 
rotamers, 4H, d, J = 7.0 Hz, Ph), 4.70 (1 x rotamer, 2H, s, PhCH2), 4.67 (1 x  rotamer, 2H, s, 
PhCH2), 4.21 - 4.12 (2 x rotamers, 6H, s, CH2), 4.12 (1 x rotamer, 2H, s, CH2), 4.05 (1 x 
rotamer, 2H, s, CH2), 4.04 (1 x rotamer, 2H, s, CH2), 1.29 - 1.23 (2 x rotamers, 6H, m, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.7 (C=O), 168.6 (C=O), 167.4 (C=O), 167.2 (C=O), 
135.7 (C), 135.1 (C), 129.1 (CH), 128.7 (CH), 128.4 (CH), 128.2 (CH), 127.9 (CH), 127.0 
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(CH), 61.8 (CH2), 61.3 (CH2), 52.4 (CH2), 50.2 (CH2), 48.5 (CH2), 47.2 (CH2), 41.1 (CH2), 
41.0 (CH2), 14.1 (CH3), 14.0 (CH3). 
IR max (cm
-1
) 2981, 2943, 1739, 1657, 1450, 1374, 1194, 1023, 952, 749, 732, 698, 497. 
Previously reported in the literature.
73 
3.118. N-Azidoacetyl-N-benzylglycine ethyl ester
 
 
To a stirred solution of N-chloroacetyl-N-benzylglycine ethyl ester 397 (1.44 g; 5.34 mmol) in 
dry dimethylformamide (20 mL), was added sodium azide (0.87 g; 13.35 mmol) under an 
inert N2 atmosphere at rt. The reaction mixture was heated at 90 ºC for 1 h. After this, the 
reaction mixture was allowed to cool to rt and the organic layer was extracted with 
dichloromethane (50 mL x 3). The combined organic extracts were dried (MgSO4) and then 
solvents were removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
Rf 0.30 (ethyl acetate/petroleum ether = 1:1); yellow oil 1.0 g, 78 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.42 - 7.28 (2 x rotamers, 6H, m, Ph), 7.27 (1 x rotamer, 
2H, d, J = 8.0 Hz, Ph), 7.20 (1 x rotamer, 2H, d, J = 7.4 Hz, Ph), 4.68 (1 x rotamer, 2H, s, 
CH2), 4.57 (1 x rotamer, 2H, s, CH2), 4.23 - 4.14 (2 x rotamers, 4H, m, CH2), 4.11 (1 x 
rotamer, 2H, s, CH2), 4.04 (1 x rotamer, 2H, s, CH2), 3.95 (1 x rotamer, 2H, s, CH2), 3.88 (1 x 
rotamer, 2H, s, CH2), 1.29 - 1.23 (2 x rotamers, 6H, m, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.7 (C=O), 168.5 (C=O), 168.3 (C=O), 167.9 (C=O), 
135.7 (C), 135.0 (C), 129.2 (CH), 128.8 (CH), 128.7 (CH), 128.2 (CH), 128.0 (CH), 126.6 
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(CH), 61.9 (CH2), 61.4 (CH2), 51.6 (CH2), 50.7 (CH2), 50.4 (CH2), 50.3 (CH2), 47.9 (CH2), 
47.3 (CH2), 14.1 (CH3), 14.0 (CH3).  
Previously reported in the literature.
73 
3.119. Ethyl (E)-N-benzyl-N-(2-((2,3-diphenylcycloprop-1-en-1-yl)imino)acetyl)glycinate 
 
To a stirred solution of N-azidoacetyl-N-benzylglycine ethyl ester 398 (0.15 g; 0.58 mmol) in 
dry tetrahydrofuran (5 mL), was added triphenylphosphine (0.23 g; 0.84 mmol) at rt. The 
reaction mixture was left to stir for 45 min at rt. After this time, diphenylcyclopropenone 
(0.11 g; 0.52 mmol) in acetonitrile (2.5 mL) was added dropwise under an inert N2 
atmosphere at the same temperature. The reaction mixture was left overnight at rt and then the 
solvents were removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
Rf 0.31 (ethyl acetate/petroleum ether = 3:1); orange yellow oil 0.140 g, 56 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.56 – 7.53 (2H, m, Ph), 7.44 – 7.32 (8H, m, Ph), 7.28 – 
7.24 (5H, m, Ph), 7.25 (1H, d, J = 6.8 Hz, Ph), 7.09 (1H, s, CH), 6.18 (1H, s, CH), 4.33 (2H, 
s, PhCH2), 4.18 (2H, q, J = 7.2 Hz, CH2), 3.66 (2H, s, CH2), 1.28 (3H, t, J = 7.2 Hz, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 169.5 (C=O), 155.8 (C=O), 151.9 (C), 139.8 (C), 137.2 
(C), 136.1 (C), 132.8 (CH), 129.4 (C), 128.9 (CH), 128.7 (CH), 128.4 (CH), 128.3 (CH), 
128.2 (CH), 128.1 (CH), 128.0 (CH), 127.8 (CH), 127.5 (CH), 102.5 (CH), 61.1 (CH2), 54.1 
(CH2), 49.6 (CH2), 14.2 (CH3). 
IR max (cm
-1
) 2979, 1739, 1596, 1193, 1158, 754, 693. 
MS (ESI)
+
 : m/z [M + H] 439.2. 
HRMS:  [M] for C28H26N2O3 calculated 438.1943, found 438.1961. 
Previously unreported. 
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3.220. Ethyl N-benzyl-N-(2-((2,3-bis(4-methoxyphenyl)cycloprop-2-en-1-
ylidene)amino)acetyl)glycinate 
 
To a stirred solution of ethyl 2-((2-azidoethyl)(benzyl)amino)acetate 398 (0.15 g; 0.58 mmol) 
in dry tetrahydrofuran (5 mL), was added triphenylphosphine (0.23 g; 0.84 mmol) at rt. The 
reaction mixture was left to stir for 45 min at rt. After this time, 2,3-bis(4-
methoxyphenyl)cycloprop-2-en-1-one (0.14 g; 0.52 mmol) in acetonitrile (2.5 mL) was added 
dropwise under an inert N2 atmosphere at the same temperature. The reaction mixture was left 
overnight at rt and then solvents were removed in vacuo. The crude product was purified by 
flash chromatography affording the title compound. 
Rf 0.31 (ethyl acetate/petroleum ether = 1:5); orange yellow oil 0.14 g, 48 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.52 – 7.41 (2 x rotamers, 6H, m, Ar), 7.39 – 7.27 (2 x 
rotamers, 8H, m, Ar), 7.20 – 7.12 (2 x rotamers, 8H, m, Ar), 7.05 – 7.01 (2 x rotamers, 4H, m, 
Ar), 4.51 (1 x rotamer, 2H, s, CH2), 4.47 (1 x rotamer, 2H, s, CH2), 4.22 (1 x rotamer, 2H, s, 
CH2), 4.21 (1 x rotamer, 2H, s, CH2), 4.06 – 3.97 (2 x rotamers, 4H, m, CH2), 3.92 (1 x 
rotamer, 2H, s, CH2), 3.82 (1 x rotamer, 2H, s, CH2), 3.74 (1 x rotamer, 3H, s, OCH3), 3.73 (1 
x rotamer, 3H, s, OCH3), 3.61 (1 x rotamer, 3H, s, OCH3), 3.60 (1 x rotamer, 3H, s, OCH3), 
1.27 – 1.21 (2 x rotamers, 6H, m, 2 x CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 168.7 (C=O), 168.5 (C=O), 168.4 (C=O), 168.0 (C=O), 
167.2 (C), 167.1 (C), 159.5 (C). 159.4 (C), 159.3 (C), 159.2 (C),157.9 (C), 157.1 (C), 136.5 
(CH), 135.3 (C), 134.4 (C), 131.7 (CH), 131.6 (CH), 131.3 (CH), 131.1 (C), 131.0 (C), 130.7 
(CH), 129.6 (CH), 128.7 (CH), 128.3 (CH), 128.0 (CH), 127.7 (CH), 127.5 (C), 127.3 (C), 
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126.5 (CH), 114.8 (CH), 114.7 (CH), 113.2 (CH), 61.4 (CH2), 60.9 (CH2), 54.9 (OCH3), 54.8 
(OCH3), 54.7 (OCH3), 54.6 (OCH3), 50.6 (CH2), 49.5 (CH2), 46.6 (CH2), 46.4 (CH2), 41.6 
(CH2), 41.5 (CH2), 13.7 (CH3), 13.6 (CH3). 
IR max (cm
-1
) 3460, 2987, 1740, 1605, 1602, 1506, 1463, 1244, 1172, 1022, 831, 699. 
MS (ESI)
+
 : m/z [M + H] 517.2. 
HRMS: [M] for C30H32N2O6 calculated 516.2287, found 516.2279. 
Previously unreported. 
3.221. (E)-4-(p-Tolyl)but-3-en-2-one 
 
To a stirred solution of p-tolualdehyde (2.01 g; 1.96 mL; 12.93 mmol) in acetone (5 mL), was 
added 4 N sodium hydroxide (3.21 g; 20 mL H2O; 80.81 mmol) at rt and after that the 
reaction mixture was left to stir at the same temperature for 18 h. After completion of this 
time, the excess acetone was removed under reduced pressure and then 4 N HCl was added 
slowly until the pH of the solution reached a value 2.0 and finally the mixture was extracted 
with dichloromethane (100 mL x 3). The combined organic extracts were dried (MgSO4) and 
the solvents were removed in vacuo. The crude product was purified by flash chromatography 
affording the title compound. 
Rf 0.28 (ethyl acetate/petroleum ether = 1:6); yellow oil 1.5 g, 56 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.49 (1H, d, J = 16.2 Hz, CH=CH), 7.45 (2H, d, J = 8.0 
Hz, Ar), 7.21 (2H, d, J = 8.0 Hz, Ar), 6.68 (1H, d, J = 16.2 Hz, CH=CH), 2.39 (CH3), 2.38 
(CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 198.5 (C=O), 143.5 (CH), 141.0 (C), 131.6 (C), 129.7 
(CH), 128.3 (CH), 126.2 (CH), 27.4 (CH3), 21.5 (CH3). 
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IR max (cm
-1
) 2982, 2934, 1660, 1606, 1512, 1353, 1293, 1260, 1206, 1183, 986, 807, 538. 
Previously reported.
125 
3.222. (E)-1-Bromo-4-(p-tolyl)but-3-en-2-one 
 
To a stirred solution of (E)-4-(p-tolyl)but-3-en-2-one 376 (1.02 g; 6.25 mmol) in dry 
tetrahydrofuran (60 mL), was added slowly pyrrolidone hydrotribromide (3.71 g; 7.49 mmol) 
at rt over 1 h under an inert N2 atmosphere. The reaction mixture was left at rt to stir for 24 h. 
After this time, excess pyrrolidone hydrotribromide was removed by filtration and the filtrate 
was evaporated under reduced pressure. The resulting residue was dissolved in diethyl ether 
(20 mL) and then washed with brine (15 mL x 2). The organic layer was dried (MgSO4) and 
then solvents were removed in vacuo. The crude product was purified by flash 
chromatography affording the title compound. 
Rf 0.29 (ethyl acetate/petroleum ether = 2:1); yellow solid 0.9 g, 61 % yield; mp 94-95 ºC.  
1
H NMR (400 MHz, CDCl3) δ ppm 7.69 (1H, d, J = 16.1 Hz, CH=CH), 7.49 (2H, d, J = 7.8 
Hz, Ar), 7.23 (2H, d, J = 7.8 Hz, Ar), 6.91 (1H, d, J = 16.1 Hz, CH=CH), 4.10 (CH2), 2.40 
(CH3).  
13
C NMR (100 MHz, CDCl3) δ ppm 191.0 (C=O), 145.5 (CH), 141.8 (C), 131.2 (C), 129.8 
(CH), 128.7 (CH), 121.3 (CH), 33.2 (CH2), 21.6 (CH3). 
IR max (cm
-1
) 2983, 2933, 1685, 1667, 1564, 1511, 1386, 1326, 1182, 1153, 1063, 976, 891, 
860, 840, 710, 643, 517. 
Previously reported.
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3.223. (E)-1-Azido-4-(p-tolyl)but-3-en-2-one 
 
To a stirred solution of (E)-1-bromo-4-(p-tolyl)but-3-en-2-one 235 (0.51 g; 0.21 mmol) in dry 
dimethylformamide (2 mL), was added sodium azide (0.013 g; 0.21 mmol) under an inert N2 
atmosphere at rt. The reaction mixture was left at rt for 6 h. After completion of reaction, the 
organic layer was extracted with dichloromethane (10 mL x 3). The combined organic 
extracts were washed with brine (15 mL x 3) and then dried (MgSO4). The solvents were 
removed in vacuo to obtain the titled compound as a yellow solid (0.4 g, 95 %). 
1
H NMR (400 MHz, CDCl3) δ ppm 7.56 (1H, d, J = 16.1 Hz, CH=CH), 7.39 (2H, d, J = 8.0 
Hz, Ar), 7.14 (2H, d, J= 8.0 Hz, Ar), 6.68 (1H, d, J = 16.1 Hz, CH=CH), 4.11 (CH2), 2.31 
(CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 193.1 (C=O), 144.7 (CH), 141.9 (C), 131.1 (C), 129.8 
(CH), 128.6 (CH), 120.9 (CH), 56.6 (CH2), 21.6 (CH3). 
IR max (cm
-1
) 2989, 2942, 2097, 1692, 1613, 1599, 1566, 1347, 1285, 1270, 1179, 1084, 998, 
909, 799. 
MS (ESI)
+
 : Not obtained. 
Previously unreported. 
3.224. (E)-1-[(2,3-Diphenylcycloprop-2-en-1-yl)oxyamino]-4-(p-tolyl)but-3-en-2-one 
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To a stirred solution of (E)-1-azido-4-(p-tolyl)but-3-en-2-one 377 (0.040 g; 0.21 mmol) in dry 
tetrahydrofuran (4 mL), was added triphenylphosphine (0.08 g; 0.32 mmol) at rt. The reaction 
mixture was left to stir for 45 min at rt. After this time, diphenylcyclopropenone (0.04 g; 0.21 
mmol) in acetonitrile (2 mL) was added dropwise under an inert N2 atmosphere at the same 
temperature. The reaction mixture was left overnight at rt and then the solvents were removed 
in vacuo. The crude product was purified by flash chromatography affording the title 
compound as a yellow solid (0.04 g, 54 %). 
1
H NMR (400 MHz, CDCl3) δ ppm 7.80 (1H, s, Ar), 7.56 (1H, d, J = 16.1 Hz, CH=CH), 7.48 
- 7.36 (5H, m, CH & Ar), 7.26 - 7.23 (2H, m, Ar), 7.13 (2H, d, J = 7.9 Hz, Ar), 7.11-7.05 (3H, 
m, Ar), 6.97 - 6.94 (2H, m, Ar), 6.61 (1H, d, J = 16.1 Hz, CH=CH), 6.44 (1H, t, J = 4.5 Hz, 
NH), 4.41 (2H, d, J = 4.5 Hz, CH2), 2.31 (3H, s, CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 193.7 (C), 167.1(C), 144.4 (CH), 141.8 (C), 137.4 (CH), 
135.9 (C), 134.9 (C), 134.1 (C), 131.1 (C), 130.5 (CH), 129.9 (CH), 129.8 (CH), 129.7 (CH), 
128.7 (CH), 128.6 (CH), 128.6 (CH), 128.2 (CH), 121.9 (CH), 48.4 (CH2), 21.6 (CH3). 
IR max (cm
-1
) 3309, 2980, 1660, 1613, 1504, 1421, 1359, 1179, 1071, 692. 
MS (ESI)
+
 : m/z [M + H] 382.2. 
HRMS: [M] for C26H23NO2 calculated 381.1729, found 381.1728. 
Previously unreported. 
3.225. 3-O-[(E)-(2-Oxo-4-(p-tolyl)but-3-en-1-yl] kaempferol. 
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To a solution of kaempferol (0.025 g; 0.09 mmol) in dry 1,4-dioxane (4 mL), was added 
potassium carbonate (0.013; 0.09 mmol) and the mixture was heated at reflux under an N2 
atmosphere at 80 ºC for 1.5 h. After this time, a solution of (E)-1-bromo-4-(p-tolyl)but-3-en-
2-one 357 (0.04 g; 0.15 mmol) in 1,4-dioxane (2 mL) was added dropwise to the reaction 
mixture and the reaction mixture was heated at 80 ºC for 48 h. The solvents were removed in 
vacuo. The crude product was purified by flash chromatography affording the title compound. 
Rf 0.36 (dichloromethane/methanol = 10:1); yellow solid 0.013 g, 34 % yield. 
1
H NMR (400 MHz, CD3OD-d4) δ ppm 8.01 (2H, d, J = 8.7 Hz, Ar), 7.68 (1H, d, J = 16.1 
Hz, CH=CH), 7.55 (1H, s, OH), 7.53 (1H, s, OH), 7.51 (1H, s, OH), 7.47 (1H, d, J = 8.0 Hz, 
Ar), 7.25 (2H, d, J = 8.0 Hz. Ar), 6.97 (2H, d, J = 16.1 Hz, CH=CH), 6.88 (2H, d, J = 8.7 Hz, 
Ar), 6.39 (1H, d, J = 1.8 Hz, Ar), 6.18 (1H, d, J = 1.8 Hz, Ar), 5.10 (2H, s, CH2), 2.35 (3H, s, 
CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 195.6 (C), 178.0 (C), 164.5 (C), 161.7 (C), 160.4 (C), 
156.9 (C), 156.3 (C), 143.9 (CH), 141.3 (C), 136.5 (C), 131.6 (C), 130.4 (CH), 129.3 (CH), 
128.4 (CH), 121.1 (C), 120.5 (CH), 115.1 (CH), 104.4 (C), 98.4 (CH), 93.4 (CH), 75.2 (CH2), 
20.1 (CH3). 
MS (ESI)
+
 : m/z [M + H] 445.1. 
HRMS: [M] for C26H20O7 calculated 444.1209, found 444.1204. 
Previously reported.
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3.226. 2,3-Bis(4-methoxyphenyl)spiro[cyclopropane-1,9'-xanthen]-2-ene 
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Cesium fluoride (0.46 g, 3 mmol) was put in a round-bottom flask which was heated for 2 h at 
100 ºC and the round bottom flask was allowed to cool to rt under an inert N2 atmosphere. 
After that, 2,3-bis(p-methoxyphenyl)cycloprop-2-en-1-one (0.09 g, 0.33 mmol), 2-
trimethylsilyl)phenyl trifluoromethanesulfonate (0.25 g, 0.20 mL, 0.83 mmole) and 
acetonitrile (1.5 mL) were added in the round bottom flask under inert atmosphere which 
contained cesium fluoride and the resulting mixture was left to stir at rt for 24 h. Solvents 
were removed in vacuo and the crude product was purified by flash chromatography affording 
the title compound. 
Rf 0.39 (ethyl acetate/petroleum ether = 1:1); white solid 0.05 g, 38 % yield. 
1
H NMR (400 MHz, CDCl3) δ ppm 7.55 - 7.41 (4H, m, Ar), 7.04 - 6.96 (4H, m, Ar), 6.91 - 
6.73 (8H, m, Ar), 3.72 (CH3). 
13
C NMR (100 MHz, CDCl3) δ ppm 154.4 (C), 138.2 (C), 131.4 (CH), 127.0 (C), 120.8 (C), 
126.7 (CH), 124.8 (CH), 122.8 (CH), 115.8 (CH), 114.6 (CH), 55.3 (CH3), 27.2 (C). 
Consistent with previously reported data.
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